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How can I then return a model right,  
That am debarr’d the benefit to know?  
When viral rule is not eased by night,  
But day by night and night by day, in vivo? 
 
And the virus a foe to the host reign, 
Do in consent up-regulate macrophage inside, 
The host by toil, immune system complain, 
How far I toil, you still further do divide. 
 
So then the host is not lame, poor, nor despised, 
Whilst that CCL2 doth substance give, 
That virus in thy abundance am sufficed  
And by in host with all glory live 
 
But daily post infection in host for no longer, 
For cytokine doth make the immunity stronger. 





Infectious respiratory viral diseases can have potentially devastating impacts upon animal health, 
welfare and production traits and thus cause considerable economic losses to the industry. Developing 
effective control measures can be challenging due to the complexity of the underlying immune 
mechanisms involved and numerous potential influential factors in the course of an infection. In the 
age of “Big Data” we can harness the power of multiple repeated measurements from large in-vivo 
virus challenge experiments to exploit a rich wealth of information about the underlying processes of 
a biological system. The insights gained from a data-driven statistical modelling approach can be then 
used to develop and inform a wide range of hypothesis surrounding infection duration, variation, 
clearance rates and the related immune processes all of which can inform future studies and aid the 
development of new disease control measures. 
In this thesis we are primarily concerned with gaining insights into the within-host dynamics of a 
specific virus infection (PRRSV) using a data-driven statistical modelling approach. Porcine 
reproductive and respiratory syndrome (PRRS) is one of the most economically significant viral 
diseases facing the global swine industry. Sequential measures of the level of the virus within a host 
following infection, i.e. longitudinal viraemia profiles, reflect the severity and progression of infection 
within the host and provide crucial information for subsequent disease control measures.  
We analyse the largest longitudinal PRRS viraemia dataset from an in-vivo experiment, and 
corresponding immune measures in the form of cytokines and neutralising antibodies. We provide a 
suitable mathematical description of all viraemia profiles with biologically meaningful parameters for 
quantitative analysis of profile characteristics.  
In the experimental study of this thesis pigs were challenged with one of two PRRSV strains. In 
Chapter 2 we derive a statistical description of the temporal changes in viraemia and determine the 
influence of diverse factors on the viraemia profiles. The typical time trends of the viraemia profiles 
were a rise to a peak followed by a period of decline with dynamics and magnitude influenced by the 
virus strain. Both uni and bimodal viraemia profiles were observed.   
The Wood’s model, a mathematical function, appeared to be a suitable candidate model for the data 
associated with uni-modal profiles. Furthermore the Wood’s model captured the time trends concisely 
in only three model parameters which also had a biological relevance.  
The longitudinal viraemia measures revealed substantial differences in the viraemia profiles between 
hosts infected with the same PRRSV challenge dose. In Chapter 3 we provide a suitable mathematical 
description of all viraemia profiles with biologically meaningful parameters for quantitative analysis 
of profile characteristics. The Wood’s function and a biphasic extended Wood’s function were used to 
model the viraemia data. Three viraemic categories emerged: cleared (uni-modal and below detection 
within 42 days post infection(dpi)), persistent (transient experimental persistence over 42 dpi) and 
rebound (biphasic within 42 dpi).  
The  variation of outcomes observed following PRRSV infection are most likely a consequence of the 
complex set of interactions between the virus and the host’s immune response. In Chapter 3 and 4 we 
explored the association between the observed PRRS viraemia profile characteristics and the 
corresponding measures of the immune response in the form of: neutralising antibody (nAb) cross 
protection data (Chapter 3) and longitudinal cytokine profiles (Chapter 4).  Cytokines are a large 
group of proteins secreted by cells of the immune system that mediate many of the processes of these 
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cells. Numerous cytokines have been reported to influence responses of pigs to PRRSV infection. 
Cytokines don’t act in isolation and their responses are transient. In Chapter 4, we determined the 
typical features and time trends of each cytokine profile, examine the associations between the 
cytokines, and characterise the cytokine response. We characterised the responsiveness for each pig of 
across all seven cytokines in this study and examined the impact of various effects on the breadth of 
cytokine response. We then determined the associations between viraemia and the ensuing cytokine 
measures and the cytokines and the ensuing viraemia measures. We assessed whether the strength of 
the serum cytokine response was associated with the rate of the serum viraemia decline. 
In conclusion, this study provides novel insights into the nature and degree of variation of hosts’ 





Porcine reproductive and respiratory syndrome (PRRS) is one of the most economically significant 
viral diseases facing the global swine industry. Viraemia profiles of PRRS virus challenged pigs 
reflect the severity and progression of infection within the host and provide crucial information for 
subsequent control measures. In this thesis we analyse the largest longitudinal PRRS viraemia dataset 
from an in-vivo experiment, and corresponding immune measures in the form of cytokine data and 
neutralising antibodies. In the PRRS Host Genetic Consortium (PHGC) trials, pigs were challenged 
with one of two PRRSV isolates (NVSL and KS06, respectively). 
In Chapter 2 we derive a statistical description of the temporal changes in viraemia and determine the 
influence of diverse factors (e.g. PRRSV strain, pig genetic background, resistance genotype, etc.) on 
viraemia profiles. The well-established methodology of linear mixed modelling with a repeated 
measures model and fitting a linearized Wood’s function, a gamma-type function, is applied to the 
viraemia dataset. The virus isolate had a significant impact on the viraemia profiles which was 
captured by statistically significant differences in model parameters via both statistical methods. The 
more virulent NVSL isolate had higher early viraemia predictions and a faster rate of decline than 
KS06. In line with previous studies the WUR “resistance” genotype, associated with lower AUC 
viraemia found in previous studies, also resulted in lower viraemia predictions in the statistical 
models. The typical time trends of the viraemia profiles were a rise to a peak followed by a period of 
decline with dynamics and magnitude influenced by the virus isolate. Both uni and bimodal viraemia 
profiles were observed.   
The Wood’s model appeared a suitable candidate model for the data associated with uni-modal 
profiles and captured the time trends concisely in only three model parameters which also had a 




) was when there was a random 
effect in Wood’s parameters b and c. Bimodal profiles significantly reduced the model fit, particularly 
in the later phase of infection resulting in large model residuals. However bimodal profiles did not 
impact upon the significance of the differences between the LSM repeated measures estimates nor the 
LSM linearized Wood’s model parameter estimates. 
The longitudinal viraemia measures from the PRRSV challenge experiment revealed substantial 
differences in the viraemia profiles between hosts infected with the same PRRSV challenge dose, 
pointing to considerable variation in the host response to PRRSV infections. In Chapter 3 we provide 
a suitable mathematical description of all viraemia profiles with biologically meaningful parameters 
for quantitative analysis of profile characteristics. The Wood’s function and a biphasic extended 
Wood’s function were fit to the individual profiles using Bayesian inference with a likelihood 
framework in Chapter 3. Using maximum likelihood inference and numerous fit criteria, we 
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established that the broad spectrum of viraemia trends could be adequately represented by either uni- 
or biphasic Wood’s functions. Three viraemic categories emerged: cleared (uni-modal and below 
detection within 42 days post infection(dpi)), persistent (transient experimental persistence over 42 
dpi) and rebound (biphasic within 42 dpi). The convenient biological interpretation of the model 
parameters estimates, allowed us not only to quantify inter-host variation, but also to establish 
common viraemia curve characteristics and their predictability. The convenient biological 
interpretation of the model parameters estimates, allowed us not only to quantify inter-host variation, 
but also to establish common viraemia curve characteristics and their predictability, which were 
utilized in subsequent quantitative genetic analyses to identify genomic regions associated with these 
new resistance traits. The Bayesian approach for curve fitting in Chapter 3 led to better model fits 
than the classical linear mixed models approach of Chapter 2. 
Furthermore in Chapter 4 we explored the association between the observed PRRS viraemia profile 
characteristics and the corresponding measures of the immune response in the form of: neutralising 
antibody (nAb) cross protection data and longitudinal cytokine profiles.  Statistical analysis of the 
profile characteristics revealed that persistent profiles were distinguishable already within the first 21 
dpi, whereas it is not possible to predict the onset of viraemia rebound. Analysis of the neutralizing 
antibody (nAb) data indicated that there was a ubiquitous strong response to the homologous PRRSV 
challenge, but high variability in the range of cross-protection of the nAbs. Persistent pigs were found 
to have a significantly higher nAb cross-protectivity than pigs that either cleared viraemia or 
experienced rebound within 42 dpi. 
We determined the typical features and time trends of each cytokine profile, examined the 
associations between cytokines, and characterised the cytokine response. A stronger association was 
found in the direction of cytokines driving the ensuing viraemia characteristics as opposed to vice 
versa. It was found that viraemia class differences were best captured in the anti-viral cytokine IFNA 
and also the chemokine CCL2, furthermore these key cytokines were the most strongly associated 
with viraemia measures. The breadth of the cytokine responsiveness was associated with viral profile 
class and genetic background but not the WUR genotype.  
The statistical categorization of pigs from each PHGC trial through model fitting provides a critical 
basis for the generation of new desirable host phenotypes, and of potential use in the genetic selection 
of pigs with favourable infection traits. Our study provides novel insights into the nature and degree 
of variation of hosts’ responses to infection as well as new informative traits for subsequent genetic 




Chapter 1. Introduction 
Infectious respiratory viral diseases can have potentially devastating impacts upon animal health, 
welfare and production traits and thus cause considerable economic losses to the livestock industry. 
Developing effective control measures can be challenging due to the complexity of the underlying 
immune mechanisms involved and numerous potential influential factors during the course of an 
infection. Thanks to recent developments in bio-technology we can harness the power of multiple 
repeated measurements from large in vivo virus challenge experiments to exploit a wealth of 
information about the underlying processes affecting host response to infection. The insights gained 
from a data-driven statistical modelling approach can be then used to develop and inform a wide 
range of hypothesis surrounding infection duration, variation, clearance rates and the related immune 
processes all of which can inform future studies and aid the development of new disease control 
measures. 
In this thesis we are primarily concerned with gaining insights into the within-host dynamics of a 
specific virus infection using a data-driven statistical modelling approach. We begin with a review of 
the particular virus in question and the associated knowledge gaps addressed in this thesis, followed -
by an outline of the experimental protocol and data generated, and conclude with an outline of the 
statistical approaches adopted thus providing an outlook for the subsequent thesis Chapters.  
The main goal of this study is to gain a deeper insight into the within-host dynamics of a Porcine 
Reproductive and Respiratory Syndrome Virus (PRRSV) infection; knowledge that can be exploited 
to improve the current disease control mechanisms and aid the development of process based-
mathematical models and genetic analysis of the host response to infection for the development of 
genetic disease control strategies. 
1.0 Porcine Reproductive and Respiratory Syndrome prevalence and related 
economic losses  
Respiratory diseases in pigs are arguably currently the most important health concern for swine 
producers[1]. PRRSV is currently one of the most economically important infectious viral diseases in 
swine with a global spread[2]. It was first recognised in the United States of America in 1989 and in 
Japan in 1989, and by 1990 it had been isolated in Germany. PRRS reportedly costs U.S. swine 
producers more than $560 million annually [3-6]. There are two related but genetically 
distinguishable strains: Type 1, predominating in Europe and known also as the European strain, and 
Type 2, mostly found in North or South America and Asia, also known as the North American strain. 
The development of the virulent and highly pathogenic Type 2 PRRSV variants, spreading throughout 
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Asia highlight the need to advance effective interventions to prevent PRRSV pathology, mortality and 
production losses [7-9]. 
Infection with PRRSV results in viraemia and virus replication in multiple organs within the host; the 
targets for replication are macrophages in various tissues, primarily the lung but also in lymph nodes, 
spleen, placenta and umbilical cord [10-12]. PRRSV targets a subpopulation of macrophages, in the 
lung and other tissues, that have reached a state of differentiation rendering them permissive to the 
virus; causing cell apoptosis to infected cells and a large proportion of uninfected neighbouring 
macrophages [13]. The virus uses several evasion strategies to thwart the unsuspecting innate and 
acquired immunity, such as interference with antigen presentation, antibody-mediated enhancement, 
reduced cell surface expression of viral proteins and shielding of neutralizing epitopes [14]. The 
immune responses elicited during a PRRSV infection are reviewed in more detail below. 
PRRS reduces reproductive performance in breeding animals and increases respiratory problems in 
animals of all ages, leading to impaired growth in young piglets and, in some cases, mortality  
[3,15,16]. PRRSV infected sows have increased rates of abortions, stillbirths, mummifications, and 
give birth to weak piglets with chronic respiratory problems. It can take weeks, even months, for pigs 
to clear this RNA virus, which evolves and adapts quickly to new environmental challenges, vaccines 
or medication [17]. Within the swine production system, PRRSV infection predominantly exists as a 
subclinical infection, often as a co-factor in various polymicrobial disease syndromes [1]. PRRSV 
infected pigs are susceptible to secondary infections such as pneumonia and postweaning 
multisystemic wasting syndrome (PMWS) caused by infection with the Porcine Circovirus Type 2 
(PCV2) [5,18-20]. 
1.1 Mode of infection and the host response to infection 
This PhD project uses data from the nursery pig infection model of the PHGC trials to assess 
resistance or susceptibility of growing pigs to primary PRRSV infection. To date, 15 groups of ~200 
crossbred pigs from high health farms have been donated by commercial sources. After 
acclimatisation, the pigs were infected with one of two PRRSV isolates (NVSL or KS06) in a 
biosecure facility and followed for 42 days post infection (dpi). Blood samples were collected at 0, 4, 
7, 10, 14, 21, 28, 35 and 42 dpi for serum and whole blood RNA gene expression analyses; weekly 
weights were recorded for growth traits [21]. 
For each trial one company was requested to provide 200 pigs at weaning from PRRSV negative 
(PRRSV-), Mycoplasma hyopneumoniae-, and swine influenza virus- farms, and if possible from 
porcine circovirus type 2 (PCV2) free farms. Pigs could be from vaccinated sows since maternal 
antibody prevents them from becoming infected with PCV2. PRRSV affects growing pigs; the pigs in 
this experiment are post-weaning, hence the impact of maternal immunity has been removed as a 
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factor impacting upon the experimental results. The impact of PCV2 was not included in the 
modelling of this thesis since the pigs were from high health farms free from PCV2. 
The source populations were crossbred commercial pigs with complete parentage and pedigree 
records. The animal composition of the full dataset is outlined in Table 1.1. There was no pre-
selection of sires for disease traits. Pigs (~200/trial) were transported to the biosecure Kansas State 
University testing facility at weaning. After arrival pigs were treated with broad spectrum antibiotics 
for 1 week, to prevent expression of other organisms. After the 7 day acclimation period, pigs were 
challenged both intramuscularly and intranasally with PRRSV and followed for 42 days post infection 
(dpi). Infection in the PHGC trials of this thesis was in line with the protocols of other challenge 
studies, such as [22,23], in which both simultaneous intranasal and intramuscular PRRSV challenges 
were used at 0dpi. It is important to note that the mode of infection via intranasal or intramuscular 
routes adopted in a challenge study could potentially induce distinct responses in the host. The route 
of infection has been found to be reflected in observed differences in the levels of the virus in the 
plasma, ability to detect the virus, and the levels and consequently ability to detect virus neutralising 
antibodies in the plasma [24] [25,26], thus care needs to be taken when comparing the inferences 
made with other challenge studies in which only one of the mode of infection was adopted. In this 
study it is assumed that the observed response is due to the primary infection. However one cannot 
exclude the potential hypothesis that co-infection could occur between the pigs due to the shared pen 
structure. Pigs were weighed weekly for growth data. Pigs were killed at 42 dpi and tonsils collected 
for viral persistence and ears for genomic DNA. Across the trials infected with NVSL, 12% of pigs 
had died or were euthanized for humane reasons before 42 dpi. Mortality rate was similar in the KS06 
trials, with 9% pigs dying or euthanized before 42 dpi across the five trials. Dead pigs were 
necropsied and subsequent gross and microscopic pathology by a board-certified pathologist 
identified PRRS associated disease as the major source of mortality, except for trial 6. Death loss was 
high in trial 6 (46% by day 42), due to secondary bacterial infections, as identified by pathology, 
including Escherichia coli, Streptococcus suis, Staphylococcus aureus, and Mycoplasma 
hyopneumoniae. 
1.1.1 Viraemia data: Blood samples were collected immediately before infection (0 dpi) and at 4, 7, 
11, 14, 19/21, 28, 35, 40/42 dpi and the level of PRRS viraemia was measured using a semi-
quantitative TaqMan PCR assay for PRRSV RNA. The viraemia quantity data from RT-PCR was 
transformed on the logarithmic scale to the base 10. Due to the sensitivity of RT-PCR the threshold of 
detection was set at 1 units on the log10 scale [27]. 
1.1.2 Cytokine data: Longitudinal cytokine measures were also taken from serum. Cytokine data from 
serum collected at 0, 4, 7, 10, 14, 21, 28, 35, 42dpi was obtained for 228 randomly chosen individuals 
from the three PHGC trials 3, 5, and 7 (with cytokine data from 35, 77, and 117 pigs in each trial 
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respectively) using Fluorescent Microsphere Immunoassay (FMIA) outlined in [28] and [22]. The 
FMIA Luminex multiplex swine cytokine assay provided simultaneous quantitative measures of the 
concentration of four innate (IL-1b, IL-8, IFNA, IL-12), two regulatory (IL-10) and Th2 (IL-4) 
cytokines and a chemokine (CCL2) at each time point of the infection. There was no successful assay 
for IFN-gamma as the monoclonal antibody that made the assay is no longer available. Trial 7 had 
missing values at 42dpi and Trial 3 had no observations for IL-1b. The log10 transformation of the 
cytokine observations were used to normalise the data. The recent development of FMIA allows for 
the reliable and effective simultaneous quantification of multiple cytokines in porcine sera [28]. 
FMIA is a relatively new method of cytokine detection for PRRSV and has only been used in one 
previous study[22]. Serum measurements were used in this PRRSV challenge study as they allowed 
for multiple repeated measures and were less labour intensive due to the scale of the PRRSV 
challenge experiment conducted. The limitations of inference from serum data as opposed to 
measures taken at the cite of infection is included in the discussion Chapter of this thesis. 
1.1.3 Neutralising antibodies (nAbs) data: nAb data from serum collected at 42dpi was obtained for 
490 individuals from the first three PHGC infection trials using a virus neutralization assay as 
outlined in [29]. Serum neutralising assays were conducted to examine the presence of cytopathic 
effects on the homologous PRRSV strain as used in the in-vivo challenge experiment (NVSL-7985 
denoted henceforth as NVSL) and three additional PRRSV isolates: KS06-72109 (KS06), P-129 and 
VR-2332 (VR). These type 2 PRRSV isolates were chosen for genetic differences based on viral 
ORF5 sequence. Excluding the relatedness between P129 and NVSL (95%), nucleotide comparisons 
within ORF5 show that the PRRSV isolates differed from each other by 10% or greater. Each serum 
sample was reacted with the panel of four type 2 viral isolates, where the NVSL isolate served as the 
homologous virus in the serum neutralisation assays. Serum samples were considered positive for 
PRRSV nAb at a titre of eight or higher.  
1.1.4 Genotyping: Ear tissue was collected from all pigs for DNA isolation. Tissues or DNA samples 
for trials 1-10 were genotyped with Illumina’s Porcine SNP60 Beadchip v1 (San Diego, California) at 
GeneSeek Inc. (Lincoln, Nebraska) and samples from trials 11-15 were genotyped with Illumina’s 
Porcine SNP60 Beadchip v2 (San Diego, California) at Livestock Gentec Delta Genomics 
(Edmonton, Alberta). Only SNPs that were included on both versions of the Illumina’s Porcine 
SNP60 Beadchip were used in this study. SNPs were removed if they were fixed within a breed, or if 
they were unmapped or mapped to a sex chromosome in build 10.2 of the swine genome 
(http://www.ncbi.nlm.nih.gov/genome/guide/pig/, accessed August 13, 2015); this left 48,164 SNPs. 
Missing genotypes were assigned the average genotype (on 0,1,2 scale) for animals in that trial for 


















1 188 LW x LR 1 
2 190 LW x LR 1 
3 184 LW x LR 1 
4 191 Duroc x LW/LR 2 
5 182 Duroc x LR/LW 3 
6 109 LR x LR 4 
7 186 Pietran x LW/LR 5 
8 158 Duroc x LW/LR 6 
9 200 Yorkshires 10 
15 166 Pietran x LW 7 
Total 1554 - 1-7, 10 
KS-2006-72109 
(KS06) 
10 184 Pietran x LW 7 
11 177 LW x LR 1 
12 146 LR x LW 8 
13 173 Duroc x LW/LR 9 
14 165 Duroc x LR/LW 3 
Total 672 - 1,3,7,8,9 
Table 1.1 Animal composition across the PHGC trials. 
1
LW = Large White; LR = Landrace. 
2





1.2 Genetic variability in the host for PRRS 
Numerous PRRSV in-vivo and in-vitro studies point to breed differences in the response to infection; 
which suggest that there is a host genetic component in the host resistance to infection [16,21,27,30-
39]. 
1.2.1 Evidence for genetic variation in host resistance to PRRSV 
Evidence for the host genetic impact on PRRSV infection was found in early studies which observed 
that different pig breeds were associated with different numbers of lung lesions [36] and rates of 
abortions (in sows) [37]. Breed differences have since been found in serum viraemia and IL-8 
expression [40]. Reiner et al.[41] observed that Pietrain pigs infected with an attenuated PRRSV 
strain had longer viraemia lasting until 72 days post infection (dpi), and a less efficient antibody 
production than Miniature pigs whose viraemia only lasted up to 35dpi. Furthermore there appeared to 
be a minor heritable component to PRRSV resistance [42]. In vitro studies indicated that macrophage 
responses were related to breed [31,32] and reduced viral replication was observed for Landrace pigs 
compared to other breeds [38]. Most recently, genetic markers associated with host resistance have 
been identified for NVSL infected pigs of genetic backgrounds 1-3 as outlined further below. 
1.2.1 The PRRS Host Genetic Consortium (PHGC) PRRSV infection trials  
The work presented in this thesis is part of a wider project of the PRRS Host Genetic Consortium 
called “Application of Genomics to Improve Swine Health and Welfare” (funded by Genome 
Canada). Genetic selection of pigs that are less susceptible to PRRS is an attractive method to 
improve the swine herd health status. The overall goal of the PRRS Host Genetics Consortium 
(PHGC) is to exploit state-of-the art genomic technologies to breed healthier pigs with improved 
resistance to PRRSV infection. Previous studies have provided evidence for a host-genetic component 
in the effectiveness of responding to and clearing a PRRSV infection [15,31,32,36,43]. However, in 
order to harness genetic variation in host response to PRRSV infections for genetic disease control 
strategies, large datasets containing records of thousands of infected animals are required. 
Furthermore, deep phenotypes for a sufficiently large number of animals are required for identifying 
the genetic loci and pathways that are responsible for the genetic control of PRRSV infection 
responses [21]. The PHGC was created to produce the necessary data for genetic analysis of pigs’ 
responses to PRRSV infections. In the PHGC PRRSV challenge trials pigs were infected with one of 
two north American PRRSV isolates (NVSL or KS06). 
The main objectives for the PHGC are to:  
1) Use genotyping and phenotyping tools to determine if there are host genes that control 
resistance/susceptibility to PRRSV infection 
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2) Verify genetic variation in response to PRRSV, via improved health, survivability and 
growth. 
3) Identify relative importance of different phenotypic traits, and their heritability, that predict 
response to PRRSV infection. 
The data analysed in this thesis was obtained from the PRRS Host Genetic Consortium (PHGC) trials, 
which is the largest PRRSV in-vivo challenge study to date. The PHGC carried out various challenge 
studies including pregnant sows and growing piglets. In this thesis we consider data from the growing 
piglet PRRSV challenges only. 
1.2.3 Previous findings for the PHGC nursery pig PRRSV challenge data relevant for this thesis: 
The WUR ‘resistance’ genotype 
Previous studies using multiple contemporary North American crossbred weaned piglets 
experimentally infected with the NVSL-97-7895 (NVSL) isolate of PRRSV identified heritable 
genetic components to the area under the curve (AUC) of the viraemia profile, up to 21dpi, and 
weight gain, and found an association between the single nucleotide polymorphism (SNP) 
WUR10000125 (henceforth referred to as WUR) on chromosome 4 and these two host response 
traits[27,33,35,44,45]. Thus the WUR genotype used in this thesis refers to the presence or absence of 
the favourable B-allele strongly associated with cumulative viraemia (viraemia AUC 0-21dpi). The 
WUR SNP was found to act in a dominant manner irrespective of whether the favorable B allele is 
inherited  from the sire or dam [44].  
While the WUR genotype does appear to play a significant role in host response to PRRSV infection, 
there is a substantial polygenic portion to viraemia: the WUR genotype only explained 13% of the 
total genetic variance in the AUC of viraemia [33,45,46]. GBP5 is the relevant candidate gene in the 
region of the WUR SNP. GBP5 plays a role in the innate immune response during infection; 
interacting with the inflammasome NLRP3 which is a multi-protein complex that acts as a sensor for 
pathogen associated damage and is associated with the cleavage of some pro-inflammatory cytokines 
[47,48].  Animals that have the AA genotype do not produce functional GBP5 [49].  
The effect of the WUR genotype on piglet response to infection has only been validated on NVSL 
infected piglets. It is currently unknown whether the host genetics influencing response to PRRSV 
infection is consistent across all North American PRRSV isolates. Also, the WUR genotype is 
associated with infection data from the primary phase of infection (0-21dpi). It would be interesting to 
assess the impact, if any, it has on the full viraemia profiles (0-42dpi). Furthermore the impact on or 
association between the WUR genotype and the longitudinal cytokine expression profiles or the 
breadth of the neutralizing antibody (nAb) response has not yet been determined. Furthermore, 
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variation in host response has only been quantified in terms of cumulative viraemia (AUC 0-21dpi); it 
has not been fully specified how the viraemia profiles differ over time. 
1.3 The “persistent” nature of a PRRSV infection 
The etiologic agent, PRRSV, is an enveloped, positive-stranded RNA virus, which belongs to the 
order Nidovirales, of the family Arteriviridae (arteriviruses are reviewed in [50]). Arteriviruses 
possess several characteristic properties related to viral pathogenesis such as: cytopathic replication in 
macrophages, the capacity to establish a persistent infection, and the ability to cause severe disease 
[51]. 
One of the most significant challenges facing the eradication of the disease is the persistent nature of 
the PRRSV virus, which may persist within the host for several weeks or months, in some cases 
maintaining a sub-clinical lifetime persistence [51,52]. By definition, PRRSV is not a “persistent” 
virus, however given the average lifetime of a production pig being approximately 180 days, PRRSV 
infection can be regarded as “life-long” [39]. 
The causes for persistence are not fully understood, however it could be due to a combination of 
factors such as: the complex virion structure that possesses a heavily glycosylated surface, the focus 
of the humoral response on the non- surface proteins, antigenic and genetic drift, and the subversion 
of interferon gene induction [21,39,53,54]. If the persistently PRRSV infected individuals also remain 
infectious, they could potentially drive the epidemiological dynamics of the disease within the 
population through perpetuating the cycle of transmission to susceptible animals [55].  
During an infection PRRSV may avoid the host immune response, possibly escaping the humoral 
immune response by localizing to certain tissues. Previous research has identified that the tonsils are a 
primary source of viral persistence [56,57]. This may be due to an abundance of memory B-cells in 
the tonsil, but the lack of effector, plasma-producing, B-cells [58]. An abundance of PRRSV in tonsils 
may result in a cyclical reappearance of circulating virus in the serum. If the ability of the virus to 
localize to tissue to escape immune response differs between isolates, this will be reflected in the 
tonsil viraemia levels. Suppression of the innate system during a PRRSV infection could also be 
responsible for the persistent or prolonged viraemia profiles. It has been reported that PRRSV can 
suppress phagocyting activity, the expression of innate cytokines and alter their expression patterns 
[14,17].  
The host immune response mechanisms and genetics associated with variation in PRRS viraemia 
clearance have not been fully determined. The quantification of inter-host viraemia variation, the rate 
of viral clearance, and the statistical categorization of “persistently” infected pigs following challenge 
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would enable the possible host genetic contribution to “persistence” or inefficient clearance of 
PRRSV to be determined.  
1.4 PRRSV viraemia profiles and inter-host variation 
Viraemia profiles of in-vivo experimentally PRRSV challenged pigs are valuable indicators of the 
severity and progression of the infection in the host, and thus provide crucial information for the 
required subsequent disease control measures [59]. The course of a typical PRRSV infection is 
characterised by an acute viraemic stage lasting approximately 4 weeks followed by a stage 
characterised by low levels and eventual resolution of viraemia [2,39,60,61]. Previous studies suggest 
that in the majority of animals viraemia reaches undetectable levels typically by 4-6 weeks, although 
the virus may still be isolated months later in the lymphoid tissues [62,63].  
In a study in involving two different breed crosses, pigs were categorized into high or low disease 
burden [64]. Viraemia differences were observed between different pig lines; pointing to genetic 
variation in responses to infection. High viraemia was associated with a high immune response, and 
low viraemia was associated with low or no changes in immune gene expression compared to the 
uninfected controls [64]. 
PRRSV challenge experiments with longitudinal viraemia measures reveal substantial differences in 
the viraemia profiles between hosts infected with the same PRRSV challenge dose, pointing to 
considerable variation in the host response to PRRSV infections. For example, numerous studies have 
shown breed differences in viraemia levels and duration and also in antibody production 
[30,40,59,64]. Reiner et al.[41] observed that Pietrain pigs infected with an attenuated PRRSV strain 
had longer viraemia lasting until 72 days post infection (dpi), and a less efficient antibody production 
than Miniature pigs whose viraemia only lasted up to 35dpi. Viraemia was classified as persistent in 
Pietrain pigs, however the profiles revealed both uni- and biphasic curves which could be a 
manifestation of viraemia reactivation from the original infection within the host or reinfection 
between the pigs [65]. In a more recent PRRSV infection study persistently infected pigs were defined 
as having positive serum viraemia levels by 28dpi [66]. Furthermore persistence was associated with 
lower serum levels of the cytokine IL-8 [66]. 
Using longitudinal viraemia records from a subset of data used in this thesis, Boddicker et al. [27] 
reported substantial differences between individual viraemia profiles and cumulative viraemia 
(viraemia AUC 0-21dpi). Furthermore, based on visual inspection, they classified pigs into two 
categories, i.e. non-rebounders and rebounders, characterised by mono- and bi-phasic serum viral 
profiles, respectively. The underlying causes for this rebound phenomenon are currently not 
understood. It is not known whether rebound occurs across all PHGC trials, PRRSV isolates or 
genetic backgrounds. Furthermore it is not known whether the viraemia rebound trend is captured in 
12 
 
immune response measures such as the longitudinal cytokine expression, responsiveness in cytokines 
or the breadth of the nAb response. The statistical categorization of viraemia profiles pigs from a 
PRRSV infection could provide a critical basis for the selection of pigs with favourable infection 
traits. Rebound could be important from an epidemiological perspective since animals in the same pen 
could potentially transfer quasispecies between each other, whereby a quasispecies from one pig 
could be transferred to another pig and cause reinfection and viral rebound [67]. The underlying 
mechanisms behind the observed viral rebound have not yet been fully determined. The association 
between longitudinal viraemia variation and the longitudinal cytokine expression has not been 
explored in previous studies. Determining the key cytokines associated with specific viraemia trends, 
such as rebound or persistence, could provide insight into the underlying mechanisms behind the 
observed inter-host variation following infection. 
1.5 Genetic diversity of the PRRS virus 
One hallmark of the PRRS virus is its high genetic diversity due to its fast mutation rate, resulting in 
continuous emergence of new quasi-species that may evade the host’s immune system [68,69]. 
PRRSV has a high mutation rate estimated at 4.7-9.8 x10
-2
 nucleotides/year which was the highest 
reported for an RNA virus [70]. This high mutation rate causes within-animal variation in the PRRSV 
genome [67], with each variant termed a quasispecies. These rapid mutation rates and antigenic 
variability of the PRRS virus are partly responsible for the limited success in past efforts to contain 
PRRS and have encumbered efforts to produce vaccines that provide protection across different 
PRRSV isolates [71]. PRRSV evolves continuously in infected pigs, with different genes of the viral 
genome undergoing various degrees of change [55]. Although the mechanism(s) by which the virus 
persists in the host are not fully understood, the high degree of genetic and antigenic variability that 
characterizes PRRSV isolates are thought to play a fundamental role in viral persistence. Indeed, 
persistence in the host and viral diversity could be two manifestations of the same function [55]. 
1.5.1 The PRRS virus structure 
 The PRRS virion appears to be an oval-shaped particle as shown in Figure 1.1. The PRRSV genome 
RNA is approximately 15 kb in length and contains 11 known open reading frames (ORFs). The viral 
genome RNA is packed by nucleocapsid proteins. Surrounding the nucleocapsid are surface 
glycoproteins (GPs) and membrane proteins to form the virion particles. The structural proteins GP5, 
M and N are needed for both virion formation and infectivity, whilst the proteins GP2, GP3 and GP4 
are needed for infectivity [51]. The link between ORF 5 and GP5 has been explored in previous 
studies[72].[53,73]; ORF 5 is encoded by GP5[53].The structure and composition of the virion are 
reviewed in detail elsewhere [53,54], but for the sake of our study we are broadly concerned with the 
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structural proteins in relation to their implications in the host’s immune response against infection 
such as the antibody response in section 1.7c below. 
 
Figure 1.1 The PRRS virion: showing the structure of the small enveloped virus with a nucleocapsid 
core and the major and minor proteins.[74]  
1.5.2  PRRS virus strains 
The different PRRSV strains include: Type 1 also known as the European strain, Type 2 also known 
as the North American PRRSV strain, and a subset of Type 2 known as highly pathogenic PRRSV 
(HP PRRSV) found in Asia [2]. It was found that a Type 1 virus (Lelystad)  and Type 2 virus (VR-
2332) shared 55-70% nucleotide identity [75]. There is also evidence for differences in the immune 
responses following infection with different PRRSV strains [2,76-78]; since GP5, the major envelope 
protein typically involved in nAb induction and cross-protection is highly variable between Type 1 
and 2, with only 50-55% identity between the two genotypes [14]. Typically the Type 2 PRRSV 
infection results in a higher peak viraemia load, higher respiratory and reproductive virulence and a 
higher evolution rate [68,76,78-80]; with the HP PRRSV infections resulting in 20% mortality in pigs 
of all ages and leading to the severest respiratory pathology [7]. ORF 5 homology between European 
field strains and 2 vaccine strains is <64% with the North American live vaccine [81].  
The association between the longitudinal viraemia and longitudinal cytokine trends or nAb cross 
protection has not been determined for NVSL or KS06 infections, used in the PHGC challenge trials. 
The PRRSV virus type differences impact upon the viraemia and immune response measures 
following infection and thus the findings following the infection with one PRRS virus type may not 
be indicative of the findings following the infection with another PRRS virus type. The main focus of 
this thesis is in vivo infection with North American PRRSV isolates; the viraemia, cytokine and nAb 
trends found in this study are thus likely to be Type 2 specific trends.  
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1.5.3 North American PRRSV isolates 
In this thesis we analysed infection data from two distinct North American PRRSV isolates: NVSL-
97-7895 (NVSL) and KS-2006-72109 (KS06). Both are Type 2 strains, but NVSL is a highly virulent 
PRRSV isolate [82] , while the more contemporary KS06 isolate is less virulent. NVSL and KS06 are 
89% similar at the GP5 nucleotide sequence level [23]. PRRSV glycoprotein 5 (GP5) is a major 
envelope protein, that plays a vital role in the virion’s formation and infectivity, and harbors a major 
neutralizing epitope [83]. This gene is often used to assess genetic differences between PRRSV 
isolates and is suggestive of differences in virulence between isolates [84]. Variation in GP5 impacts 
the pig’s ability to produce neutralizing antibodies, which may not be protective against different 
isolates [84,85]. NVSL and KS06 were isolated from different geographic regions nearly ten years 
apart, and are 89% similar at the GP5 nucleotide sequence level. Molecular phylogeny clustered these 
viruses into two distinct branches [23].  
1.6 Immune responses to a PRRSV infection 
The  variation of outcomes observed following a PRRSV infection are a consequence of the complex 
set of interactions between the virus and the host’s immune response. Typically PRRSV elicits weak 
innate and adaptive immune responses, associated with immune modulation, but induces a strong 
immunosuppressive response, resulting in delayed onset of a Th1 immune response [80,86-88]. Below 
we briefly review the current understanding of the immune responses to a PRRSV infection relevant 
to this thesis (i.e. we focus on implications for viraemia, cytokines and neutralising antibodies 
(nAbs)). 
a) Innate Immune Responses 
The first line of defence in a viral infection is the innate immune response; comprising of physical 
barriers, chemical barriers and immune cells such as macrophages, dendritic cells and natural killer 
(NK) cells as well as cytokines. The latter are a large group of proteins, peptides or glycoproteins 
secreted by cells of the innate and adaptive immune systems that mediate many of the processes of 
these cells [89]. Their functions fall into three broad categories of (i) pro-inflammatory cytokines, 
which amplify the recruitment of innate cells to the site of infection, (ii) antiviral cytokines, which 
inhibit the infection of cells and the viral replication, and (iii) immune-regulatory cytokines, which 
orientate the adaptive response. Numerous cytokines have been reported to influence responses of 
pigs to PRRSV infection [22,66,87,90-94]. Cytokines don’t act in isolation and their responses are 
transient [95]. 
Infection with PRRSV results in a weak induction of the innate immune response; in vitro studies on 
pulmonary alveolar macrophages (PAMs) have shown that PRRSV infection results in the 
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downregulation of IFNA (interferon alpha), and TNF-A (tumour necrosis factor alpha) and increased 
production of IL-1; it can thus be hypothesied that these responses could be responsible for resulting 
in an influx of macrophages at the site of infection, if replicated in in vivo conditions, this 
hypothesised increase in the number of potentially susceptible cells in the infected tissues could thus 
be a driving factor in the dynamics of a PRRSV infection [18,92,96]. The low levels of TNF-A and 
IFNA contribute to the high permissiveness of the target cells and the high virus replication rate.  
The quantity of innate cytokines secreted in PRRSV-infected pigs is strain dependent, significantly 
lower compared to that associated with other viral infections, and leads to the delayed activation and 
dampened adaptive immunity [92]. PRRSV infection typically results in low levels of innate antiviral 
cytokines [2], however previous studies have established that the anti-viral cytokines IFNA, IFN-
gamma, and TNF-A play a key role in the clearance of PRRS viraemia [14,66,97,98]. There are 
conflicting reports on IFNA expression following PRRSV infection: the North American PRRS virus 
can inhibit type-1 interferon production [99], or lead to no significant increases in expression 
following PRRSV infection [28,90]. Conversely isolate dependent increases in IFNA expression have 
also been observed [22,100-102]. TNF-A response to PRRSV infection is variable, often weak, and 
also strain dependent [78,98]. Known cytokines with immune-regulatory roles in PRRSV infection 
include: IL-12, IFN-gamma, IL-6, IL-4, TGF-b (transforming growth factor beta), and IL-10 
[2,71,80,97,103]. Reduced NK (natural killer) cell cytotoxicity was associated with increased plasma 
concentrations of IL-4, IL-10 and IL-12 [101]. NK cell function regulation during PRRSV infections 
is coordinated by multiple cytokines: IFN-A/B, IL-12, and IL-15 [104]. Reduced NK cell activity was 
found in pigs with low levels of IFNA secretion [86,94,105].  
Secretion of serum IL-8, IL-1b and IFN-gamma have been found to be correlated to virus level 
accounting for ~84% of the observed variation [66]. IL-10 has an immune-modulatory role acting as a 
potent suppressor of macrophage functions [106] and the activator of antigen presenting cells through 
toll like receptors (TLRs) [107]. There are conflicting reports on whether PRRSV infection elicits an 
up-regulation of IL-10 expression [88,91,108,109] or no significant response [110,111]. Generally the 
role of IL-12 is typically that of activating NK cells and inducing CD4 T-cell differentiation in other 
species [106]. However both in vivo and in vitro treatment with IL-12 was capable of significantly 
reducing PRRSV titres in PAMs or in the lungs and blood [112]. IL-12 positive cells have been 
detected in the lung as early as 1 day post infection (dpi) with a peak at 5dpi, which suggests IL-12 




b) Adaptive Immune Responses 
The main aim of the adaptive immune response, cells and related processes is the pathogen specific 
elimination and prevention of pathogen growth. The adaptive immune response consists of pathogen 
specific clearance mechanisms comprised of highly specialised cells and systems that appear later 
than the innate immune response such as: the cellular response, the regulatory response and the 
antibody response (outlined below). The adaptive immune response is often considered the key 
system for the successful resolution of the infection in numerous infections and is triggered by a 
pathogen which successfully evades the innate immune response and hence appears at a later time 
than the innate response.  
In many species IL-4 is a cytokine of the adaptive immune response with the principle cellular 
sources from CD4+ T cells and mast cells, targeting B cells (causing isotype switching), T cells 
(causing differentiation and proliferation), and Mast cells (causing proliferation)[89]. However the 
role of IL-4 is species dependent and in swine IL-4 is not a stimulatory factor for porcine B cells, 
instead it blocks antibody and IL-6 secretion and suppresses the antigen-stimulated proliferation of B 
cells [114]. Following a PRRSV infection IL-4 is up-regulated and appears to have some immune-
modulatory consequences [101]. One study reports that swine IL-4 markedly enhanced the protective 
immune response of pigs and improved the efficacy of a modified live vaccine in preventing PRRS 
disease and resulted in a higher antibody titre, higher sera neutralizing efficacy, higher ratio of 
CD3⁺CD4⁺/CD3⁺CD8⁺ T lymphocytes, and lower virus loads in peripheral blood [115].  
Cellular response: IFN-gamma is a regulator of the adaptive immune response [92] and appears 2-4 
weeks post (PRRSV) infection. The cellular (i.e. T-cell reponse) to PRRSV is weak and delayed when 
contrased to the peak viraemia which typically occurs between 7-9 dpi. The transient T-cell response 
is: variable,  appears uncorrelated to the level of the virus, is detected between 4-12 weeks post 
infection, and remains detectable up to 3 months post infection [116]. T cells thus appear to play a 
secondary role in PRRS virus clearence [95]. Furthermore there was no correlation between tissue 
viral levels and the number of PRRSV-specific T-cells [116]. Long term persistence, discussed 
earlier, of the virus could be due to the ineffective cellular response against PRRSV. Conversely pigs 
were protected against PRRS viraemia by a live attenuated PRRSV vaccine which elicted a response 
with high titers of cytotoxic T cells[14]. The cellular response has the potential to be effective but 
may not be activated to the correct strength in hosts where the levels of viraemia remain high over 
time and are able to persist. However increasing the cytotoxic T cells may not significantly improve 
infection clearence and they remian difficult to observe both in vitro and in vivo [117]. Cytotoxic T 
cells and Th1 cells (T helper cells) are IFN-gamma (interferon gamma) producing cells. During a 
PRRSV infection the IFN-gamma levels are typically low whilst IL-10, which is produced by Th2 
cells (T helper cells) and Tregs (regulatory T cells), is typically high. This immunosuppressive 
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cytokine, IL-10, inhibits functions of the innate, adaptive and in particular the cellular adaptive 
response thus indicating that PRRSV is capable of shifting the immune response towards a less 
effective Th2-mediated immune response. However, this may not always be observed due to inter-
host variation in the synthesis of IFN-gamma. Furthermore the ability of PRRSV strains to induce 
protective immunity could also be dependent on their ability to induce a strong cellular immune 
response[71]. 
Regulatory response: PRRSV infection evades the host immunity through promotion of a strong 
immunosuppressive response, and a delayed onset of the Th1 immune response [80,86-88]. The N 
protein up-regulates the number of Foxp3+ T-regulatory cells (Tregs) and the IL-10 production [118]. 
Despite recent studies on the role of  the Tregs (regulatory T cells) there are still limited results on the 
role of the Tregs during a PRRSV infection. However, TGFβ-dependent induction of Tregs by 
PRRSV-infected dendritic cells has been observed and the infection of dendritic cells appears to be 
adequate to induce Tregs [119]. A study using an experimental infection of a North American PRRSV 
isolate induced Tregs from 28dpi, furthermore the Treg concentration and the viraemia were found to 
be positively correlated (for Type 2 infection) [120]. There appear to be strain differences between the 
North American and the European types in their ability to generate Tregs; the Tregs induced by the 
North American strain more strongly impair the host immune response than the European strain 
[119,121]. The exploitation of Tregs has been shown to be related to persistence in other arterivirus 
infections [122]. Tregs inhibit immune functions and could contribute to delayed viraemia clearance 
and thus the persistence of PRRSV in young pigs could be the result of an active regulatory response 
[71]. However the roles of Tregs, their ability to suppress antiviral immunity, and facilitate 
establishment of PRRSV or the effect of PRRSV infection on CD8+ T-cell frequencies has not yet 
been fully determined [2]. 
c) Antibodies 
Variation is the hallmark of a PRRSV infection in both the host and the virus; high levels of genetic 
and antigenic variability are typically observed between different PRRSV isolates [71]. Antibody 
responses can be categorized into a neutralizing antibody response, where the antibody directly 
inhibits the function of the virus in some way [123] and non-neutralizing antibody response, where 
the antibody binds to the virus in order to tag it for virolysis or viral clearance via phagocytosis [124]. 
Following infection, the earliest and strongest antibody response is a non-neutralizing (IgG) response 
against the virus nucleocapsid (N) protein [125]. Virus neutralizing antibodies are typically weak and 
delayed during PRRSV infection but once an antibody is produced that successfully neutralizes the 
virus, this response is effective [123]. 
Understanding the host’s ability to mount a non-neutralizing PRRSV-specific antibody response, such 
as PRRSV N-protein specific IgG, may afford a better understanding of host response to PRRSV 
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infection that is not specific to the isolate of PRRSV. One hypothesis is that the breadth and 
magnitude of the nAb (neutralizing antibody) response could have a host genetic component. Genetic 
improvement that enhances the response to vaccination creates the opportunity to bring the production 
pig closer to the vaccine that has remained so elusive for PRRS. Development of an effective PRRSV 
vaccine has been widely unsuccessful because they lack cross protection against different PRRSV 
strains [71]. Selecting pigs that are resistant to a broad selection of currently circulating PRRSV field 
isolates could be a successful disease control measure [126,127]; in order for this to be achieved the 
nAb cross-protection for pigs would need to be determined. The characterization of the breadth of the 
nAb response has not been conducted in previous studies.  
The majority of the antibody response during infection is primarily directed against viral proteins and 
is not associated with virus neutralization. Antibodies with PRRSV-neutralising activity usually 
appear from 14-28 days post infection (dpi), when the virus levels already appear to have declined 
[20],  and are correlated with the reduction of PRRSV in the lung and the peripheral blood [95]. There 
appear to be conflicting  reports on the significance of neutralizing antibodies in anti-PRRSV 
protection [128]. The causes for the delayed production of nAbs have not been fully determined, 
however current potential hypothesis include: 
1. Glycan shielding [84] 
2. Decoy epitopes in GP5 [129] 
3. Antibody dependent enhancement of viral entry into target cells [130] 
4. Suppression of the  innate immune response (reviewed below)[131] 
5. Modulation of B cell repertoire development [117].  
Virulent field isolates have been found to cause longer and more elevated viraemia profiles, and can 
induce a faster and more intense humoral response [132]. Antibody differences could be a reflection 
of the genetic differences between the PRRSV isolates. The anti-N protein antibodies appear within 
one week of infection [103] , and can remain uncorrelated with protection against the virus [128,133], 
whilst a strong antibody response is also made against nsp (non-structural protein) [134,135]. 
Following infection the antibody response against the major surface component, the GP5-M 
heterodimer, is weak and delayed with some animals even failing to make a detectable antibody 
response against GP5 [14,136]. However it is important to note that even without the development of 
neutralising antibodies (nAb) viraemia resolution can occur in a PRRSV infection [17,97,137], thus 
the importance of the humoral response in PRRS viral clearance remains unclear. Furthermore it is 
important to note that PRRSV infection is not fully immunosuppressive. When antibody dependent 
enhancement occurs in, for example, Dengue fever then a later reinfection with a different serotype 
leads to a highly severe disease [138]. The same phenomenon is not observed in the infections of 
North American PRRSV isolates. However, the delayed  production of virus neutralising antibodies 
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and long-term virus persistance indicates the relience on cell-mediated immunity to clear the virus 
[139,140]. 
Currently modified live vaccinations for PRRSV can provide protection against the homologous 
strain, however work needs to be continued to develop a vaccine that provides adequate cross 
protective immunity against a wide range of strains that would be observed in field conditions [141]. 
Intramuscular PRRSV vaccination with a modified live virus induces a virus specific T cell response 
in pigs, but work needs to be done to improve the strength cross-protective immunity against 
challenge strains. In a recent study the route of immunisation was found to be a contributing factor in 
the protective impact of a modified live vaccine during a PRRSV challenge with a heterologous 
PRRSV strain [24]. The study showed that intramuscularly vaccinated pigs had greater numbers of 
RNA copies  of the virus at 14 and 26 days post vaccination (dpv) than intranasally vaccinated pigs. 
At 26 dpv intramuscularly vaccinated pigs had increased levels of CD4 and CD8 T cells, and at 14 dpi 
increased levels of IFN-gamma
+
 total lymphocytes, NK, CD4, CD8 and γδ T cells. Intramuscularly 
vaccinated pigs also had detectable nAb titres against the vaccine and challenged virus which is 
indicative of immune competence and could potentially be utilised in future vaccine development.  
Microarray studies have the potential to obtain a deeper understanding of the molecular differences 
related to high or low immune competence and disease resistance for a PRRSV infection. In a recent 
study from the PHGC consortium the associations of gene expression with weight gain and viral load 
phenotypes were investigated. The effect of the single nucleotide polymorphism (SNP) marker 
WUR10000125 (WUR) on the porcine 60 K SNP chip on the expression in whole blood indicated that 
there are molecular differences in blood RNA patterns between pigs with high or low disease 
resistance (i.e. high or low viral load and weight gain) or with a different WUR genotype following 
PRRSV infection[142]. Furthermore it has been found that gene expression patterns are different 
between the WUR genotypes. The presence of the desirable allele (B allele) associated with the traits 
of weight gain and reduced cumulative viral load is associated with the presence of an intact as 
opposed to truncated GBP5 protein which enables the pigs to successfully inhibit viral entry and 
replication[143]. 
The majority of studies of the immune response to PRRSV do not use longitudinal data with several 
repeated measures. Furthermore it is not fully known how time trends in viraemia are captured in the 
time trends of cytokine expression following infection. The responsiveness in cytokines over the full 
time course of infections (0-42dpi), and the association between host genetics, the WUR genotype or 
viraemia trends has not been determined in previous studies. The key cytokines associated, and the 
timings of the strongest associations, with the viraemia measures and profiles have not been fully 
explored in previous studies; neither has the rate of viraemia decline and its’ relationship with the 
strength of cytokine response been fully determined. Finally the association between the variation in 
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the time trends of PRRSV viraemia profiles following infection and the breadth of the nAb cross-
protection is yet to be explored. 
1.7 Mathematical modelling of within-host virus infection dynamics 
Mathematical modelling is the representation of a system or process that allows for investigation of 
its’ properties and, in some cases, make predictions about future outcomes using the language of 
mathematics. The dynamics between a host’s immune system and the virus involve numerous factors 
and hence the principles governing the infection dynamics and outcome need more than just verbal or 
graphical reasoning. Mathematical models can be useful tools to represent and explore the within-host 
dynamics of infection. There are two distinct types of mathematical modelling approaches: process-
based mechanistic mathematical modelling or a data driven statistical modelling approach.  
Process based mathematical modelling is an alternative approach to exploring hypotheses surrounding 
the within host dynamics of viral infections. Systems of ODEs have been used to represent the various 
components of within host dynamics of virus infections such as HIV [144-149], influenza [150-152] 
and more recently PRRSV [153,154]. 
In this thesis, we adopt a statistical modelling approach to the data generated by the PHGC PRRSV 
infection trials in order to address knowledge gaps in terms of PRRSV viraemia and cytokine 
responses. The insights gained in our study could be used to inform, parameterise and validate future 
within-host PRRSV infection process-based dynamic mathematical models. A statistical modelling 
approach is a logical place to start when presented with experimental data such as the longitudinal 
measures from in-vivo PRRSV challenge experiments.  
1.7.1 Statistical modelling and inference approaches adopted in this thesis 
Statistical models establish relationships or patterns between measured quantities such as, for 
example, viraemia and cytokine responses over time.  Firstly statistical models can allow the filtering 
out of noise whilst retaining the relevant features of inherently noisy biological data. Using statistical 
modelling we can obtain estimates for the mean response and assess factors influencing the variation 
on the response. 
Secondly, the use of statistical inference allows the statistical relationships between different data to 
be determined. The main aim of the inference approach is to fit appropriate mathematical functions to 
data and to estimate the best function parameters. Mathematical functions with parameters that have a 
biological relevance are ideal candidates for statistical modelling and inference as the significant 
effects on the fitted model parameters can be related to the underlying biology of the system.   
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In this thesis we analyse both continuous data (viraemia and cytokine measures), and discrete data 
(nAb cross-protection and the breadth of the cytokine response). Longitudinal viraemia and cytokine 
measures are analysed and the time trends and associations between them are explored; whilst cross-
sectional data such as the viraemia profile classes and WUR genotypes is also included in the 
analysis. 
Statistical models are used to filter out biological noise from the data, to quantify the mean and the 
variation in response profiles and underlying factors responsible for the observed variation and to 
establish relationships between quantities over time. 
1.7.2 Linear and non-linear mixed models: Mixed models are a well-established statistical 
modelling methodology, that allows for the inclusion of both fixed and random effects that could 
potentially influence the response variables [155-160]. A mixed model can be linear or non-linear.  
Fixed effects occur in a model when the levels of an effect constitute the entire population[161]; in 
this thesis, for example, the virus strain,  WUR genotype, genetic background and trial are all 
potential fixed effects that could impact upon the viraemia. Significance of fixed effects in the model 
can be determined according to the F-test at the 95% significance level [161]. A random effect is 
modelled when conclusions are to be drawn about the population from which the observed units were 
taken, rather than about the particular units themselves [162]; in this thesis the effect of pig, or pen, 
were potential random effects in the model. The significance of random effects can be determined by 
the likelihood ratio test (LRT) at the 95% significance level. In summary, fixed effects have levels 
that are of primary interest and would be used again if the experiment were repeated, whilst random 
effects have levels that can be considered as a random selection from a much larger set of levels 
[163]. The standard linear mixed model is represented by the following equations: 
𝑌 = 𝑋𝑏𝑏 + 𝑍𝑢 + 𝜀 (1) 
𝑢~𝑁(0, 𝐺) 
𝜀~𝑁(0, 𝑅) 
Where: Y is the vector of the response variables (e.g. viraemia or cytokine), b is the vector of fixed 
effects, u is the vector of random effects, and ε is the vector of the residual effects. The matrices Xb, 
and Z are incidence matrices assigning individuals to their corresponding effects. G and R are the 
covariance matrices for the random effects and the random errors, respectively. It is generally 
assumed that the covariance between random effects and errors is zero.  
Mixed models can be applied to both, cross-sectional or longitudinal data with continuous or discrete 
predictors.  They allow for great flexibility in the covariance structures, e.g. by allowing for serial 
correlation  between consecutive observations along a longitudinal viraemia or cytokine profile[164]. 
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In this thesis, linear mixed models were used to analyse the viraemia and cytokine responses of the 
PRRSV infected pigs over time and in relation to each other.  
In this thesis, linear mixed models were implemented using PROC MIXED in SAS. The MIXED 
procedure estimates parameters by likelihood or moment- based techniques[161] . In this thesis the 
default fitting method was used i.e. maximizing the restricted likelihood of the data under the 
assumption that the data are normally distributed and any missing data are missing at random.  
The linear mixed modelling framework was adopted in Chapters 2 & 4 of this thesis. Whereas 
Chapter 2 implemented linear mixed models to identify influencing factors determining the PRRS 
viraemia profiles, in Chapter 4 mixed models were applied for multiple regression.  These were used 
to determine the statistically significant associations between viraemia measures and their preceding 
cytokine viraemia measures, i.e. using viraemia measures as the response variables and the preceding 
cytokine measures as the potential predictors, and vice versa.  
To perform multiple regression, additional covariates representing potential predictors were added to 
the null model (equation (1)) for testing the associations between viraemia and cytokine and vice 
versa: 
𝑌 = 𝑋𝑏𝑏 + 𝑋𝑐𝑐 + 𝑍𝑢 + 𝜀 (2) 
Where in addition to the terms defined in equation (1), c is the vector of fixed effects for the 
additional covariates, the matrix Xc is the incidence matrix assigning individuals to their 
corresponding additional fixed effects.  
Mixed models were also used to perform logistic regression to obtain odds ratios associated with 
discrete data in order to determine the association of nAb cross protection (broad or narrow) and 
cytokine responsiveness (high responsiveness or low) with viral profile class, WUR and genetic 
background. Logistic regression was implemented using PROC GLIMMIX in SAS 9.3, which allows 
for the inclusion of both fixed and random effects included in the model. For analysis of categorical 
data a generalized linear mixed model (GLMM) was applied with a logit link function: 
𝐸[𝑌|𝑢] = 𝑔−1(𝑋𝑏 + 𝑍𝑢)  (3) 
Where Y is the vector of the response variable, b is the vector of fixed effects, u is the vector of 
random effects and g
-1
 is the inverse logit link function.  







Unless stated otherwise, residual errors were assumed to be independently normally distributed. 
However, models that included repeated measurements serial correlations between consecutive 
measures were implemented in the residual error structure.  
Non-linear mixed models can also be implemented in SAS using PROC NLMIXED, however it was 
not used in this thesis due to a failure to converge with the inclusion of fixed effects when applied to 
the viraemia data. Mixed models can also be implemented in Bayesian framework however this 
approach was not adopted in this thesis.  
1.7.3 Repeated measures models 
The response variable in this PRRSV experiment was measured at different time points between 0-
42dpi thus a further modification to the linear mixed models framework described above was adopted 
for “repeated measures” modelling in Chapter 2 and 4. In this thesis repeated measure models are 
mixed models implemented using the mixed modelling framework in SAS in which time is included 
as a fixed effect and the serial correlation was represented by specifying a correlation structure in the 
residuals. 
1.7.4 Curve fitting 
For the analysis of the longitudinal viraemia and cytokine measures two types of curve fitting 
approaches were adopted: spline functions and established mathematical functions with few 
parameters with a related biological meaning.  
a) Spline functions: are defined as piecewise polynomial functions, of degree n, the pieces 
join at “knots” whose location and number can be specified in programs such as MATLAB[165]. 
Splines have the flexibility to capture disjointed time trends [165]. Splines are a useful and convenient 
statistical tool for expressing the relationship between measured traits due to their flexibility and 
ability to adjust well to the data [166]. For example in previous animal science studies splines have 
been used, and are not limited, to: expressing the relationship between the body area and the live 
weight of pigs before conducting mixed models analysis[167], estimating of genetic parameters for 
lactation [168], and the genetic evaluation of growth in beef cattle [169]. Polynomials with a high 
degree of mathematical complexity often provide a good empirical fit to a set of data [170].  Splines 
are particularly useful tool for cleaning noise from the observational data or determining the role of 
influencing factors at different stages of the spline. In Chapter 4 splines are used to filter noise from 
the longitudinal cytokine profiles. The limitation in the spline approach, however, is that this method 
doesn’t lend itself for the extraction of fitted parameters that specify physical properties of the 
biological system, which would be important for the understanding the dynamics of PRRSV infection. 
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Hence in the next section the curve fitting approach in which parameter estimates with a biological 
interpretation for the quantitative assessment of viraemia profile characteristics is outlined. 
b) Mathematical functions with biological interpretation: Numerous previous studies have 
used non-linear mathematical functions for the quantitative analysis of growth, weight gain and 
lactation [160,171-182] . Non-linear functions have been used to describe the temporal evolution of 
measured quantities to assess individual patterns (such as in milk yield [171]) and quantify inter-host 
variation for subsequent genetic analysis [168,174]. 
The Wood’s curve, an incomplete gamma function often used to model lactation yield in dairy cattle 
[172-174], will be used to describe viraemia profiles in this thesis: 
Y(t) = ⁡a1t
b1e−c1t 
where Y(t) is serum viraemia on the log10 scale at time⁡t dpi, a1⁡impacts the magnitude of all points on 
the curve, b1⁡is an indicator of the initial rate of increase to peak viraemia, 𝑐1 is an indicator of the 
rate of decline after the peak and dominates the viraemia profile at the later stages of infection. Using 
the piglet specific curve parameters estimates, a1̂, b1̂, and⁡c1̂, a fitted viraemia value can be estimated 
for each piglet for each time point (Y(t)̂ ). 
Derived phenotypes can be generated from the Wood’s model and are outlined below. The area under 
the Wood’s curve (AUC) up to each observation, (e.g 0-21dpi), was given by the definite integral: 





The viraemia AUC is a measure of both the level of viraemia and the extent to which viraemia is 
maintained. The range 0-21 dpi is presented above but I4, I7, …, I35,42 can also be obtained to 
explore different phases of the infection. Previous analyses on the PHGC trials 1-8 fitted a Loess 
curve through viraemia and integrated to get area under the curve from 0-21 dpi [33,45,46]. In 
Appendix 4 the results from these two approaches for the AUC will be compared.  
The time to peak of the curve (Tmax), derived by setting the first derivative of the Wood’s equation to 















When used for modelling viraemia the terms Tmax and Vmax are related to the host’s ability to 
respond during the replication-dominant phase of early PRRSV infection [183]. Vmax is reached 
when the rate of virus clearance from serum is equal to the number of virus particles released into the 
blood stream. Tmax is the time it takes to reach Vmax, with animals that can mount a response early 
in infection expected to have a shorter Tmax. 
Curve characteristics that relate to the host’s response to the post-peak, clearance-dominant phase of 
PRRSV infection can also be derived from the Wood’s model. The maximal decay rate (DeltaV) is 
reached when the rate of viral clearance from serum is highest compared to the rate of viral 
replication. Time to maximal decay (DeltaT) was derived by setting the second derivative of the 





Substituting this value in for t in the first derivative and taking the absolute value gave DeltaV: 








DeltaV is thus defined as the absolute value of the first derivative for ease of interpretation, whereby 
an animal with a larger DeltaV cleared viraemia from the serum more quickly. 
In this thesis the estimation of the Woods model parameters was carried out using 2 alternative 
approaches: linear mixed models and Bayesian inference. The derived parameters from the Woods 
model will be used for genetic analysis in Appendix 4. 
1.7.5 Bayesian inference: Mathematical functions can be fit to longitudinal data in a classical 
frequentist framework (incorporated e.g. with PROC MIXED in SAS in Chapters 2 and 4) or via 
Bayesian inference (Chapter 3). Due to limitations encountered in the model fitting in Chapter 2 we 
adopt a Bayesian model fitting approach in Chapter 3. In depth reviews of the benefits and limitations 
of the Bayesian approach can be found in [184-188]. Bayesian inference allows a way of combining 
prior information with data within a solid decision theoretical framework. Bayesian model fitting has 
a typically higher computational cost, especially in models with a large number of parameters, than 
the frequentist approach. In Chapter 3 model fitting was conducted using Bayesian inference with a 
likelihood framework. This approach allows for the fitting of a wider range of functions to the data 
than the linear mixed models approach, i.e. the fitting of bimodal functions. Model parameter 
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Where 𝑃(𝜃|𝑑𝑎𝑡𝑎) is the posterior distribution of the parameter given the data, 𝑃(𝑑𝑎𝑡𝑎|𝜃) is the 
likelihood, 𝑃(𝜃)is the prior distribution for the parameters, and 𝑃(𝐷) = ∫ 𝑃(𝐷|𝜃)𝑃(𝜃)𝑑𝜃
∞
−∞
 is a 
normalizing constant. 
1.8  Thesis outline 
The overarching aim of this thesis is to gain insights into the within-host dynamics of an in-vivo 
PRRSV infection using a statistical modelling approach. We aimed to quantify the inter-host 
variation, explore the time trends of the longitudinal viraemia and cytokine measures, and determine 
the influencing factors on these as well as the relationship between the viraemia and immune response 
characteristics over time. Data analysis was conducted on longitudinal viraemia, cytokine measures 
and nAbs cross-protection data generated by the recent PRRS Host Genetic Consortium (PHGC) 
infection trials; in which pigs were challenged with one of two PRRS virus isolates (NVSL or KS06). 
Various mathematical functions will be applied to the data generated from the PRRSV challenge 
study in this thesis. The candidate functions will be chosen according to visual properties of the data 
with the ideal candidate capturing the biological phenomenon, removing experimental noise and being 
a suitable description of the data for obtaining derived phenotypes with biological relevance. Spline 
functions will be applied in cases where a clear pattern is not observed. Alternative highly relevant 
functions that could have been applied to the data include, but not limited to: Legendre polynomials 
[189],  the Ali-Schaeffer curve [190], the Wilmink curve [191], the Lidauer-Mäntysaari function 
[192], and regression splines [193].    
In Chapter 2 we apply the linear mixed model framework to analyse viraemia time trends and the 
corresponding influencing factors.  In particular, two alternative approaches (repeated measures 
models and linearized mathematical power functions) are used to address the following questions:  
 What are the typical time trends in the PHGC viraemia data? 
o How are these time trends influenced by the virus isolate, genetic 
background, trial and WUR genotype? 




 What impact do bimodal profiles have on the model fits and the significant fixed 
effects? 
 How suitable is the linear mixed modelling approach for modelling the full range of 
observed viraemia trends and what are the limitations? 
The longitudinal viraemia measures from the PHGC PRRSV challenge experiment reveal substantial 
differences in the viraemia profiles between hosts infected with the same PRRSV challenge dose, 
pointing to considerable variation in the host response to PRRSV infections. The limitations in the 
ability to fit bimodal functions and the poor fit of the linearized approach in Chapter 2 led to a 
Bayesian model fitting approach being adopted in Chapter 3. Given the apparent diversity in viraemia 
patterns, several important questions will be explored in Chapter 3: 
 Is the viraemia rebound (or bimodal viraemia profile) phenomenon genuine and 
evenly distributed across all trials? 
 Can the information derived from the early stage of infection be used to predict the 
serum viraemia characteristics at the later stage of infection? 
 Can we quantify inter-host variation from all types of viraemia profiles with a 
mathematical function? 
 Can we define an objective method of classifying viraemia profiles? 
 Can we adequately represent the full range of viraemia profiles obtained from a large 
scale PRRSV infection experiment, and use these to determine quantitative 
characteristics of infection dynamics? 
 Is there a relationship between the breadth of the nAb response and the WUR 
genotype or viraemia profile classes? 
In Chapter 4 we combine the viraemia profiles with measures of the immune response in the form of 
longitudinal cytokine profiles. Linear and non-linear mixed models are used in Chapter 4 to explore 
and answer the following questions: 
 What are the typical time trends in the PHGC cytokine data? 
o How are these time trends influenced by the virus isolate, genetic 
background, trial and WUR genotype? 
o Are host differences in viraemia patterns also reflected by differences in the 
cytokine expression profiles? 
 How are the cytokine responses related to each other? 
o Is the strength of cytokine response related between the cytokines and how 
does this relationship change over the time course of the experiment? 
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o Which cytokines are related to each other and what are the key timings of the 
strongest associations? 
 Is there a relationship between the cytokine responsiveness and the WUR genotype, 
host genetic background or viraemia profile classes defined in Chapter 3? 
 What is the relationship between cytokine and viraemia response over time? 
o Does a stronger cytokine response imply a faster rate of viraemia decline? 
o Is the strength of the cytokine response related to the strength of the viraemia 
load? 
o Which were the key serum cytokines, and timings for serum viral dynamics? 
 Do cytokines drive viraemia characteristics or vice versa?  
In the General Discussion we summarise the novel findings of this thesis outlining the limitations and 
implications of the findings for future PRRSV research. Furthermore the host genetic impact on the 
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Examining PRRS viraemia profiles of pigs from an experimental 
challenge: a repeated measures and mixed modelling approach 
2.0 Introduction 
Viraemia profiles of pigs experimentally challenged with PRRSV are valuable indicators of the 
severity and progression of the infection in the host, and thus provide crucial information for the 
required subsequent disease control measures [1,2]. The course of a typical PRRSV infection is 
characterised by an acute stage lasting approximately 4 weeks followed by a stage characterised by 
low levels and eventual resolution of viraemia [3]. Previous studies suggest that in the majority of 
animals viraemia reaches undetectable levels typically by 4-6 weeks, although the virus may still be 
isolated months later in the lymphoid tissues [4]. In the PRRS Host Genetic Consortium (PHGC) 
trials, pigs were challenged with one of two PRRSV isolates (here denoted as NVSL and KS06, 
respectively) [2]. Visual observation of the viraemia profiles (Figure 2.1) indicates that the majority of 
viraemia profiles exhibit uni-modal or bi-modal trends. 
The longitudinal viraemia profiles from the PHGC PRRSV challenge experiment used in this study 
reveal substantial differences in the temporal viraemia patterns between hosts infected with the same 
PRRSV challenge strain and dose, pointing to considerable variation in the host response to PRRSV 
infections (Figure 2.1 A and B). Following infection at 0dpi with the same isolate and infection dose, 
a rise to peak viraemia level by approximately 10dpi for NVSL and 7dpi for KS06 was observed. This 
is followed by a decline in viral load and eventual resolution of viraemia by 42dpi. Inter-host variation 
increases with time for both isolates and there is substantial variation in the rate of viraemia decline. 
Visual inspection of viraemia profiles indicates that the general trend in profiles could be described by 
the Wood’s model. The latter model is based on a gamma-type function often used to empirically 
describe lactation curves in dairy cattle [5-7], and appears to be a suitable candidate model as it 
matches the above described data characteristics of a sharp rise followed by a peak and gradual 
decline of the uni-modal profiles and the primary phase of the bimodal viraemia profiles. 
Furthermore, it is determined by only three parameters with straightforward interpretation and can 
easily be linearized, thus facilitating statistical analysis and providing a biological interpretation of the 
results.  
Previous studies using the PHGC challenge data identified heritable genetic components to the 
cumulative viraemia (viraemia AUC 0-21dpi), and weight gain, and found an association between the 
single nucleotide polymorphism (SNP) WUR10000125 (henceforth referred to as WUR) on 
chromosome 4 and these two host response traits [8-12]. It is not known to what extent the WUR SNP 
affects the time course of infection such as the rate of increase nor the rate of post-peak viraemia 
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decline. The effect of the WUR genotype on pigs’ response to infection has been validated on NVSL 
infected piglets only. It is currently not known whether the host genetic influence to PRRSV infection 
is consistent across all PRRSV isolates. The WUR genotype is associated with infection data from the 
primary phase of infection (0-21dpi).  It would thus be interesting to assess the impact, if any, it has 
on the full viraemia profiles (0-42dpi). Furthermore, variation in host response has only been 
quantified in terms of cumulative (AUC 0-21dpi) viraemia; it has not been fully specified how the 
PHGC viraemia profiles differ over time.  
Figure 2.1 Viraemia profiles from a PRRSV challenge at 0dpi with either PRRSV isolate NVSL or 
KS06. Figure 2.1 A Viraemia profiles from PHGC trial 1 in which pigs were challenged with the 
PRRSV isolate NVSL. Figure 2.1 B Viraemia profiles from PHGC trial 11 in which pigs were 
challenged with the PRRSV isolate KS06. 
The primary objective of this chapter is to gain an insight into the factors of significant influence on 
the observed viraemia time trends such as the different viral strains, the pig’s genetic background 
(breed cross & breeding company), the WUR resistance genotype and other random effects that may 
possibly influence viraemia trends. In this chapter we apply the well-established methodology of 
linear mixed models for the statistical analysis of the longitudinal viraemia data due to the ability of 
these models to include both fixed and random effects [13-17]. Our analysis is conducted via two 
alternative approaches: a repeated measures model and a linearized version of the non-linear uni-
modal Wood’s function. The repeated measures model provides least square mean (LSM) estimates 
for log-transformed viraemia at the observation times, but does not capture the non-linear time trend 
of the individual viraemia profiles.  In contrast, the linearized Wood’s model implemented in the 
mixed model framework provides LSM estimates of the Wood’s model parameters, and impact of the 
various factors on these. The Wood’s model allows construction of viraemia curves based on these 
parameter estimates, thus making it a powerful approach to analyse changes of infection severity over 




2.1 Materials and Methods 
2.1.1 The Experimental Data 
The data analysed in this study was obtained from the PRRS Host Genetic Consortium (PHGC) trials, 
the largest PRRSV in-vivo challenge study to date. Pigs from the same breeding company and the 
same breed cross were considered to be from the same genetic background. The full dataset in this 
chapter consisted of: 13 PHGC trials, 8 genetic backgrounds and 2 PRRSV isolates as outlined in 
Table 2.1. Nine trials used infection with NVSL and five trials used KS06. A detailed description of 
















1 188 LW x LR 1 
2 190 LW x LR 1 
3 184 LW x LR 1 
4 191 Duroc x LW/LR 2 
5 182 Duroc x LR/LW 3 
6 109 LR x LR 4 
7 186 Pietran x LW/LR 5 
8 158 Duroc x LW/LR 6 
15 166 Pietran x LW 7 
Total 1554 - 1-7 
KS-2006-72109 
(KS06) 
10 184 Pietran x LW 7 
11 177 LW x LR 1 
12 146 LR x LW 8 
14 165 Duroc x LR/LW 3 
Total 672 - 1,3,7,8 
 
Table 2.1 Animal composition across the PHGC trials. 
1
LW = Large White; LR = Landrace. 
2
Genetic 
background is defined as pigs from the same breeding company and the same breed cross. 
Briefly, viraemia data was obtained from pigs which were experimentally infected with a PRRSV 
isolate in thirteen separate infection trials (ca. 200 pigs/ trial) with an infection dose of 10
5
 tissue 
culture dose50 (TCID50). In trials 1-8 and 15 the virulent PRRSV isolate NVSL 97-7985 (NVSL) was 
used [19,20], and in trials 10-14 the more contemporary PRRSV isolate KS-2006-72109 (KS06) was 
used. Trial 9 had only one WUR genotype and thus was excluded from the analysis in this study, 
since the exploration of genotype effects on the viraemia is one of the main objectives of this chapter. 
Trial 13 was also excluded from the analysis due to a likely co-infection resulting in unusual viraemia 
profiles not observed in any other infection trial. Some trial 13 animals showed delayed presence of 
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serum viraemia, and all individuals had low and noisy viraemia levels compared to individuals in 
other trials, suggesting the virus was attenuated or the piglets were not naïve. 
Pigs were from the same high health farm, except for trials 5, 8 and 12, which each included pigs 
from one supplier but two farms. Prior to challenge pigs were tested to be free of PRRSV, 
Mycoplasma hypopneumoniae and swine influenza virus. Animals were transported at weaning 
(average age of 21 days) to Kansas State University, randomly placed into pens of 10 to 15 pigs, and 
were infected with PRRSV after a 7 day acclimation period, i.e. at 0dpi. Blood samples were collected 
immediately before infection (0dpi) and at 4, 7, 11, 14, 21, 28, 35, 42dpi. The level of PRRS viraemia 
was measured using a semi-quantitative TaqMan PCR assay for PRRSV RNA. The viraemia quantity 
data from RT-PCR was transformed on the logarithmic scale to the base 10 before the model fitting. 
Due to the sensitivity of RT-PCR the threshold of detection was set at 1 unit on the log10 scale [8]. 
Pigs were euthanized at 42 dpi. Trials 7 and 8 were stopped at 35 dpi due to facility unavailability.  
WUR genotype:  The WUR genotype accounted for in this study refers to the presence or absence of 
the favourable B-allele at the single nucleotide polymorphism (SNP) WUR 1000125 on Sus Scrofa 
(SSC) chromosome 4 previously identified  to be strongly associated with lower cumulative viral load  
(viraemia AUC 0-21dpi) [8,10,12]. This SNP was identified using 60K SNP chip panels for trials 1-3 
of the dataset analysed in this chapter, and has further been verified for most PHGC trials and both 
PRRS isolate types (see Appendix 3) [8]. The WUR SNP was found to act in a dominant manner 
without imprininting, with the B allele estimated to decrease AUC of the viraemia and increase the 
weight gain irrespective of whether the favorable B allele is inherited  from the sire or dam [10].   
Isolate differences: The two PRRSV isolates used in this study, NVSL 97-7985 and KS-2006-72109, 
here denoted as NVSL and KS06 respectively, were isolated from different geographic regions nearly 
ten years apart, and are 89% similar at the GP5 nucleotide sequence level. PRRSV glycoprotein 5 
(GP5) is a major envelope protein that plays a vital role in the virion’s formation and infectivity, and 
harbours a major neutralizing epitope [21]. This gene is often used to assess genetic differences 
between PRRSV isolates and is suggestive of differences in virulence between isolates [22]. Variation 
in GP5 impacts the pig’s ability to produce neutralizing antibodies, which may not be protective 
against different isolates [22,23].  
2.1.2 Classifying bimodal profiles and subdividing the viraemia dataset 
Visual inspection showed that viraemia profiles were either uni-modal or bimodal. Uni-modal profiles 
were typically in a decline phase from the peak viraemia levels during 21-42dpi. Bimodal profiles 
experienced a second peak during 21-42dpi. In line with a previous study on the first three trials in 
this dataset [1], profiles were classed as bimodal if the viraemia observations from 21dpi onwards 
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rebounded by a value of greater than or equal to 1.5 on the log base 10 scale. This was calculated 
using observation differences on the log10 scale when:  
1) Log10 RT-PCR at 42dpi – Log10 RT-PCR at 35dpi ≥ 1.5 therefore bimodal  
2) Log10 RT-PCR at 35dpi – Log10 RT-PCR at 28dpi ≥ 1.5 therefore bimodal  
3) Log10 RT-PCR at 28dpi – Log10 RT-PCR at 21dpi ≥ 1.5 therefore bimodal  
To quantify the effect of virus isolate and other factors on the viraemia profiles, a repeated measures 
model and the linearized Wood’s model was fit to transformed viraemia data as outlined below. 
However, the Wood’s function only describes uni-modal profiles and cannot capture the secondary 
phase of bimodal profiles as shown in Table 2.2.  
To explore whether bimodal profiles affect the influence of other factors on viraemia trends the model 
fitting was carried out on the full dataset (dataset 1) and then on a dataset with the bimodal profiles 
removed (dataset 2). The first dataset includes all profiles, i.e. bimodal profiles are not treated as 
outliers that need to be removed from the dataset and hence conduct the analysis including bimodal 
profiles. Furthermore, in contrast to most previous studies on these viraemia data, the dataset is not 
truncated to only contain the primary phase of infection (0-21dpi) as that would result in the loss of 
valuable information corresponding to the infection dynamics at the later stage of infection. 
Beginning with all profiles for the full time course of infection (dataset 1), the best model is identified 
and used to test the effect on model parameter estimates and viraemia predictions. The impact of the 
bimodal profiles on the model fit, significant effects and the parameter estimates is then tested using 










1 Yes 0-42 2640 
2 No 0-42 2072 
Table 2.2 Two longitudinal PRRS viraemia datasets used in this statistical analysis. The full viraemia 
dataset was subdivided through the removal of bimodal profiles.  
2.1.3 Statistical analysis 
Repeated measures model 
The following repeated measures model was fit in SAS for both the viraemia datasets (datasets 1 and 
2) with the random effects of pig and pen within trial. The fixed effects of WUR genotype, virus 
isolate type, parity, sex, age, genetic background, trial, time and all their interactions were also fit, as 
defined by: 
Y ijklmnop = µ + Wl + Sj + Pk + Al + Gm + Tn+ Vo + I + RIi +RPp+ εin 
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Where Y is the viraemia quantity from RT-PCR on the the log10 scale of individual i of: WUR 
genotype Wl, sex Sj, parity Pk, age Al, genetic background Gm, of time Tn, virus isolate Vo, εin is the 
residual , and I represents all possible interactions between all the fixed effects. RIi and RPp are the 
random effects of individual and pen within trial respectively. Note that trial was not fitted in these 
models due to confounding with genetic background and PRRSV isolate. The PROC MIXED 
procedure of SAS was used where autocorrelation between repeated measurements could be taken 
into account using the repeated statement. Autocorrelations between repeated measures were 
examined using the repeat statement of PROC MIXED, and various residual covariance matrix 
structures were explored (e.g vc -standard variance components; ar(1) -first order autoregressive; cs- 
compound symmetry; un -unstructured; toep –toeplitz). A stepwise approach was adopted for 
identifying the model of best fit, starting from a model that included all the fixed effects and 
covariates described above and their interactions, followed by stepwise removal of statistically non-
significant factors at the 95% significance level (P<0.05) using the likelihood ratio test (LRT).  
The impact of the following fixed effects on the repeated measure LSM (least square mean) estimates 
was explored: 
1. Virus isolate,  
2. WUR genotype 
3. Genetic background 
The contrast statement (F –test statistic) was used to assess the differences between various levels of 
the fixed effects in the LSM viraemia measures.  
Since most trials consisted of pigs from different genetic backgrounds or the same genetic background 
but different virus isolate, the estimated effects associated with different genetic backgrounds and 
virus isolate are potentially confounded with trial effects. For this reason additional models were fitted 
in which the genetic background was substituted by the PHGC trial.   
The linearized Wood’s model 
The Wood’s function is given by the following equation and can be linearized by taking the natural 
log transformation:  
𝑦 = 𝑎𝑡𝑏𝑒−𝑐𝑡 
where y represents the level of viraemia in the blood (log10 RT-PCR) at 𝑡  days post infection (dpi). 
The parameter a is a scalar quantity and impacts upon the magnitude of all the points on the curve. 
The parameter b is an indicator of the initial rate of increase to the peak viraemia level and the 
parameter c is an indicator of the rate of decline after the peak and dominates the function as  
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t . Thus the Wood’s model parameters have a biological relevance and the function can be 
linearized by taking the natural log transformation for fitting in SAS using the procedure PROC 
MIXED. The linearised version of the Woods function is a function with variables T1 = ln(t) and T2= 
t and parameters A = ln(a), b and c as specified above, i.e. ln(𝑦) = 𝐴 + 𝑏 𝑇1 − 𝑐 𝑇2. Individual-
specific random effects were added to the initial fixed effects model as perturbations of one of the 
model parameters at a time or a combination of model parameters. Furthermore when the pen within 
trial was included in the model it failed to converge and hence it was not included in the final model. 
The covariance structure adopted for the random effects was unstructured, which is the most liberal 
covariance structure. As for the repeated measurement model, used above, the: virus isolate type, 
genetic background, trial, WUR genotype, sex, and parity as well as all significant interactions were 
included as potential fixed effects, in all the model parameters. Significance of the fixed effects was 
determined by the F-test at the 95% significance level (P<0.05). The contrast statement in SAS was 
used to determine statistically significant differences in the LSM parameter estimates associated with 
different levels of the fixed effects [15]. The model fitting was conducted on both datasets (datasets 1 
and 2) to determine the impact of the bimodal profiles on the significance of the fixed effects on the 
model parameters. 
Assessment of goodness of fit and comparisons of the different Wood’s mixed models with different 
fixed and random effects were based on the: likelihood ratio test,  Akaike’s Information Criteria 
(AIC), Pearson’s correlation (R), Residual Standard Deviation (𝑅𝑆𝐷 =  √ 
∑ 𝑟𝑒𝑠𝑖𝑑𝑢𝑎𝑙2
(𝑛−𝑝)
 , where p is the 
number of model parameters) and inspection of the Wood’s model residuals. The statistical 
significance for inclusion of one or more random effects in the model parameters was determined by 
the likelihood ratio test between the model with (n) random effects and the null model fewer (i.e. n-1) 




2.2 Results  
2.2.1 Qualitative assessment and univariate statistics of the longitudinal PRRS viraemia data 
Visual inspection of the individual viraemia profiles from both PRRSV isolates indicated a general 
trend of rise to a peak followed by a decline. Boxplots allow us to obtain a preliminary description of 
the PRRS viraemia dataset before model fitting in SAS. The maximum viraemia values occur at 7dpi 
for both NVSL and KS06 with more variation in NVSL than KS06 at 4, 28, and 35dpi as shown in 
Figures 1.2 A&B. Viraemia values were generally higher for the more virulent isolate NVSL than 
KS06. Larger variation in both isolates from 28dpi onwards could be due to an increased inter-host 
variation in profiles from 21dpi onwards and the presence of bimodal profiles in the datasets. 
Removal of the bimodal profiles (Figures 1.2 C &D) reduced the inter-host variation in the dataset at 
28-42 dpi for both NVSL and KS06.  
 
Figure 2.2 Boxplots of the viraemia data from the PHGC trials. Figure 2.2A NVSL virus isolate, 
Figure 2.2B KS06 virus isolate, Figure 2.2C NVSL with the bimodal profiles removed, Figure 2.2D  
KS06 with the bimodal profiles removed. The length of the box represents the interquartile range, the 
diamond in the box interior represents the group mean, the horizontal line in the box interior 
represents the group median and the vertical lines (whiskers) issuing from the box extend to the 
minimum and maximum values at each time point of the experiment.  
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Frequency of the WUR genotype in the viraemia dataset across PHGC trials 
The WUR 0 [AA] genotype was the most frequent (45-92%), whilst WUR 2 [BB] was the least 
frequent (0-12%) genotype across all trials (Table 2.3). There was variation in the distribution of the 
WUR genotypes between the trials. Trial 6 had the fewest percentage of WUR 0. Trials 6, 8 10 and 12 
had no WUR 2 pigs. Trial 7 and 10 had the largest percentages of WUR 0 genotypes. The distribution 





WUR 0 [AA] 
(%) 
WUR 1  
[AB or 
BA] (%) 






1 134 (75.7%) 39 (22%) 4 (2.3%) 1 
2 143 (75%) 43 (23%) 4 (2%) 1 
3 112 (61%) 63 (34%) 8 (4%) 1 
4 163 (84%) 28 (14%) 4 (2%) 2 
5 134 (68%) 60 (30%) 4 (2%) 3 
6 114 (91.2%) 11 (8.8%) 0 4 
7 88 (45%) 86 (44%) 23 (12%) 5 
8 169 (85%) 29 (15%) 0 6 
15 156 (78%) 42 (21%) 2 (1%) 7 
Total 1213 (73%) 401 (24%) 49 (3%) - 
KS-2006-72109 
(KS06) 
10 170 (53.5%) 30 (46.5%) 0 7 
11 157 (80.5%) 37 (19%) 1 (0.5%) 1 
12 158 (85%) 27 (15%) 0 8 
14 144 (77%) 36 (19%) 7 (4%) 3 
Total 629 (82%) 130 (17%) 9 (1%) - 
Table 2.3 The distribution of the WUR genotype across the PHGC trials.  The percentages were 




Frequency of bimodal profiles in the viraemia dataset across PHGC trials 
The frequency of bimodal profiles was consistent between trials within each PRRSV isolate (Table 
2.4). Overall KS06 had fewer bimodal profiles than NVSL (total of 16% for KS06 compared to 27% 
for NVSL). 
 

















1 188 125 (66%) 63 (34%) 1 
2 190 133 (70%) 57 (30%) 1 
3 184 124 (67%) 60 (33%) 1 
4 191 124 (65%) 67 (35%) 2 
5 182 129 (71%) 53 (29%) 3 
6 109 87 (80%) 22 (20%) 4 
7 186 161 (87%) 25 (13%) 5 
8 158 129 (82%) 29 (18%) 6 
15 166 120 (72%) 46 (28%) 7 







10 184 162 (88%) 22 (12%) 7 
11 177 142 (80%) 35 (20%) 1 
12 146 108 (74%) 38 (26%) 8 
14 165 153 (93%) 12 (7%) 3 






The distribution of the WUR genotypes across uni- and bimodal viral profiles 
The WUR genotypes were distributed similarly across uni- and bimodal profiles for both isolates as 
shown in Table 2.5. For the KS06 infection there was a marginally higher percentage of WUR 0 [AA] 
genotypes than there were for NVSL. Overall, the similar distributions of the WUR genotype across 











WUR 1  
[AB or BA] 
(%) 






Uni-modal 896 (72%) 305 (25%) 39 (3%) 




Uni-modal 635 (78%) 164 (20%) 10 (1%) 
Bimodal 118 (82%) 21 (15%) 4 (3%) 
Table 2.5 The frequency of the WUR genotypes across uni and bimodal viral profiles. The 
percentages are calculated for each bimodal/uni-modal class within the PRRSV isolate. 
2.2.2 Repeated measures models of PRRS viraemia 
The full repeated measures model contains all the fixed and random effects was reduced after 
removing non-significant effects at the 95% significance level (P>0.05). The final repeated measures 
model for the viraemia data with a first order autoregressive covariance structure and the random 
effect of pig and pen within trial was: 
Y ijlmnop = µ + Wl + Sj + Al + Gm + Tn+ Vo + Gm*Tn+Wk*Tn+Vo*Tn + RIi +RPp+ εin 
Where t is the time (dpi), W is the WUR genotype, G is the genetic background, S is the sex, V is the 
virus isolate, RI and RP are the random individual and pen within trial effects respectively, ε is the 
error, and * indicate interactions between the fixed effects. 
The results of the significant effects in the repeated measures model imply that the viraemia trends 
were statistically different between genetic background, the WUR genotype and the virus isolate. 
These differences are explored by examining the differences between the least square means (LSMs) 
of these groups over time. Sex and age of the pigs also contributed to the variation in viraemia 
measures, but did not correspond to different time trends. Although trial was not included in the 
original statistical model due to confounding with genetic background and virus isolate type, models 
including trial instead of genetic backgrounds showed that Trial and the Trial*Time effects were both 
statistically significant. The final model was the same for both dataset 1 and dataset 2; the inclusion of 
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bimodal profiles did not change the significance of the effects in the model. Therefore, the significant 
effects were robust with the inclusion of bimodal profiles.  
The model residuals 
The repeated measures model was applied to both dataset 1 (all profiles) and dataset 2 (only uni-
modal profiles) and their model residuals are shown in Figure 2.3A and 1.3B respectively. In Figure 
2.3A the value range of the residuals at 21dpi were within 3 log10 units and within 5 log10 units at 
35dpi; these large residuals thus indicate that the repeated measurements model provides a poor fit to 
dataset 1 from 21dpi onwards. The model residuals are normally distributed around 0 for 4-28dpi but 
there is a bias of under-prediction at 35-42dpi.The model residuals increase with time, which is 
expected due to the increased inter-host variation in the rate of viraemia decline from the peak and the 
presence of bimodal profiles. 
Removal of the bimodal profiles improves the model fit as indicated by model residuals up to 3 to 4 
log10 units (for 5 pigs) at all observed time points (Figure 2.3b). Residual variation still increases over 
time indicating that the repeated measures model is not good at capturing the increase in inter-host 
variation at the later stage of infection. However, removal of the bimodal profiles reduces the bias of 
under-prediction at 35dpi (Figure 2.3B).   
 
Figure 2.3 The model residuals from fitting the final repeated measures model to the full dataset 1 




Examining the impact of fixed effects on the repeated measure model LSM viraemia estimates 
Below the impact of the virus isolate, genetic background, WUR genotype and trial on the LSM 
viraemia estimates is examined. The interaction between time and the fixed effect of interest is 
included in the final repeated measures model. 
1. The virus isolate 
The LSMs for each virus isolate obtained from fitting the repeated measures model to dataset 1 (all 
profiles) are shown in Table 2.6 and depicted in Figure 2.4. Except for day 4, the LSMs for both virus 
isolates differed by less than one log-unit with statistically significant differences at all days of the 
experiment except for 42dpi (Table 2.6). The average profiles for both PRRS virus infections consist 
of a period of rise to peak viraemia at 7dpi followed by decline to clearance (Figure 2.4). However, 
NVSL has a significantly higher peak viraemia at around 7dpi and a faster rate of decline than KS06, 
as indicated by significantly higher LSM estimates for KS06 between 21 and 35dpi.  Differences 
between the virus isolates are smaller from 21 dpi onwards compared to the earlier stages of the 
infection. Note that due to the large sample size the SEMs are small at all observation times of the 









between NVSL and 
KS06 (p value) 
4 5.9046 (0.03) 4.6056 (0.04) <.0001 
7 6.3372 (0.03) 5.8381 (0.04) <.0001 
11 6.1106 (0.03) 5.574 (0.04) <.0001 
14 5.5687 (0.04) 5.1608 (0.04) <.0001 
21 3.9594 (0.04) 4.2929 (0.05) <.0001 
28 2.5559 (0.04) 2.7525 (0.06) <.0001 
35 1.554 (0.04) 1.8099 (0.07) <.0001 
42 0.5017 (0.04) 0.4152 (0.05) 0.07 
Table 2.6 The least square mean estimates (standard error of the mean) for each PRRSV isolate from 
fitting the repeated measures model to dataset 1. 
Removing bimodal profiles 
Similar significant differences between the LSMs, and time trends for the two PRRSV isolates were 
found when the bimodal profiles were removed from the data i.e. when the repeated measures model 
was fit to dataset 2 (Table 2.7).  Removal of bimodal profiles leads to small differences in the LSMs 
estimated (Figure 2.4). Figure 2.4 further shows that the LSMs from dataset 2 are slightly smaller than 
for dataset 1 at 35dpi with stronger differences for NVSL for which viraemia rebound was more 
pronounced. Overall, the statistical results with regards to the impact of the virus isolate are robust to 
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the inclusion of bi-modal profiles. Bimodal profiles only affect the goodness of fit, but not the size or 









between NVSL and 
KS06 (p value) 
4 5.8522 (0.03) 4.5527 (0.04) <.0001 
7 6.2914 (0.03) 5.7859 (0.04) <.0001 
11 6.0655 (0.03) 5.5461 (0.04) <.0001 
14 5.5141 (0.03) 5.1336 (0.04) <.0001 
21 4.0076 (0.03) 4.3067 (0.04) <.0001 
28 2.6254 (0.03) 2.8193 (0.04) <.0001 
35 1.1875 (0.03) 1.6983 (0.04) <.0001 
42 0.1803 (0.04) 0.2698 (0.04) 0.06 
Table 2.7 The least square mean estimates, LSM (standard errors of the mean, SEM) for each PRRSV 
isolate from fitting the repeated measures model to dataset 2. 
 
Figure 2.4 Comparison of the least square mean estimates obtained from fitting the repeated measures 
model to both datasets. NVSL (virus 1) is in black and KS06 (virus 2) is in red. The LSMs from 
dataset 2 (bimodal profiles removed) are denoted by the dashed lines. 
2. The WUR genotype 
The LSMs for each WUR genotype obtained from fitting the repeated measures model to dataset 1 
(all profiles) are shown in Table 2.8. The LSMs for all three WUR genotypes had a similar range on 
the logarithmic scale with statistically significant differences between WUR 0 and WUR 1 at 11-
35dpi, WUR 0 and WUR 2 at 35dpi and WUR 1 and WUR 2 at 28dpi. The average profiles for all 
three WUR genotypes consist of the same time trends of a period of rise to peak viraemia at 7dpi 
followed by decline to clearance (Figure 2.5). The WUR 0 genotype had significantly higher viraemia 
LSM at most observations than the other genotypes, which would explain the observed differences in 
the area under the viraemia curve associated with this SNP. However despite the statistical 
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significance of the differences between the LSMs of the WUR genotypes the actual LSM differences 
are less than 0.55 log units at all time points (Table 2.8). 
 
Table 2.8 The LSMs for each WUR genotype from fitting the repeated measures model to dataset 1. 
Significant differences at the 95% significance level are in bold. 
Removing bimodal profiles 
Comparison of the repeated measures model LSMs between dataset 1 and 2 indicate that the results 
are almost identical when the bimodal profiles are removed (Figure 2.5). With the exception of the 
LSM differences between WUR 0 and WUR 2 at 35dpi, which are no longer statistically significant 
when bimodal profiles are reduced (p<0.37),  the majority of the statistical results with regards to the 





















































































Figure 2.5 Comparison of the LSMs from dataset 1 (lines) and dataset 2 (dashed lines) for each WUR 





















































<.0001 0.1924 0.4314 






<.0001 0.2524 0.1652 






<.0001 0.7866 0.0095 






0.0001 0.3746 0.6156 






0.2114 0.823 0.5602 
Table 2.9. The least square mean estimates for each WUR genotype, from fitting the repeated 
measures model to dataset 2. Significant differences (p<0.05) are in bold. Differences that were found 
to be significant for dataset 1 that are no longer significant for dataset 2 are in blue. 
3. The genetic background 
Genetic background had a significant effect on the LSMs for viraemia. The least square mean 
estimates for each genetic background obtained from fitting the repeated measures model to dataset 1 
(all profiles) are shown in Figure 2.6. The least square means for all 8 genetic backgrounds had a 
similar range on the logarithmic scale and followed similar time trends; however there were 
differences in the magnitude of the peak and rate of decline from the peak viraemia between genetic 
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backgrounds. For ease of interpreting the results, the LSMs that were not significantly different with 
each other at the 95% significance level are presented in Table 2.10. 
Genetic backgrounds 7 and 8 were infected with KS06 only, whilst pigs from genetic backgrounds 1 
and 3 were infected with virus isolate NVSL or KS06 in separate infection trials. Below the trial 
differences, in order to disentangle the effect of virus isolate type from the genetic background, are 
examined.  
 
Figure 2.6 The least square mean estimates for each genetic background at each observation of the 
PRRSV challenge experiment. 
 
1 2 3 4 5 6 7 8 
4  6 8   2 8 3,7 
7  6,8  7 7 2,8  2,6 
11 3,8   5,8 4,6 5  1,4 
14 3,5,6,8  1,5,6  1,3,8 1,8  1,5 
21 3,5 7,8 1,5  1,3,6  2,8 2,7 
28 6  4 3 6,8 1,8  5,6 
35 3,4 6,8 1 1 6,8   2,5 
42  3,4,7,8 2 2   2 2 
Table 2.10 The non-significant differences between the LSMs of the genetic backgrounds at each 
experimental observation at the 95% significance level. 
Removing bimodal profiles 
The same significant differences between the LSMs, and time trends for the 8 genetic backgrounds 
were found when the bimodal profiles were removed from the data i.e. when the repeated measures 
model was fit to dataset 2. Comparison of the LSM trends associated with both datasets in Figure 2.7 
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further indicates that the removal of bimodal profiles leads to only very small differences in the LSMs 
estimated. Thus the statistical results with regards to the impact of the genetic background are robust 
to the inclusion of bi-modal profiles. Bimodal profiles only affect the goodness of fit, but not the size 
or direction of estimated effects for the genetic background. 
 
Figure 2.7 Comparison of LSM estimates for different genetic background from dataset 1 (solid lines) 
and 2 (dashed lines). 
4. The PHGC trial 
Trial differences allow us to examine the genetic background differences whilst separating out the 
virus isolate differences. Substituting the PHGC trial for the genetic background in the final repeated 
measure model yielded the LSMs estimates for each trial shown in Figure 2.8A for NVSL and 1.8B 
for KS06 infections.  
Except for trials 1-3, trials within each virus isolate used pigs from different genetic backgrounds, 
thus causing confounding between trial and genetic background. However, trials 1-3 using the same 
genetic background and same virus isolate resulted in significantly different LSM viraemia estimates 
from 21dpi onwards (p<0.05) (Table 2.11), which suggests in addition to genetic background, the trial 






Figure 2.8 The LSMs for each trial fitting the repeated measures model with trial substituted for 
genetic background to dataset 1. Figure 2.8A shows trials infected with NVSL and Figure 2.8B shows 
trials infected with KS06. 
To disentangle virus isolate and genetic background the LSMs for the trials from genetic backgrounds 
1, 3 and 7 are shown in Table 2.11. There were significant differences between trials infected with 
NVSL and KS06 within the same genetic background at the majority of the observation times. 
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Table 2.11 LSM differences for trials from the same genetic backgrounds. * indicates significant 
differences between the LSMs at that time associated with  NVSL and KS06 at the 95% significance 





Removing bimodal profiles  
Removal of bimodal profiles led to only very small differences in the estimated viraemia LSMs 
associated with different trials (Figure 2.9) and led to almost identical results to those reported for 
dataset 1.   
Figure 2.9 Comparison of the LSMs for each trial from fitting the repeated measures model with trial 
substituted for genetic background to dataset 1(lines) and dataset 2(dashed lines). Figure 2.9A shows 
trials infected with NVSL and Figure 2.9B shows trials infected with KS06. 
2.2.3 Fitting the linearized Wood’s function for modelling viraemia profiles 
Identifying the fixed and random effects in the linearized Wood’s model 
Firstly, the significant random effects in the mixed model incorporating the linearized Wood’s 
function was identified, since they will impact upon the predictions of the fixed effects [24]. The 
resulting fit statistics from fitting the linearized Wood’s function to all the viraemia data with an 
unstructured covariance structure between the random effects are shown in Table 2.12. Comparisons 
of the Wood’s models with different random effects (Table 2.12) indicate that significantly better fits 
were achieved with models allowing for individual variation in parameter c. This result is expected 
due to the fact that the variation in parameter c reflects variation in the rate of decline from the peak 
viraemia which captures the increased inter-host variation from 7dpi onwards. The AIC was smallest 
when there was individual variation in all three model parameters. The Pearson’s correlation was 
highest between the data and predictions when there was a random effect in parameters b and c, thus 
allowing for individual variation in the time of the peak viraemia which is defined by =
𝑏
𝑐
 . The 
residual standard deviation was lowest for the model with a random effect in parameters a and c.   
Overall, according to the likelihood ratio test and the AIC, the best model is one in which there was a 
random effect in two model parameters: b and c. The likelihood ratio test in Table 2.12 is the result 
from testing the model in consideration with the models with 1 less random effects thus allowing us to 





Model name AIC R 
squared 






Null model name 
Wood’s model 
with no random 
effects 
10415.2 0.75346 0.3632 - 10413.2* - 
Wood’s model 
with random effect 
in parameter A 
10379.3 0.79158 0.3379 10413.2 10375.3* Wood’s model 
with no random 
effects 
Wood’s model 
with random effect 
in parameter b 
9967.2 0.81559 0.3203 10413.2 9963.2* Wood’s model 
with no random 
effects 
Wood’s model 
with random effect 
in parameter c 
8901.3 0.84417 0.2969 10413.2 8897.3* Wood’s model 
with no random 
effects 
Wood’s model 
with random effect 









with random effect 
in parameters A, c 
7745.4 0.83743 0.2919 8897.3 
 





with random effect 
in parameters b, c 





with random effect 
in parameters A, b 
,c 
6932.2 0.83261 0.3059 7568.5 8897.3 Wood’s model 
with random 
effect in 
parameters b, c 
Table 2.12 Comparison of goodness of fit indicators for each model in which there were different 
random effects in the Wood’s model parameters. Model fit statistics were Akaike’s information 
criteria (AIC), Pearson’s correlation between predicted and observed values (R squared), residual 
standard deviation (RSD) and the -2log likelihood for the model with the additional random effect and 
the null model specific to that model where * indicates LRT significant at the 95% significance level. 
The model parameters are the Woods parameters A, b and c from the equation ln(𝑦) = 𝐴 + 𝑏 𝑇1 −




As shown in Table 2.12 the final linearized Wood’s model had a random effect in parameter b and c 
only. In the final linearized Wood’s model the significant fixed effects (95% significance level) were: 
the genetic background in all the model parameters, the virus in all the model parameters, and sex 
only in model parameter c. 
Ln(y)moij= [µ + Gm + Vo] + [Gm*T1 +Vo*T1+R i *T1]+ [Gm*T2 + Vo*T2 + Sj*T2 +R i *T2] +εi 
Where Ln(y) is the natural log transformed log10 RT-PCR viraemia data, G is the genetic background, 
V is the virus isolate, S is sex and R is an individual random effect in the linearized Wood’s 
parameter.  
Assessing individual model fits to the data  
Individual Wood’s model fits are shown in Figure 2.10, which illustrate that the general shape of the 
Wood’s function follows the same typical time trends of the viraemia profiles. From visual inspection 
of all individual model fits, the Wood’s model appears to be overall an adequate candidate model to 
represent individual uni-modal viraemia profiles. However, as shown below, the model residuals are 
generally large and visual inspection of the individual profiles and residuals indicates a bias of over-
prediction at the later stages of infection (Figure 2.10). 
 
Figure 2.10 Individual Wood’s model fits (black solid line) to the log10 viraemia data (blue crosses).  
The residuals from fitting the final linearized Wood’s function to dataset 1 and 2 are shown in Figure 
2.10A and B. These residuals increase with time being largest between 28-35dpi. The residuals are 
generally normally distributed except for a bias of over-prediction at 28 and 35dpi. The residuals in 
Figure 2.10A and B indicate that differences between the transformed data and the model predictions 
are within 1-2 units on the transformed Ln(log10 RT-PCR) scale. When the predictions and data are 
back transformed to be on the log10 scale the residuals are generally within 4 log10 units (Figures 
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2.10C and D). Removal of the bimodal profiles significantly improves the Woods model fit to the data 
particularly from 21-42dpi (Figures 2.10B and D). 
 
Figure 2.11. Plot of the residuals from fitting the final linearized Wood’s model. The residuals are 
denoted by blue crosses. Figure 2.11A and B are the residuals directly from the linearized model 
fitting and are on the Ln(log10 RT-PCR) scale. Figure 2.11A are the residuals from fitting the 
linearized model to dataset 1. Figure 2.11B are the residuals from fitting the linearized Woods model 
to dataset 2. Figure 2.11C and 1.11D are the residuals from the back transformed data and model 
predictions i.e. on the log10 RT-PCR scale. Figure 2.11C are the residuals from dataset 1 and Figure 
2.11D are the residuals from dataset 2. 
As shown in Table 2.5, removal of bimodal profiles changes the LSM estimates for all parameters. 
However, differences in the model fit and LSM values of the Wood’s parameter estimates did not 
translate into drastic differences in the resulting viraemia predictions (Figure 2.11). The removal of 










Table 2.5. LSM estimates for the parameters of the linearized Woods model fit to the full dataset 
(dataset 1) and when bimodal profiles were removed (dataset 2). Note that AIC depends partly on the 
sample size. Hence quantitative comparison of goodness of fit associated with both datasets, based on 
AIC, or any of the other fit statistics, is not feasible. The parameters V1,1, V2,1, and V2,2 are the 
components of the variance-covariance matrix for the Woods parameters b and c. 
 
Figure 2.12 Estimated viraemia curves obtained from LSM parameter estimates obtained when fitting 
the final linearized Wood’s model. The profiles for dataset 1 are in black and dataset 2 are in red. The 
dashed lines depict the respective confidence intervals constructed by the model predictions from the 
upper and lower parameter estimates determined by: LSM(model parameter)±1.96 SE(model 
parameter).  
  
Dataset LSM Parameter Estimates AIC* 
A (SE) b 
(SE) 


































Examining the impact of fixed effects on the linearized Woods model parameters and 
resulting viraemia profiles 
Below the impact of the virus isolate, genetic background, WUR genotype and trial on the linearized 
Wood’s parameters and their resulting viraemia profiles is examined. The fixed effect of interest was 
fit in all the model parameters in addition to significant fixed and random effects of the final 
linearized model. Significance was taken at the 95% significance level. 
1. The virus isolate 
There were significant differences between NVSL and KS06 in all three Wood’s parameters as shown 
in Table 2.13. NVSL had a much higher value of Wood’s parameter A (=ln(a)), and  lower values for 
the Wood’s parameters b and c than KS06. The differences in parameters translated to differences in 
the Wood’s model predictions particularly in the early phase of infection i.e. 0-14dpi (Figure 2.13). 
The model predicts that NVSL has an earlier and higher peak viraemia than KS06. The magnitude of 
all points on the Wood’s curve for NVSL are larger than that of KS06, furthermore the differences 
between the two PRRSV isolates decreases with time.  
Parameter NVSL KS06 Significantly different between NVSL & 
KS06 (p-value) 
A (SE) 1.65 (0.044) 0.90 (0.060) p<0.001 
b (SE) 0.43 (0.028) 0.83 (0.038) p<0.001 
c (SE) 0.08 (0.002) 0.10 (0.003) p<0.001 
Table 2.14. The estimated Wood’s parameters for the two virus isolates, all three Wood’s parameters 





Figure 2.13. Predicted viraemia profiles estimated by the linearised Wood’s model (lines), together 
with the estimates produced by the repeated measures models (green and blue points with confidence 
limits). Viraemia profiles for NVSL are shown in black and those for KS06 in red. The dashed lines 
delimit the respective confidence intervals constructed by the model predictions from the upper and 
lower parameter estimates determined by: LSM(model parameter)±1.96 SE(model parameter). For the 
repeated measures model LSM estimates with confidence intervals for NVSL are shown in green and 
for KS06 in blue 
2. The WUR genotype 
There were no statistically significant differences between the linearized Wood’s parameters for the 
WUR genotypes as shown in Table 2.15. The WUR 0 and 1 profiles were very similar throughout the 
infection. Despite the parameters not being significantly different between the WUR genotypes, 
Figure 2.14 shows that the WUR 2 genotype has viral profile with a lower magnitude throughout the 
experiment compared to WUR 0 and 1. The statistical results with regards to impact of fixed effects 
on Wood’s parameters and resulting profiles are robust to the inclusion of bi-modal profile (see 
Appendix 1). 




















1 & 2 
(p-value) 






0.74 0.91 0.81 






0.43 0.64 0.87 






0.68 0.48 0.40 
Table 2.15 Estimated parameters of the Wood’s model for WUR 0, 1, 2. No significant differences 




Figure 2.14 Wood’s model predictions for WUR genotypes. The WUR genotype 0, 1 and 2 are in 
black, blue and red respectively. The WUR genotype 0 (AA) has the highest level of peak viraemia 
compared to WUR 1 and 2, implying that the B allele confers lower levels of peak viraemia. The 
dashed lines delimit the respective confidence intervals determined by: LSM(model parameter)§ 1.96 
SE(model parameter). The corresponding LSM estimates with confidence interval from the repeated 
measures model are shown for comparison, where the different colours refer to the different WUR 
genotypes 0(green), 1(purple), 2(brown). 
3. Genetic background 
Genetic background had a significant effect on all three Wood’s model parameter with LSM 
parameter estimates for each genetic group shown Figure 2.15 and Table 2.16. Pairwise contrasts 
were conducted in SAS to determine differences in the Wood’s parameters between genetic groups, as 
shown in Table 2.17. Our focus is the impact of genetic background within the same virus isolate. In 
section 4 (below) the trial differences in order to disentangle virus isolate type from the genetic 
background is examined.  
The differences within the virus isolate were smaller than between virus isolates. It is not surprising 
that genetic backgrounds 1,3 and 8 were significantly different from the other backgrounds since they 
included trials infected with KS06. Examining for NVSL only (genetic backgrounds: 2, 4, 5 and 6) 
only a few significant differences between the linearized Wood’s parameters were observed: genetic 
background 2 was significantly different in parameter A only with backgrounds 4 and 5, and genetic 
background 6 was significantly different in parameter A and b with backgrounds 4 and 5. Genetic 








A (SE) b (SE) c (SE) Virus Trials 
1 0.90 (0.07) 0.69 (0.05) 0.08 (0.004) NVSL & 
KS06 
1-3 & 11 
2 0.52 (0.09) 1.03 (0.06) 0.11 (0.005) NVSL 4 
3 0.67 (0.08)  0.80 (0.05) 0.08 (0.004) NVSL & 
KS06 
5 & 14 
4 0.49 (0.10) 1.00 (0.66) 0.09 (0.005) NVSL 6 
5 0.53 (0.10)  0.96 (0.06) 0.10 (0.005) NVSL 7 
6 0.79 (0.10) 0.94 (0.06) 0.09 (0.005) NVSL 8 
7 0.70 (0.08) 0.84 (0.05) 0.09 (0.004) NVSL & 
KS06 
15 & 10 
8 0.91 (0.06) 0.82 (0.04) 0.10 (0.003) KS06 12 
Table 2.16 Estimated parameters of the Wood’s model for each genetic background with a 
breakdown of the virus and trials involved. The standard errors are in brackets. 
Genetic 
background 
1 2 3 4 5 6 7 8 Virus Trials 
1 -        NVSL 
& 
KS06 
1-3 & 11 
2 X*O -       NVSL 4 
3 X*O X*O -      NVSL 
& 
KS06 
5 & 14 
4 X*O O X*O -     NVSL 6 
5 X*O O *O  -    NVSL 7 
6 X*O   X* X* -   NVSL 8 
7 X*O X*O O X* X  -  NVSL 
& 
KS06 
15 & 10 
8 X*O *O XO X* X O XO - KS06 12 
Table 2.17 Significant differences (95% significance level) in the LSM estimates of the Woods 




Figure 2.15. Wood’s model predictions for each genetic background (lines) together with the 





4. The PHGC Trial 
Trial differences allow us to examine the genetic background differences whilst separating out the 
virus isolate differences. The predicted Wood’s profiles for all the trials separated by virus isolate are 
shown in Figure 2.16A and B; the repeated measures model and Woods model approaches lead to 
similar results. There were significant differences between the Wood’s parameters between trials 
within virus isolate. Differences between trials could be due to the virus or the genetic background. 
The Wood’s parameters from the trials, which were from the same genetic background are shown in 
Table 2.18. The Wood’s parameters for trials 1-3 were not significantly different from each other; 
which indicate that the differences between the other trials would mainly be due to genetic 
background and virus type as opposed to a function of trial (which is simply an artefact of the 
experimental protocol). 
 
Figure 2.16. Wood’s model predictions for each trial (lines) and corresponding LSM viraemia 
estimates obtained from the repeated measures models (asterisks). Figure 2.6A refers to the trials with 












Virus NVSL KS06 NVSL NVSL NVSL KS06 NVSL KS06 
 























































Table 2.18 Estimated parameters of the Wood’s model for trials from the same genetic background. 
*indicates significant differences at the (95% significance level) within each genetic background. For 
genetic background 1 the colour of the asterisk indicates the trial’s parameter being compared. 
Significance at the 95% significance level between trial x and trial 1(red), 2(purple), 3(green), and 11 
would be represented by ****. 
The effect of removing the bimodal profiles on the linearized Woods model 
The removal of bimodal profiles results in the same significant fixed and random effects in the final 
linearized Wood’s model for the fixed effects: virus isolate, WUR genotype, genetic background and 
trial. There were slight differences in the LSM Wood’s parameter estimates but these translated to 
small differences in the final Wood’s curves as shown in the Appendix 1. Generally the removal of 
the bimodal profiles lowers the predicted Wood’s profiles, making them closer to the LSMs of the 
repeated measures model. The removal of the bimodal profiles from the dataset leads to the same 




Empirical mathematical models have proven useful for describing the temporal evolution of a 
response variable and filtering stochastic noise from dynamic biological systems whilst retaining the 
most fundamental features [6,13,25,26]. Linear mixed models are a well-established methodology 
used to model longitudinal data with the inclusion of both fixed and random effects [13-17]. The 
comprehensive PHGC dataset comprising of repeated PRRS viraemia measurements from 2640 
commercial pigs in this chapter provided a unique opportunity to assess the influential factors on 
PRRS viraemia profiles. The main aims of this chapter were to gain insights into temporal changes in 
viraemia and the factors which may potentially contribute to the observed viraemia time trends such 
as the different viral strains, the host’s own genetic background, and the WUR genotype. For this 
purpose, two alternative approaches were implemented into the linear mixed model framework.  
The advantage of the repeated measures modelling approach is that no prior information about the 
shape of the viraemia profiles is needed and is thus a logical place from which to begin analysing the 
impact of diverse influencing factors on longitudinal viraemia  data [15,17]. Through the repeated 
measures model LSMs for viraemia were obtained at each observation time, and the effects of the 
influencing factors on these were examined. But the repeated measures modelling approach did not 
capture the full non-linear time trends of the individual viraemia profiles, thus the Wood’s model 
fitting approach was adopted which allowed us to construct full viraemia curves for the entire time 
course of the experiment, and also examine the effect of the various factors on the model parameter 
estimates. 
The fixed effects of virus isolate, genetic background or trial were consistently significant in both 
statistical modelling approaches. In the repeated measures model, however, the WUR genotype, age 
and sex were also a significant fixed effects but not in the Woods model. The age range was only 17-
36 days. The lack of significance of age in the linearized Wood’s model could be due to the age range 
of the pigs not being large enough to capture the variation it could contribute to the viraemia profile, 
Furthermore one can hypothesize that at a later age, that would be captured in a future experiment 
which contains a larger age range of pigs, the sex could have a more significant impact upon the 
viraemia in the linearized Woods model. 
The significance of the genetic background on the viraemia profiles supports the increasing evidence 
in support of the host genetic contribution to a PRRS virus infection. Previous PRRSV challenge 
experiments have already revealed breed differences in viraemia levels and duration [1,27-29]. Reiner 
et al.[30] observed that Pietrain pigs infected with an attenuated PRRSV strain had longer viraemia 
lasting until 72 days post infection (dpi), whilst for Miniature pigs the viraemia only lasted up to 
35dpi. Viraemia profiles in Pietrain pigs revealed both uni- and bimodal curves similar to the bimodal 
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profiles observed in this chapter [31]. Significant differences between genetic background, within 
each virus isolate, found in both linear mixed modelling approaches in this chapter is in line with the 
previously observed concept of inter-breed variation in viraemia. The WUR SNP was found in several 
previous quantitative genetic studies that already been performed on a subset of the viraemia data 
used in this chapter [8,10,12,32]. Using the repeated measures models the WUR genotype 0 had 
higher viraemia values at all stages of infection than the WUR 1 and 2 genotypes and the WUR 2 
genotype had lower Wood’s profile, despite non-significant Wood’s parameter differences, than the 
other genotypes, in this chapter. These results for the WUR genotype are in line with the previous 
studies on this dataset which have shown that the WUR SNP resulted in reduced AUC of viraemia 
[8,10,32]. In a previous study as part of the PHGC consortium the WUR genotype has been tested for 
the Hardy-Weinberg equilibrium and the BB homozygotes were less frequent than expected[8]. 
Significant differences between the viraemia profiles (for 0-21dpi) of the two virus isolates NVSL and 
KS06 were found using both statistical approaches. The viraemia profiles between the two isolates 
differed in the rate of increase to peak viraemia, magnitude of the peak, the time of the peak and the 
rate of clearance. The viraemia LSMs for both virus isolates obtained from the repeated measures 
model were not significantly different at 42dpi, which would suggest that the host’s immune response 
to NVSL infections was similarly effective at the later stages of infection as the response to KS06.  
According to the Wood’s model, NVSL infection generates on average a faster increase to a higher 
and earlier peak than infection with KS06, followed by a faster rate of decline. However the virus 
isolate differences reduce over time. NVSL had lower parameter values for b and c, higher parameter 
A than KS06 and a shorter time to the peak (𝑏/𝑐 dpi). Different virus strains can differ in virulence 
levels and their ability to cause reproductive failure [33]. The isolate differences were expected since 
NVSL is known as a highly virulent isolate [19,20]. A previous study found strain differences 
manifesting in differences between the viraemia profiles [34]. Furthermore these differences could be 
related to differences in the immune response to the particular PRRS viral strains, such as differences 
in expression of the anti-viral cytokine interferon alpha [34]. In Chapter 4 the relationship between 
viraemia and cytokine profiles from a subset of the NVSL profiles will be analysed.  
The majority of profiles were uni-modal, however bimodal viraemia profiles were also observed: 16% 
for KS06 compared to 27% for NVSL. Bimodal profiles were observed across all trials, genetic 
backgrounds and WUR genotypes. There were a similar percentage of bimodal profiles between trials 
within each virus isolate. The WUR genotypes were distributed similarly between the uni- and 
bimodal profiles within each virus isolate. Overall NVSL had a higher percentage of bimodal profiles 
than KS06. This could be due to the faster viraemia dynamics allowing for a second peak to be 
captured in the current time course of the experiment. The slower dynamics of a typical KS06 
viraemia profile could result in a second peak hypothetically arising after 42dpi and would thus not be 
captured in the experiment. The statistical results with regards to the impact of fixed effects on the 
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repeated measures LSMs, Wood’s parameters and resulting profiles were robust to the inclusion of bi-
modal profiles, with only one discrepancy in the significance of the repeated measures LSMs between 
the WUR genotype 0 and 2 at 35dpi. Inspection of the model residuals for the repeated measures 
model revealed that the model was adequate for the early phase of infection (up to 14dpi) with 
residuals within 2 units on the log10 scale. Inspection of the raw data indicated that inter-host variation 
increased over time. In line with this increase of variation, residual variation also increased at the later 
infection stages. However, residuals reached magnitudes of up to 5 units on the log10 scale, indicating 
a poor model fit. The fit of the repeated measures model improved substantially after removal of 
bimodal profiles.  Nevertheless, there were still residuals greater than 3 units on the log10 scale at 
35dpi suggesting that the repeated measures model did not adequately capture the late stage viral 
dynamics for all profiles.  
The Wood’s model appeared a suitable candidate model for the data associated with uni-modal 
profiles since its shape matches the shape of a typical uni-modal viraemia profile. Furthermore the 
Wood’s model captures the time trends concisely in only three model parameters which also have a 
biological relevance. Overall the best fitting Wood’s model was when there was a random effect in 
Wood’s parameters b and c according to the LRT. In particular, models with individual variation in 
the parameter c provided better fits than those without variation in this parameter. This result is 
expected due to the fact that the variation in parameter c results in variation in the rate of decline from 
the peak viraemia which captures the increased inter-host variation from 7dpi onwards. There is a 
general tendency for the Woods model to over-predict viraemia at 42dpi, which can easily be 
explained by the fact that the Wood’s curve converges to but never reaches, zero. This latter property 
of the Wood’s function may in fact be a clearer representation of reality; we are never able to confirm 
that viraemia levels truly reach zero, but only that they have reached levels below the detection 
threshold determined by the accuracy of experimental observations.  
The residuals from fitting the final linearized Wood’s function revealed that, as with the repeated 
measures approach, the bimodal profiles reduced the model fit to the data. The magnitude of the 
residuals on the scale on which they are calculated were a misleading indication of the model fit; 
back-transformation of the data and predictions to the log10 scale revealed that the residuals were 
actually relatively high values reaching 3 units of the log10 scale. Similar to the repeated measures 
model, the Woods model fit was adequate from 0- 14dpi. However, from 14dpi the range of residuals 
was high and indicative of poor fits particularly at 35dpi. Comparison of the residuals revealed that 
the repeated measures approach led to a slightly better fit to the data, particularly at 0-14dpi. A better 
fit is needed in order to determine the host genetic influence on viraemia profiles and to explore the 
relationship between viraemia profiles and the immune response. The poor Wood’s model fits are 
likely a manifestation of the linearization process as opposed to a reflection of the suitability of the 
Wood’s function as a candidate model for viraemia profiles. Ideally a nonlinear function would be fit 
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directly to the data since the process of linearizing the function provides LSM estimates and standard 
errors for the parameters of the linearized model on the natural log-scale. Directly fitting the nonlinear 
Wood’s function to the log-transformed viraemia data would overcome this problem. However when 
this approach was adopted and PROC NLMIXED was used, it failed to converge when random 
effects were included into the model. Thus in Chapter 3 the method of directly fitting the Woods 
model to the data using a Bayesian model fitting approach will be adopted. 
The Wood’s model is a uni-modal function and cannot capture the second phase of the bimodal 
profiles.  In order to capture the full range of viraemia profiles the Wood’s model needs to be 
extended. Fitting a bimodal Wood’s function is not possible in the linear mixed modelling framework 
used in this chapter. Furthermore the current method of bimodal classification was derived from 
visual observation and results from calculating the differences between two observations separately. A 
better approach may be to evaluate the whole infection period and use the statistical significance of 
the fit of a bimodal model to derive viraemia classification, which will be explored in the next 
chapter. Deriving a better model fit in the next chapter will allow for a deeper analysis of the time 
trends of viraemia profiles from a PRRSV challenge. However the correlations between the AUC of 
the viraemia and the profile type would not be a useful analysis since by definition the viraemia 
bimodality or “viraemia rebound” results in a larger AUC, Conversely a more useful scientific 
question to explore is whether the information derived from the early phase of infection can be used to 
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Quantitative analysis of Porcine Reproductive and Respiratory 
Syndrome (PRRS) viraemia profiles from experimental infection: a 
Bayesian statistical modelling approach  
3.0 Introduction 
Empirical mathematical models have proven useful for describing the temporal evolution of a 
response variable and filtering stochastic noise from dynamic biological systems whilst retaining the 
most fundamental features [6,13,25,26]. In the previous chapter linear mixed models were used to 
capture the viraemia profiles from a PRRSV challenge however better model fit is needed in order to 
determine the host genetic influence on viraemia profiles and to explore the relationship between 
viraemia profiles and the immune response. The poor Wood’s model fits are likely a manifestation of 
the linearization process as opposed to a reflection of the suitability of the Wood’s function as a 
candidate model for viraemia profiles. Ideally a nonlinear function would be fit directly to the data 
since the process of linearizing the function provides LSM estimates and standard errors for the 
parameters of the linearized model on the natural log-scale. Directly fitting the nonlinear Wood’s 
function to the log-transformed viraemia data would overcome this problem. Thus in this chapter the 
method of directly fitting the Woods model to the data using a Bayesian model fitting approach is 
adopted. 
In Chapter 2 the Wood’s model appeared a suitable candidate model for the data associated with uni-
modal profiles since its shape matches the shape of a typical uni-modal viraemia profile. Furthermore 
the Wood’s model captures the time trends concisely in only three model parameters which also have 
a biological relevance. However the Wood’s model is a uni-modal function and cannot capture the 
second phase of the bimodal profiles.  In order to capture the full range of viraemia profiles the 
Wood’s model needs to be extended. Fitting a bimodal Wood’s function is not possible in the linear 
mixed modelling framework hence a Bayesian approach is adopted in this chapter. Furthermore the 
method of bimodal classification in Chapter 2 was derived from visual observation and results from 
calculating the differences between two observations separately. A better approach in Chapter 3 may 
be to evaluate the whole infection period and use the statistical significance of the fit of a bimodal 
model to derive viraemia classification. Deriving a better model fit in this chapter will allow for a 
deeper analysis of the time trends of viraemia profiles from a PRRSV challenge. The primary 
objective of this chapter was to find mathematical functions that adequately represent the full range of 
viraemia profiles obtained from a large scale PRRSV infection experiment, and use these to determine 
quantitative characteristics of infection dynamics. The functions will be used to derive an objective 
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method of classification of viraemia profiles based on statistical inference and to assess the 
relationship between the breadth of nAb response and viraemia profile. 
Chapter 3 has been published in Plos One and below is an outline of the contribution of the authors: 
Zeenath U. Islam: carried out the analysis, developed hypotheses  
Stephen C. Bishop, Andrea B. Doeschl- Wilson: directed the analysis and informed the development 
of hypotheses 
Raymond R.R. Rowland, Joan K. Lunney, Benjamin Trible: provided the viraemia and nAb data.  
Nicholas J. Savill: provided the computer program for fitting the functions to the viraemia data.   
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Abstract
Porcine reproductive and respiratory syndrome (PRRS) is one of the most economically significant viral diseases facing the
global swine industry. Viremia profiles of PRRS virus challenged pigs reflect the severity and progression of infection within
the host and provide crucial information for subsequent control measures. In this study we analyse the largest longitudinal
PRRS viremia dataset from an in-vivo experiment. The primary objective was to provide a suitable mathematical description
of all viremia profiles with biologically meaningful parameters for quantitative analysis of profile characteristics. The Wood’s
function, a gamma-type function, and a biphasic extended Wood’s function were fit to the individual profiles using Bayesian
inference with a likelihood framework. Using maximum likelihood inference and numerous fit criteria, we established that
the broad spectrum of viremia trends could be adequately represented by either uni- or biphasic Wood’s functions. Three
viremic categories emerged: cleared (uni-modal and below detection within 42 days post infection(dpi)), persistent
(transient experimental persistence over 42 dpi) and rebound (biphasic within 42 dpi). The convenient biological
interpretation of the model parameters estimates, allowed us not only to quantify inter-host variation, but also to establish
common viremia curve characteristics and their predictability. Statistical analysis of the profile characteristics revealed that
persistent profiles were distinguishable already within the first 21 dpi, whereas it is not possible to predict the onset of
viremia rebound. Analysis of the neutralizing antibody(nAb) data indicated that there was a ubiquitous strong response to
the homologous PRRSV challenge, but high variability in the range of cross-protection of the nAbs. Persistent pigs were
found to have a significantly higher nAb cross-protectivity than pigs that either cleared viremia or experienced rebound
within 42 dpi. Our study provides novel insights into the nature and degree of variation of hosts’ responses to infection as
well as new informative traits for subsequent genomic and modelling studies.
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Introduction
Porcine reproductive and respiratory syndrome (PRRS) is one
of the most important infectious diseases threatening pig
production worldwide [1]. PRRS reduces reproductive perfor-
mance in breeding animals and increases respiratory problems in
animals of all ages, leading to impaired growth in young piglets
and, in some cases, mortality [2–4]. Infection with the PRRS virus
(PRRSV) results in viremia and virus replication in multiple
organs within the host; the targets for replication are macrophages
in various tissues, primarily the lung but also in lymph nodes,
spleen, placenta and umbilical cord [5–7]. One of the most
significant challenges facing the eradication of the disease is the
persistent nature of the etiological agent, PRRSV, which may
persist within the host for several weeks or months, in some cases
maintaining a sub-clinical lifetime persistence [8,9]. If the
persistently PRRSV infected individuals also remain infectious,
they can drive the epidemiological dynamics of the disease within
the population through perpetuating the cycle of transmission to
susceptible animals [10].
Viremia profiles of in-vivo experimentally PRRSV challenged
pigs are valuable indicators of the severity and progression of the
infection in the host, and thus provide crucial information for the
required subsequent disease control measures [11]. The course of
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a typical PRRSV infection is characterised by an acute viremic
stage lasting approximately 4 weeks followed by a stage
characterised by low levels and eventual resolution of viremia.
Previous studies suggest that in the majority of animals viremia
reaches undetectable levels typically by 4–6 weeks, although the
virus may still be isolated months later in the lymphoid tissues
[12,13].
PRRSV challenge experiments with longitudinal viremia
measures reveal substantial differences in the viremia profiles
between hosts infected with the same PRRSV challenge dose,
pointing to considerable variation in the host response to PRRSV
infections. For example, numerous studies have shown breed
differences in viremia levels and duration and also in antibody
production [11,14–16]. Reiner et al.[17] observed that Pietrain
pigs infected with an attenuated PRRSV strain had longer viremia
lasting until 72 days post infection (dpi), and a less efficient
antibody production than Miniature pigs whose viremia only
lasted up to 35 dpi. Viremia was classified as persistent in Pietrain
pigs, however the profiles revealed both uni- and biphasic curves
which could be a manifestation of viremia reactivation from the
original infection within the host or reinfection between the pigs
[18]. Using longitudinal viremia records collected over a 42 day
period from 531 pigs challenged with a virulent PRRSV strain,
Boddicker et al. [19]reported substantial differences between
individual viremia profiles and also in total viremia, summarised as
‘‘area under the curve’’ (AUC) or viral load (VL). Furthermore,
based on visual inspection, they classified pigs into two categories,
i.e. non-rebounders and rebounders, characterised by mono- and
bi-phasic serum viral profiles, respectively.
Given the apparent diversity in viremia patterns, several
important questions arise. For example, for vaccine development
or consideration of genetic disease control strategies it is important
to determine whether and to what extent the observed differences
in the profiles are influenced by the host and the virus genotype. In
the longitudinal study of Boddicker et al. [20], the VL measure
was found moderately heritable (h2 = 0.3), pointing to significant
host genetic influence underlying disease severity and progression.
Rebound was however not found to be heritable and thus thought
to be controlled more by the virus than the host genotype [20].
However, the low heritability estimate of this trait (0.03) may have
arisen due to the limited dataset, insufficient observations to
capture the rebound phase, or the potential misclassification of
individuals based on visual inspection of the profiles. Furthermore,
there may be other profile characteristics representing host genetic
variation in specific immune functions.
One hallmark of PRRSV is its high genetic diversity due to its
fast mutation rate, resulting in continuous emergence of new
quasi-species that may evade the host’s immune system [21,22].
Antibodies with PRRSV-neutralising activity usually appear from
14–28 days post infection (dpi) and are correlated with the
reduction of PRRSV in the lung and the peripheral blood [23].
Despite conflicting reports on the significance of neutralizing
antibodies (nAb) in anti-PRRSV protection [24], one would
expect that diversity in the nAb response is important for cross-
protective immunity against different PRRSV isolates, mutants or
quasi-species. Thus, it would be useful to know whether host
differences in viremia patterns are also reflected by differences in
the breadth of nAb, and whether these measures are directly
related. For example, one may hypothesize that a host that is able
to clear the virus faster may have a less diverse nAb response than
hosts with persistent or bi-phasic viremia profiles experiencing
more cycles of virus replication and mutation.
From an epidemiological perspective, viremia rebound may
constitute a problem as pigs diagnosed as cleared may have high
levels of infectious virus a few days later. It would be useful to
know whether viremia rebound reflects genuinely viremia
reactivation rather than fluctuations in circulating virus load or
measurement errors, and whether all or only a subset of pigs
experience rebound. In particular, it would be useful to know
whether virus rebound, or persistence, can be predicted based on
early serum profile characteristics.
Addressing the questions raised above would require frequent
repeated measurements of viremia, as well as of nAb diversity, on a
large number of pigs subjected to the same experimental PRRSV
challenge conditions. Such data are now available from the PRRS
Host Genetic Consortium [1]. However, raw viremia data are
inherently noisy and incomplete. Empirical mathematical func-
tions have proven a useful tool for smoothing noisy data profiles
and for exploring characteristics of dynamic patterns [25,26].
Thus, an appropriate mathematical function may be able to
concisely represent the full range of viremia profiles using only a
few parameters. In particular, functions in which individual
parameters represent specific curve characteristics provide an
opportunity to apply rigorous statistical analysis to quantify
differences in viremia patterns.
The primary objective of this study was to find mathematical
functions that adequately represent the full range of viremia
profiles obtained from a large scale PRRSV infection experiment,
and use these to determine quantitative characteristics of infection
dynamics. The functions will be used to derive an objective
method of classification of viremia profiles based on statistical
inference and to assess the relationship between the breadth of
nAb response and viremia profile.
Materials and Methods
Experimental Data
The data analysed in this study was obtained from the PRRS
Host Genetic Consortium (PHGC) trials, the largest PRRSV in-
vivo challenge study to date; a detailed description of the
experimental protocol is outlined in [1,27]. Briefly, viremia data
was obtained from pigs which were experimentally infected with
NVSL 97–7985, a virulent isolate of PRRSV, [28], in eight
separate infection trials (ca. 200 pigs/trial) with an infection dose
of 105 tissue culture dose50 (TCID50). The challenged pigs came
from high health farms that were free of PRRSV, Mycoplasma
hypopneumoniae and swine influenza virus. Pigs were placed
randomly in pens of 10–15 pigs and were infected with PRRSV
after a 7 day acclimation period, i.e. at 0 days post infection
(0 dpi). Blood samples were collected immediately before infection
(0 dpi) and at 4, 7, 11, 14, 19/21, 28, 35, 40/42 dpi and the level
of PRRS viremia was measured using a semi-quantitative
TaqMan PCR assay for PRRSV RNA. The viremia quantity
data from RT-PCR was transformed on the logarithmic scale to
the base 10 before the model fitting. Due to the sensitivity of RT-
PCR the threshold of detection was set at 1 units on the log10 scale
[20].
For the purpose of this study, only individuals with a minimum
of 6 serum viremia observations were retained. This resulted in a
viremia dataset comprising 1371 pigs in total, with over 170 pigs
per trial, with the exception of trial 6 for which data from 89 pigs
with less than 6 viremia observations had to be discarded. The
majority of missing observations in Trial 6 were from 14 dpi
onwards due to the outbreak of a bacterial infection, thus reducing
the potential to capture viremia rebound. All individuals from
Trials 7 and 8 were missing the last observation at 40/42 dpi due
to management issues in the experimental facility.
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To explore hypotheses surrounding the association between
viremia profiles and the variability of the nAb response to PRRSV,
nAB data from serum collected at 42 dpi was obtained for 490
individuals from the first three trials using a virus neutralization
assay as outlined in [29]. Briefly, serum neutralising assays were
conducted to examine the presence of cytopathic effects on the
homologous PRRSV strain as used in the in-vivo challenge
experiment (NVSL-7985 denoted henceforth as NVSL) and three
additional PRRSV isolates: KS06-72109 (KS06), P-129 and VR-
2332 (VR). These type 2 PRRSV isolates were chosen for genetic
differences based on viral ORF5 sequence. KS06 had been
isolated in 2006 and as a more contemporary isolate is still found
in the field. Excluding the relatedness between P129 and NVSL
(95%), nucleotide comparisons within ORF5 show that the
PRRSV isolates differed from each other by 10% or greater.
Each serum sample was reacted with the panel of four type 2 viral
isolates, where the NVSL isolate served as the homologous virus in
the serum neutralisation assays. Serum samples were considered
positive for PRSSV nAb at a titre of eight or higher. Individuals in
PHGC Trials 1–3 were assigned to one of the following five nAb
categories: 1) failed to produce a nAb response, 2) only produced
antibodies against the challenge virus (homologous nAb response),
3) produced nAb against the original and a different isolate (mild
heterologous response), 4) produced nAb against the original and
two different isolates (moderate heterologous response), 5)
produced nAb against all four isolates (broad response). Analysis
was conducted on the combined nAb categories of no cross
protection (categories 1–2) and cross-protection (categories 3–5) as
this was the most biologically relevant grouping of the nAb classes.
Viremia Profile Characteristics and Mathematical Models
Visual inspection of the individual viremia profiles from the raw
data indicated that the profiles can be empirically grouped into
three categories, illustrated in Figure (1): undetectable viremia
levels at 42 dpi, persistence up to 42 dpi, and apparent clearance
within the first 35 dpi followed by viremia rebound. Thus,
observed profiles were either uni- or biphasic. Apparent viremia
rebound occurred from 28 dpi onwards. A suitable mathematical
model should thus be able to represent both uni-modal clearance
and persistence as well as biphasic viremia rebound. Despite large
inter-host variation in the individual profiles, visual inspection
further indicated that all non-rebound viremia profiles and the
primary phase of rebound profiles are characterised by a relatively
rapid viremia increase towards the peak followed by a gradual
exponential decline. Furthermore inter-host variation in the
profiles is initially small, but increases over time.
Wood’s Model
The Wood’s function, a gamma-type function often used to
empirically describe lactation curves in dairy cattle [25,30,31], was
chosen as candidate model as it appears to satisfy the above
described data characteristics of the uni-modal profiles and the




where y(t) represents the level of viremia in the blood (log10 RT-
PCR) at t days post infection (dpi). The constant a1 is a scalar
quantity and impacts upon the magnitude of all the points on the
curve. The parameter b1 is an indicator of the initial rate of
increase to the peak viremia level and the parameter c1 is an
indicator of the rate of decline after the peak and dominates the









e{b1 . Other curve characteristics, such as the rate
of viremia decline at any point in time or the cumulative viremia
load up to a given time t post infection can be readily obtained by
differentiation or integration of the above function.
Extended Wood’s Model
In order to represent the bi-phasic profiles, the Wood’s function
was extended to a biphasic function described by equation (0.2):
y(t)~a1t
b1 e{c1tz max (0,a2(t{t0)
b2 e{c2 (t{t0)) ð0:2Þ
where the model parameters a1,b1 and c1 define the primary
phase of the rebound profile as described for the Wood’s model
above. Time t0 denotes the onset of the second phase of the
profile, which is assumed to follow the same (Wood’s) shape as the
primary phase and is thus defined by the second set of Wood’s
model parameters: a2,b2,c2. For tvt0 the Extended Wood’s
model is equivalent to the Wood’s model. The Extended
Wood’s model has the derived parameters denoting the time








e{b2 . Similarly, rates of viremia
decline or cumulative viremia load at any time post infection
can be calculated through differentiation and numerical integra-
tion of the Extended Wood’s function.
Model Fitting and Parameter Estimation
Both the Wood’s and Extended Wood’s function were fitted to
the individual data profiles using Bayesian inference with a
likelihood framework. This was implemented by using an
adaptive, population based Markov chain Monte Carlo method
with power posteriors as described in [32–35]. The prior
distributions for the function parameters were assumed to be
uniformly distributed within a biologically realistic range. Param-
eters were estimated separately for each pig. The resulting
inferences are based on 3000 samples, thinned from 2|105
iterations of a non-adaptive Markov chain, with the first half of the
chain discarded as burn in. For observations greater than the RT-
PCR measurement threshold of 1 units on the log10 scale the
errors were assumed normally distributed around 0 with a
standard deviation of 0.5 log units, and for observations less than
or equal to the RT-PCR observation threshold the errors were
assumed cumulative normal.
Both the Wood’s and Extended Wood’s functions were fitted to
all pigs. Thus the fitting procedure provided for each individual
pig posterior distributions for every parameter of the Wood’s and
Extended Wood’s function, respectively, from which parameter
means, modes and credibility intervals were derived.
Assessment of Model Fit
The accuracy of the model fit and choice of best model was
assessed based on the Akaike’s Information Criterion (AIC),
together with inspection of the predicted model profiles with 95%
posterior credibility intervals for every individual, to gain insight
into both the accuracy and potential bias of the model predictions
over the time course of the experiment. This included plotting
histograms of the parameter estimates, inspection of the residuals,
as well as calculating the (product moment) correlation between
observations and predictions at each sampling time point.
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Objective Classification of Profiles
Due to the high degree of fluctuation in the viremia
measurements, classification of the raw data profiles into the
three categories shown in Figure 1 is somewhat arbitrary and not
always straight-forward. However, the two alternative mathemat-
ical viremia models, i.e. the Wood’s and the Extended Wood’s
model, together with statistical measures of goodness-of-fit
provided an objective method for assigning the profiles into uni-
modal and biphasic categories.
An individual was classified as experiencing viremia rebound if
the biphasic Extended Wood’s model had a statistically superior
fit to the data than the uni-modal Wood’s model at the
95% significance level. For this purpose, both models were
separately fitted to the individual’s log10 RT-PCR data and
the Akaike’s Information Criterion (AIC) was obtained. The
AIC difference between the competing models for each
individual pig is analogous to the likelihood ratio test statistic (D)
when adjusted for twice the difference in the number of
model parameters of the two models. The Wood’s model has
3 parameters and the Extended Wood’s model has 7
parameters, thus the AIC difference adjusted for the number
of parameters becomes:AICWOODS{AICEXTENDEDWOODS~D{
2(7{3)~D{8. Thus at the 95% significance level the
required likelihood ratio test, obtained from the chi-
squared distribution, with 4 degrees of freedom, was D~9:488
[36], corresponding to a critical difference in the AIC
ofAICWOODS{AICEXTENDEDWOODS~9:488{8~1:488. Thus,
if the AIC difference was greater than or equal to this value
(1.488) then the profile was classed into the biphasic rebound
category, otherwise it was classed as uni-modal.
Transient experimental persistence henceforth referred to as
persistence was defined as a subset within the non-rebound profiles
according to the Wood’s model prediction at the end of the
experiment, i.e. at 42 dpi. If the model prediction at that time
point remained above the detection threshold of one RT-PCR
unit on the log10 scale then the profile was classified as ‘persistent’
within the 42 day observation period, otherwise it was referred to
as ‘cleared’.
Assessment of Individual Viremia Profile Properties
Description of the individual viremia profiles by analytical
functions provides the opportunity to explore whether viremia
features associated with different phases of the infection are
related, and to construct and test hypotheses. Pearson product-
moment correlations were calculated between individual Wood’s
and Extended Wood’s function parameter estimates and the
derived parameters -(t1,v1,t2,v2) to determine whether general
patterns were apparent in the fitted profiles (e.g. is there an
association between viremia increase before the local peak and
post-peak decrease, etc.). In particular, within the category of
rebounders, associations between the shapes of the viremia curves
describing the primary and the rebound phase of infection (i.e.
tvt0 and twt0, respectively) were tested.
Furthermore, to determine whether the phenomenon of
transient persistence or viral rebound could be predicted by the
shape of the profile during the earlier phase of infection, the
Wood’s model was fitted to the truncated dataset comprising
observations from all pigs (rebounders and non-rebounders) from
0 to 21 dpi only. A linear mixed model analysis (using PROC
MIXED of SAS 9.3) was then carried out to assess statistical
differences in the individual Wood’s curve parameter estimates
associated with the different profile types (cleared, persistent and
rebound), respectively. The dependent variables were the individ-
ual mean values of the estimated posterior distributions of the
Wood’s model and derived parameters obtained from the primary
phase:a1,b1,c1,t1,v1. Fitted random effects were pen within trial
Figure 1. Raw phenotypic data profiles of three representative pigs experimentally infected with PRRSV. The viremia profile categories
are: undetectable within 42 dpi (black dotted line), mono-phasic experimental persistence up to 42 dpi (grey line ), and bi-phasic rebound (black
line).
doi:10.1371/journal.pone.0083567.g001
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and dam within trial. In the full model the fixed effects were the
rebound class, trial, sex, parity and the interaction between trial
and parity. Fixed and random effects were hierarchically removed
according to statistical significance. Pairwise differences between
the profile classes were assessed using the contrast statement of
SAS PROC MIXED, which uses the F-test statistic.
Association Between Viremia Profiles and Neutralising
Antibody Response
To test the hypothesis whether viremia rebound, clearance or
persistence was associated with greater within host viral diversity
and thus more diverse neutralizing antibodies, logistic regression
was carried out for the 439 pigs with nAB assays, using PROC
GLIMMIX in SAS 9.3, assuming an exponential distribution of
the data, conditional on random effects. In the full mixed model
the dependent variable was the neutralising antibody class (i.e.
binary as the nAB categories were pooled), the independent
variables were the class of the viremia profiles (i.e. cleared,
persistent or rebound). In addition, trial, profile class, parity, sex
and corresponding interactions were fitted as fixed effects and dam
within trial and pen within trial were fitted as random effects.
Similar to the mixed model analysis above, the number of random
and fixed effects in the full model was hierarchically reduced by
examining their impact on the AIC model fit statistics, and




Visual inspection of the predicted individual profiles (example
shown in Figure 2) confirmed the appropriateness of the statistical
classification method based on goodness of model fit. Only 12 and
4 of 1371 individuals had to be removed as outliers from the
Wood’s and Extended Wood’s analysis, respectively, as several of
their predicted viremia values differed from the corresponding
observed values by more than 2 log differences. Overall 17% of
the individuals were classified to experience viremia rebound while
83% were classified as non-rebounders (Table 1). Within the class
of pigs with a uni-modal viremia profile, 46% of pigs were
classified as pigs with persistent viremia whilst the remaining 54%
of the non-rebounders appeared to have cleared the viremia. The
percentages differed slightly between trials (Table 1). The lower
percentage of rebounding profiles in trials 6–8 (7%, 6%, and 9%
respectively), was possibly due to the higher number of missing
values particularly in the later stage of the infection in these trials.
Trails 7 and 8 were terminated at 35 dpi.
Goodness of Model Fits
Inspection of the individual model fits (e.g. Figure 2), residual
plots (Figure 3), and the Pearson product-moment correlations
(Figure 4), revealed that the vast majority of profiles are adequately
described by either the Wood’s or the Extended Wood’s model.
The mean of the Wood’s model residuals was close to zero at all
sampling times and the majority of the residuals were within 2
standard deviations from the mean residual, with an increased
residual variance and a slight tendency towards over-prediction
from 28 dpi onwards (Figure 3). The Wood’s model Pearson
product-moment correlations (Figure 4) indicated that the model
predictions and the data were highly correlated throughout the
experiment. The average predicted time for the peak viremia was
7 dpi (Figure 4A), which coincided with the time of the second
observation in the experiment, however a small subset of
individuals with flat observations between 4 and 14 dpi contrib-
uted to a bias towards over-prediction at 7 dpi, leading to the
lowest correlation between the predictions and the data being
observed at this time point. The Wood’s model also had a
tendency to over-predict viremia at the late stages between 35–
42 dpi, resulting from the fact that by model definition viremia
levels are always positive (i.e. converge to zero but never reach
zero), whereas data were truncated to zero when viremia was
below the detection level. In fact, only 4 individuals had
observations of viremia level below detection at 19 dpi and
21 dpi, however by 28 dpi 15% of the observations were below
detection. By the end of the experiment 77% of the 492 individuals
with viremia observations at 42 dpi were below detection.
The extended Wood’s model gave a tighter plot of residuals
(Figure 3B) with a reduced overall bias, and stronger correlations
between observed data and fitted values (Figure 4B), than the
Wood’s curve. However, for individual pigs there were wide
posterior predictive intervals (PPIs) around the second viremia
peak for the biphasic profiles (see example in Figure 2D), with this
uncertainty resulting from the fact that the viremic rebound was
generally represented by only one or two data points. As with the
Wood’s model, the Extended Wood’s model had a tendency to
over-predict the initial peak and also to over-predict viremia
around the second peak, a tendency most likely compounded by
the sparse data around these points.
Properties of Individual Viremia Profiles
Shape characteristics. The Pearson product-moment cor-
relations between the individual model parameters (Table 2) reveal
a strong relationship between the individual model parameter
estimates describing the first mode of the viremia profiles
(a1,b1,c1,t1,v1), but not between the parameter estimates related
to the second mode (a2,b2,c2,t2,v2), indicating a higher variation
in the predicted individual profile shapes related to the rebound
phase. In particular the estimates of the Wood’s parameters b1 and
c1 were highly correlated with a correlation of 0.92 and 0.87 for
uni- and biphasic profiles respectively, indicating that a rapid
increase to the peak viremia also corresponds to a rapid post peak
viremia decline during this phase. This was confirmed by highly
negative correlations (r = 20.84 and 20.88) between the deriva-
tives of the viremia functions at 4 and 19/21 dpi for the Wood’s
and Extended Wood’s model, respectively. This association did
not occur for the rebound phase (the correlation between b2 and
c2 was 0.15). As expected, the time of the second peak (t2) and the
value for the time of onset of the rebound phase t0 were highly
correlated; later onset of the secondary phase corresponded to a
later time of peak viremia in the secondary phase. Correlations
between the times and levels of peak viremia (i.e. between t1 and
v1, and between t2 and v2, respectively ) were generally weak.
Furthermore, the correlations between the corresponding Extend-
ed Wood’s model parameters defining the first and second mode of
the viremia curve, i.e. (a1,b1,c1,t1,v1) and (a2,b2,c2,t0,t2,v2),
respectively, were generally weak, with the exception for a
moderately strong negative correlation of 20.52 between the
parameters c1 and c2. Thus a fast viremia decline in the primary
phase tended to correspond to a slower decline in the secondary
phase and vice versa. Interestingly, the analysis revealed an
apparently strong negative association between the predicted peak
viremia and subsequent decline associated with the rebound phase
only (i.e. r(v2,c2) = 20.89, but r(v1,c1) = 0.23).
Is viremia clearance, persistence or rebound
predictable. The final mixed models for original and derived
Wood’s model parameters obtained from the truncated data from
the primary phase only (0–21 dpi), included fixed effects of profile
class (cleared, persistent or rebound) determined on the complete
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dataset, as well as the trial and the trial by parity interaction, with
pen within trial and dam within trial as random effects.
Statistically significant differences for all the individual Wood’s
curve parameter estimates (i.e. a1,b1,c1,t1 andv1 ) were found
between animals classified into the cleared and persistent viremia
classes, and between those classified as persistent and rebounders,
but not between animals classed as cleared and rebound (Table 3).
Inspection of the pairwise scatter plots of Wood’s model parameter
estimates (Figures 5A-C) shows clustering associated with the
different profile categories, in concordance with the statistical test
statistics (Table 3). Furthermore, identified differences between
parameters corresponding to persistent and non-persistent profiles
are also transparent in plots of the mean viremia predictions
together with their 95% confidence intervals (Figure 5D). Thus,
the results suggest that whereas persistence is predictable based on
the profile of the first 21 dpi, viremia rebound is not.
Association Between Viremia Profiles and Neutralising
Antibody (nAb) Response
The percentages of individuals in each nAb category for each
viremia profile class are presented in Table 4 and odds ratios of
nAb cross-productivity associated with different viremia profiles
classes are presented in Table 5. The final model used to test the
association between the profile-class and the nAb response
contained only the nAb class as dependent variable and the
viremia profile class as independent variable, with no other fixed
or random effects. There was a statistically significant association
Figure 2. Wood’s and Extended Wood’s model fits to viremia data of two representative pigs classified as non-rebounder (top
graphs) and rebounder (bottom graphs). Light-grey regions correspond to 95% posterior predictive intervals (PPI); dark-grey regions
correspond to 50% PPIs. The actual data are shown as green dots and the green solid lines give the best-fit solutions for the Wood’s model (A,C ) and
Extended Wood’s model (B, D), respectively.
doi:10.1371/journal.pone.0083567.g002
Table 1. Summary of the statistical classifications of the viremia profiles from the PRRSV challenge experiment
Number (percentage) of individuals within a specific viremia profile category
Class 1: Uni-modal Class 2: Biphasic
Trial Clearance within 42 dpi Persistence until 42 dpi Rebound
1 79 (61) 50 (39) 55 (30)
2 119 (83 ) 24 (17) 28 (16)
3 51 (37) 86 (63) 36 (21)
4 71 (47) 81 (53) 39 (20)
5 70 (48) 77 (52) 36 (20)
6 35 (35) 66 (65) 8 (7)
7 96 (55) 78 (45) 12 (6)
8 85 (59) 58 (41) 15 (9)
All (% of total) 606 (45) 520 (38) 229 (17)
Classifications of the viremia profiles are based on the likelihood ratio test comparing the Wood’s and the Extended Wood’s models. Trial 6 had 48% death prior to
21 dpi. Due to facility availability issues trials 7 and 8 had to be terminated at 35 dpi. Overall 17% were rebound, 38% were persistent and the remaining 45% were
clearance profiles.
doi:10.1371/journal.pone.0083567.t001
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(at the 95% significance level) between the profile class and the
diversity of the nAb response when the nAb categories were
pooled into two groups (i.e. no nAb cross-protection and cross-
protection). Clearance corresponded to a less diverse nAb response
than persistence and pigs with persistent viremia had a more
diverse nAb response than those with rebound profiles (Table 5).
However, there was no statistical significant difference in nAb
cross-protectivity between pigs that cleared viremia within 42 dpi
and rebounders (Table 5).
The results thus suggest that the slower clearance rate of viremia
in the persistent profiles, but not viremia rebound, is associated
with a more diverse nAb response.
Discussion
Empirical mathematical models have proven useful for describ-
ing the temporal evolution of a response variable and filtering
stochastic noise from dynamic biological systems whilst retaining
the most fundamental features [31,37–39]. Previous studies have
used such models for the quantitative analysis of growth, weight
gain and lactation [37,40]; however to our knowledge this is the
first study in which they have been applied to infection profiles.
The comprehensive PHGC dataset comprising repeated PRRS
viremia measurements from 1371 commercial pigs provided a
unique opportunity to assess the nature and degree of variation in
the host response to PRRSV infection. The main aims of this study
were to obtain a mathematical function to aid the characterisation
and to further our current understanding surrounding the wide
spectrum of observed PRRS viremia profiles.
Using maximum likelihood inference and numerous model fit
criteria, we established that the broad spectrum of observed
viremia trends from 0–42 dpi could be adequately represented by
either the uni- or biphasic Wood’s functions. Representative
parameter estimates of the data resulting in good model fits and
residuals were obtained for the vast majority of individuals, and
pigs could be objectively classified into one of three viremic
categories. This together with the convenient biological interpre-
tation of the model parameters and derived parameter estimates,
such as the time and level of viremia peak, allowed us not only to
quantify inter-host variation, but also to establish common viremia
curve characteristics and determine their predictability.
Assessment of the fitted models revealed a generally close fit of
the Wood’s and Extended Wood’s model to the log transformed
viremia data over the whole 42 day duration of the experiment,
with few exceptions. The lowest data-prediction correlation was
observed at 7 dpi, which corresponds to the average time for the
peak viremia level. The residuals showed that for certain
individuals the model over-predicts the value at this observation.
There are two main factors which may contribute to this lack of fit:
firstly for individuals whose peak viremia may lie between 4–7 dpi,
the lack of data representing the dynamics of the infection during
this period of rapid change may contribute to the over-prediction.
Secondly for individuals with a fairly flat plateau of observations
between 4–14 dpi the issue lies with the Wood’s model itself; in
this case the model systematically predicts a higher and sharper
peak than the data would suggest as it is unable to produce a flat
plateau near the peak. The Wood’s (and Extended Wood’s) model
itself is constrained by the model parameters; the time of the peak
viremia level is dependent on both parameters b1 and c1 which in
turn contribute to the rates of pre-peak viremia increase and post-
peak viremia decline. In contrast, the general tendency to over-
predict viremia from 28 dpi onwards for non-rebounders can
easily be explained by the fact that the Wood’s curve converges to,
but never reaches, zero. This latter property of the Wood’s
function may in fact be a clearer representation of reality; we are
never able to confirm that viremia levels truly reach zero, but only
that they have reached levels below the detection threshold
determined by the accuracy of experimental observations. Note
that theoretically the log- transformed viremia data could reach
negative values which the Wood’s model would be unable to
capture. However such viremia observations never arise in
practice due to the experimental threshold of detection and hence
a function such as the Wood’s model that approaches zero is
appropriate for the current PRRS viremia dataset.
By parsimony, in the absence of more frequent measurements,
the Extended Wood’s model was chosen as it is a simple model
representing the main features of the biphasic profiles. It
encapsulates the assumption that the second phase of the profile
has the same essential shape characteristics as the primary phase.
Furthermore the Extended Wood’s model parameters were also
able to encapsulate the possible anamnestic nature of the immune
response; the parameters allowed for variation in the size, timing,
rate of increase and rate of decline in the secondary phase. The
consistency of the model residuals and correlations indicate that
the Extended Wood’s model provides indeed a good fit during
both phases of the profile; in fact the correlations between the data
and model predictions were highest during the second phase. The
second phase was generally shorter (28–42 dpi) and less severe
Figure 3. The Wood’s model residuals (3A) and the Extended Wood’s model residuals (3B). The red line shows the residual mean and the
blue lines delimit two standard deviations from the mean.
doi:10.1371/journal.pone.0083567.g003
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than the first phase (0–28 dpi), as indicated by greater predicted
rates of viremia increase and decline in the second phase of the
profile (parameter means for the primary and secondary phase
were: mean(b1,c1) = (0.66,0.10) and mean(b2,c2) = (4.67,3.78)),
and lower levels of peak viremia associated with the second phase.
This contrast in timing and size of the primary and secondary
phases supports evidence of the anamnestic nature of an
individual’s immune response in a rebound profile.
Despite the generally good fit of the Wood’s and Extended
Wood’s models, it is likely that a candidate model of greater
mathematical complexity could provide a better empirical fit to
the data; indeed much effort has been dedicated to the
identification of appropriate functions to describe e.g. lactation
Figure 4. The Wood’s(4A) and Extended Wood’s(4B) model mean predictions and data-prediction correlations. The black lines outline
the mean model predictions, and the dashed grey lines delimit the 95% prediction confidence intervals. The dotted black lines joined with crosses
show the Pearson product-moment correlations between observed data and predicted values.
doi:10.1371/journal.pone.0083567.g004
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or growth profiles in livestock [31,40]. Amongst these candidates
are spline functions, which indeed were able to provide a closer fit
to the present viremia data (results not shown). However their
increased complexity requires biological interpretation and does
not lend itself to a quantitative assessment of profile characteristics.
The Wood’s and Extended Wood’s models in contrast constitute
worthy candidates for this analysis, particularly as biologically
meaningful interpretations can be given to their parameters.
The 42 day study period gave rise to uni- or biphasic viremia
profiles only. It is possible that the observed biphasic profiles
represent damped oscillations which are truncated after 6 weeks
post infection. Oscillations often represent negative feedbacks with
delay in biological systems [41]. Such behaviour could arise from
the virus-host immune response interactions. An oscillatory
mathematical function such as a sine function may constitute a
plausible alternative to the Wood’s functions presented here and
would be attractive from the mathematical perspective due to the
few parameters needed to determine the period of the cycles and
damping factor of the oscillations. However the current dataset
doesn’t span a sufficient duration to inform parameter estimates
for such models; data from longer PRRS virus challenge
experiments would be required to test these hypotheses.
Table 2. The Wood’s and Extended Wood’s model parameter’s Pearson product-moment correlations.
Extended Wood’s Parameters a1 b1 c1 t1 v1 a2 b2 c2 t0 t2
a1 - 20.91 20.71 20.81 0.04
b1 20.85 - 0.92 0.59 0.21
c1 20.52 0.87 - 0.26 0.26
t1 20.84 0.52 0.39 - 0.004
v1 0.19 0.12 0.23 20.16 -
a2 20.05 0.07 0.10 20.02 20.01 -
b2 0.02 0.01 0.04 20.03 0.02 20.10 -
c2 0.03 20.30 20.52 0.33 20.27 20.08 0.15 -
t0 0.15 20.14 0.07 20.13 0.05 20.04 20.09 20.09 -
t2 0.17 20.10 0.57 20.20 0.10 20.06 20.05 20.24 0.98 -
v2 0.07 0.25 0.47 20.33 0.30 0.14 0.08 20.89 0.13 0.29
Upper triangle in bold: Wood’s model parameter correlations. Lower triangle: correlations between the Extended Wood’s model parameters.
doi:10.1371/journal.pone.0083567.t002
Figure 5. Woods parameters and mean model predictions for the 3 profile classes. Figure 5A-C. Pair-wise scatter plots and clustering of
primary phase Wood’s model parameters for the 3 profile classes: cleared (blue circles), persistent (pink diamonds) and rebound (black crosses).
Figure 5D. Mean Woods model predictions with the 95% Confidence Intervals (dashed lines) based on the truncated data from 0–21 dpi for
individuals previously classified as rebound (black), persistent (pink) and cleared(blue), respectively.
doi:10.1371/journal.pone.0083567.g005
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One of the advantages of fitting alternative mathematical
functions to viremia data is that it provided an objective method
for distinguishing uni-modal from biphasic viremia profiles based
on statistical inference. This helped to confirm previous observa-
tions from smaller scale studies (e.g. [17] and [20] ) that viremia
rebound is a genuine and common phenomenon in PRRSV
infections. This may have important epidemiological consequenc-
es, as individuals diagnosed as non-viremic at time of sampling
may harbour and shed infectious virus some days later. Similarly,
individuals with persistent viremia profiles are likely to be
infectious for longer. The question thus arises whether serum
viremia persistence or rebound can be predicted, e.g. based early
profile characteristics. Our statistical analyses, using data from the
primary phase (0–21 dpi) of the experimental infection, revealed
that profiles classed as persistent had, on average, a faster increase
to the peak and slower decline from the peak viral load than both
the rebound and clearance profiles. However, the results also
suggest that rebound and clearance profiles cannot be distin-
guished based on information from the primary phase. This result
has however important implications with regards to the following
hypothesis: considering that serum viremia data were only
collected for 42 dpi, one may hypothesise that every pig may
eventually experience rebound, provided that the virus has not
been completely cleared, and that rebound could only be observed
for a subset of pigs in this study due to censoring. However, if this
hypothesis was correct, there would be a higher probability of
observing rebound in individuals with faster viremia decline within
21 dpi. But, since no statistical difference was observed between
rebound and clearance on the truncated dataset, the existing
evidence would suggest that only a subset of pigs experiences
viremia rebound. Furthermore, we also observed that none of the
pigs with non-detectable viremia levels for 2 or more weeks
experienced viremia rebound within 42 dpi (results not shown),
Table 3. Viremia profile class and their Least Square Means (LSM) from the truncated data.
Wood’s parameter LSM (SE): Cleared LSM (SE): Persistent LSM (SE): Rebound PCP PCR PPR
a1 3.83 (0.049) 4.16 (0.051) 3.84 (0.066) ,.01 0.98 ,.01
b1 0.68 (0.011) 0.53 (0.012) 0.68 (0.017) ,.01 0.91 ,.01
c1 0.097 (0.0014) 0.072 (0.0015) 0.096 (0.0022) ,.01 0.92 ,.01
t1 6.90 (0.11) 7.82 (0.12) 6.99 (0.16) ,.01 0.58 ,.01
v1 6.60(0.018) 6.56 (0.019) 6.61 (0.024) 0.02 0.78 0.04
The LSM parameters estimates and standard errors (SE) derived from fitting the Wood’s model to the truncated dataset from 0–21 dpi for pigs whose viremia profiles
were classified as cleared, persistent and rebound, respectively. P-values corresponding to the associated test between the profile groups denoted by the subscript C, P,
R for cleared, persistent and rebound respectively.
doi:10.1371/journal.pone.0083567.t003
Table 4. Neutralising antibody (nAb) data and viremia class.
nAb category (1–5) Class Number Of Individuals Percentage [% of Class]
1 Rebound 6 5.9
2 Rebound 55 53.9
3 Rebound 11 10.8
4 Rebound 21 20.6
5 Rebound 9 8.8
Total (1–5) Rebound 102 -
1 Cleared 21 9.4
2 Cleared 104 46.6
3 Cleared 51 22.9
4 Cleared 33 14.8
5 Cleared 14 6.3
Total (1–5) Cleared 223 -
1 Persistent 16 14
2 Persistent 61 54
3 Persistent 21 18
4 Persistent 11 10
5 Persistent 5 4
Total (1–5) Persistent 114 -
Frequency and percentages of individuals classified as cleared, persistent and rebound, within each neutralizing antibody (nAB) category. nAB category 2 refers to
individuals whose serum contains nAB that can only neutralize the homologous PRRSV strain (NVSL) as used in the in-vivo infections; nAB categories 3–5 correspond to
nAB response to the homologous strain and k-2 other PRRSV strains.
doi:10.1371/journal.pone.0083567.t004
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thus indicating that rebound is unlikely to occur if the serum virus
has been cleared for a period of several weeks.
Analysis of the nAbs of infected pigs collected at 42 dpi
indicated that there was a strong homologous response to the
PRRSV challenge, in agreement with observations from previous
studies [42,43]. Our study not only revealed a high degree of inter-
pig variation in viremia profiles but also high variability in the
range of cross-protection of neutralizing antibodies collected at
42 dpi. Furthermore, a statistical association between the two
quantities was identified, which may point to the host-pathogen
interactions underlying the observed viremia and antibody
patterns. Both virus persistence within the host and cross-
protection of host antibodies have been previously linked to virus
mutation and emergence of quasi-species [9,38]. PRRSV evolves
rapidly in infected pigs with a high mutation rate of 1{3|10{2
substitutions per nucleotide and year [21,44]. Furthermore,
multiple variants of PRRSV were found to exist simultaneously
within individual animals [22]. Thus, in order to efficiently clear
the range of PRRSV quasi-species, a versatile neutralizing
antibody response would be required.
Our study revealed that pigs that manage to clear the virus from
the blood within 42 dpi have on average a less diverse nAB
response than pigs with persistent viremia profiles. In light of the
pathogen co-evolution, these results could be interpreted as rapid
clearance of the virus limiting the duration in which the virus may
evolve, resulting in an efficient, but relatively narrow antibody
response. Persistent profiles, in contrast, may be the result of a host
immune response that is inefficient in clearing the virus but in
which the diversification of the neutralizing antibody response is
driven by rapid virus mutation. Rebound is characterised by two
phases; the viremia decline in the first phase may be caused by an
effective, but narrow nAb response. However, before the immune
response has managed to fully clear the virus within the primary
phase, the emergence of a new quasi-species capable of escaping
the existing antibodies may cause the viremia to increase in a
second phase driving the continual diversification of nAbs that
eventually reduce viremia again. Thus, given that the majority of
rebound profiles are at the declining phase by 42 dpi, viremia
rebound would be expected to be associated with a more versatile
nAb response at 42 dpi than clearance, but a more narrow
response than persistence, which is in agreement with the results,
although the differences were not always found to be statistically
significant.
It should be noted, however, that the observed associations
between the nAB response and viremia patterns may equally arise
from confounding immune quantities affecting both nAB and
viremia, which were not measured in these studies. Indeed, several
alternative hypotheses, not necessarily involving virus mutation,
emerge as potential causes for viremia rebound. For example
viremia rebound may correspond to the second cycle of an
oscillating viremia profile which may arise naturally (and in the
absence of virus mutation) from predator-prey type interactions
between the virus and the immune response [45,46]. Alternatively,
rebound could arise from the heterogeneity of the virus
distribution in various tissues within the host. Previous studies
have observed that although viremia may be below detection in
the serum, persistent infection in the tonsils and lymphoid tissues
can last for longer than 6 months [18]. Thus, the site of replication
may be hidden from the serum and the infection may remain
localised in certain tissues. Rebound may be a manifestation of the
virus from these localised tissue infections being poured back into
the system; thus becoming detectable in the serum. The influx of
virus into the serum may occur in occasional bursts or as a final
out-pouring into the serum determined by some environmental
stimulus, immune response mechanism, or stochastic process. This
second hypothesis would imply that viremia rebound follows more
a distinct bi- or multi-modal pattern rather than a damped
oscillatory behaviour. Virus rebound manifesting itself in biphasic
viremia profiles is a common phenomenon in equine influenza
infections, the causative processes of which remain a mystery [47].
Additional information about virus heterogeneity and/or nAb
characteristics at different stages post infection would be needed to
assess these hypotheses.
Similar arguments may be used to interpret the observed high
inter-host variation in viremia decline post the initial viremia peak.
Variation in the rate of viremia reduction may be a function of the
host’s own immune response, virus mutation mechanisms or the
interaction between both processes. The moderate negative
correlation between parameters c1 and c2 (-0.52) indicates that a
slow decline in the first cycle corresponds to faster decline in the
second cycle and vice versa. This association may be indicative of
the temporal evolution of the immune response. A slow immune
response in the primary phase may prolong the conditions
required to produce neutralising antibodies and thus manifest in
a stronger or more diverse nAb at the end of the second phase.
Conversely, a fast initial immune response may indicate an
effective, but narrow nAb response during the primary phase so
that fewer or less diverse nAB are available for the second phase.
The identified association between nAb and viremia categories
would support this hypothesis, since persistent profiles have the
broadest response of all the profile categories.
From the current study we cannot affirm that there would be
infectious and epidemiological consequences in the secondary
phase of rebound profiles. Inferences made on infectiousness and
epidemiological consequences using the data obtained via
quantitative RT-PCR may be limited due to the potential
discrepancy between the measured viral genome load and the
non-measured true viral load. Thus, the observed secondary phase
of rebound may be the result of detecting circulating junk genomes
rather than genomes of infectious particles and may thus have no
significant epidemiological consequence. However, previous stud-
ies have explored the relationship between diverse viremia
measurements an infectiousness of pigs infected with PRRSV
[29,48,49]. For example, Charpin et al. [48] detected viral
genome in the blood of inoculated pigs from 7–77 dpi using RT-
PCR, whereas viral genome shedding was detectable from nasal
swabs from 2–48 dpi. Furthermore their study concluded that
infectiousness was indeed correlated with the time course of viral-
genome in the blood measured by RT-PCR and that the decrease
in infectiousness was related to the increase in antibodies[48]. In a
study by Rowland et al.[49]it was observed that even when there
Table 5. Odds ratios of the cross protectivity of neutralising
antibodies (nAbs) from individuals from profile Class 1 relative
to that of nAbs from individuals from viremia profile Class 2.
Class 1 Class 2
Odds ratio (95% Confidence
interval) P- value
Clearance Persistence 0.61 (0.38, 0.98) 0.04
Clearance Rebound 0.86 (0.53, 1.38) 0.53
Persistence Rebound 1.40 (0.80, 2.45) 0.24
The columns class 1 and class 2 indicate which two viremia categories are being
compared. The nAb class was a pooled into a binary trait: cross-protective (nAb
class 1–2) or not cross-protective (nAb class 3–5). The 95% significance level was
used (p,0.05). For further explanation see text.
doi:10.1371/journal.pone.0083567.t005
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were low levels of the virus replication the virus was easily
transmitted and it was only by 260 dpi that pigs were no longer
able to transmit the virus to sentinel pigs[49]. Thus it has been
established that some PRRSV-infected pigs can support virus
replication and transmit infection for an extended period far
beyond the duration of the secondary phase of the profiles in our
study. By this logic one may argue that the observed rebound in
viral genome load may indeed have biological consequences in
terms of viral shedding and transmission to susceptible animals.
Previous PRRS studies alluded to the phenomenon of viremia
rebound [14,20,50] based on qualitative inspection of viremia
profiles, but have not analysed the duration, defining character-
istics or relationship with the antibody response of this phenom-
enon. Using data from the first 3 out of the 8 trials analysed in this
study, Boddicker et al. [20] defined biphasic profiles subjectively
by a rebound of 2 units on the logarithmic (base 10) scale of
viremia observations from 21 dpi onwards. Using this definition
rebound was not found to be heritable, indicating that rebound is
more likely to be determined by either the virus or the
environment as opposed to host genetics [20]. However, the low
heritability estimate of this phenotypic trait (0.03) may be due to
poor trait definition arising from too few successive observations to
accurately capture the rebound phase (i.e. between 21–42 dpi),
and hence errors in classifying animals. The statistical classification
used in this study resulted in 22% of the pigs from trials 1–3
classed as rebounders as opposed to the 33% of pigs classed into
the rebound category in the previous study [20].
Lastly, there is accumulating evidence for substantial host
genetic variation in response to PRRSV [1,4], increasing the
potential for the control of PRRS through genetic selection. In
particular, a quantitative trait locus (QTL) was identified for the
area under the viremia curve spanning the first 21 days post
infection [20]. Our study provides opportunity to assess whether
clearance, persistence or rebound, and other derived features, such
as level of or time to peak viremia and the rates of increase and
decline in the profiles are genetically determined, and to
potentially identify QTL associated with these new phenotypes.
The new derived phenotypes may provide deeper insights into the
underlying molecular mechanisms. Furthermore, the hypotheses
for host-pathogen interactions emerging from the current study
will be used to inform and validate process-based dynamic
mathematical models of in-vivo PRRSV infections in future studies.
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The Bayesian approach in Chapter 3 allowed for: 
1. Directly fitting of nonlinear functions to the viraemia data 
2. Fitting the uni modal Woods model and the bimodal extended Woods model to the data 
3. A better fit to the data than via the linearized mixed models approach in Chapter 2 
Using maximum likelihood inference and numerous model fit criteria, we established that the broad 
spectrum of observed viraemia trends from 0-42dpi could be adequately represented by either the uni- 
or biphasic Wood’s functions. Representative parameter estimates of the data resulting in good model 
fits and residuals were obtained for the vast majority of individuals, and pigs could be objectively 
classified into one of three viraemic categories. This together with the convenient biological 
interpretation of the model parameters and derived parameter estimates, such as the time and level of 
viraemia peak, allowed us not only to quantify inter-host variation, but also to establish common 
viraemia curve characteristics and determine their predictability. 
The Woods model was an adequate description of the viraemia profiles across the PRRSV isolates 
(NVSL and KS06). The residual plots for the KS06 challenged pigs are presented in Appendix 2.  
Figure 3.1 outlines the derived parameters obtained for each pig from the model fitting in this chapter. 
The derived parameters will be used in the next chapter of this thesis for analysis of the associations 
between viraemia and cytokine measures and also in subsequent genetic analysis such as Appendix 3.  
 
Figure 3.1 A typical viraemia profile with the derived variables from the Woods model 
annotated. The AUC up to 4dpi i.e. I4 is denoted by the orange region and the variables 






Exploring the relationship of PRRS viraemia profiles with 
longitudinal cytokine expression  
4.0 Introduction 
In Chapter 3 we established three types of viraemia profiles from the same PRRS virus infection: (i) 
cleared (resolution of viraemia to levels below detection at 42 days post infection (dpi)), (ii) transient 
experiment persistence hitherto referred to as persistence (viraemia remains above the level of 
detection at 42dpi), and (iii) rebound (bimodal) profiles [1]. Exact knowledge about the underlying 
immune mechanisms responsible for the observed discrepancy between viraemia profiles is still 
sparse. Previous studies of the same dataset as used here identified a single nucleotide polymorphism 
(SNP) WUR10000125 (WUR) on chromosome 4 associated with reduced cumulative viral load [2-4] 
and the GBP5 candidate gene.  GBP5 plays a role in the innate immune response during infection and 
interacts with the inflammasome NLRP3 multi-protein complex that acts as a sensor for pathogen 
associated damage and is associated with the cleavage of some pro-inflammatory cytokines [5,6]. The 
WUR SNP accounts for 15.7% of the total variation in cumulative viraemia [7]. Gaining a more 
comprehensive understanding of the underlying immune mechanisms would be useful to aid the 
control of infection which is a major issue for swine production. For this purpose, measurements of 
cytokines and neutralising antibodies (nAbs) have been collected for a subset of the pigs in the PHGC 
infection trials. 
Cytokines play a fundamental role in both the innate and adaptive immune response and are thus 
likely to have a significant influence on the observed viraemia patterns. Numerous cytokines have 
been reported to influence responses of pigs to PRRSV infection [8-16].The quantity of innate 
cytokines secreted in PRRSV-infected pigs has been found to be strain-dependent (i.e. between north 
American strains VR-2323 and KS06)[17] , significantly lower than for other viral infections (i.e. 
swine influenza virus (SIV) and porcine respiratory coronavirus (PRCV)) [13], and could be partly 
responsible for the delayed activation and dampened adaptive immunity [13,18,19]. Secretion of 
several serum cytokines such as IL-8, IL-1b and IFN-gamma have been found to be correlated to virus 
level accounting for ~84% of the observed variation in viraemia up to 42dpi [16]. 
Previous studies have linked the pro-inflammatory cytokines IL-1b and IL8 to viral persistence in 
PRRSV infections. For the innate cytokines IL-8 and IL-1b it was found that levels were up-regulated 
by 7dpi  and that persistent pigs had a higher concentration of IL-1b and a lower concentration of IL-8 
[16]. Substantial inter-host variation in the ability to synthesise IL-8 has been previously reported, 
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where strong IL-8 synthesis is associated with high host resistance to PRRSV defined by the 
susceptibility of target cells in vitro  [20].  
PRRSV infection typically results in low levels of innate antiviral cytokines [8]; however previous 
studies have established that the anti-viral cytokines IFNA (interferon alpha), IFN-gamma, and TNF-
A (tumour necrosis factor alpha) play a key role in the clearance of PRRS viraemia [16,21-23]. There 
are conflicting reports on IFNA expression following PRRSV infection: the North American PRRS 
virus has been shown to inhibit type-1 interferon production [24], resulting in no significant increases 
in expression of type-1 interferon following PRRSV infection [9,25]. Conversely, isolate dependent 
increases in IFNA expression have also been observed [12,26-28]. Similarly, TNF-A response to 
PRRSV infection is variable, often weak, and also strain-dependent [23,29]. Other known cytokines 
with immune-regulatory roles in PRRSV infection include IL-12, IFN-gamma, IL-6, IL-4, TGF-b 
(transforming growth factor beta), and IL-10 [8,21,30-32]. NK cell function regulation during PRRSV 
infections is coordinated by multiple cytokines, such as IFN-A/B, IL-12, and IL-15 [33]. Pigs with 
low levels of IFNA secretion have been shown to elicit reduced NK (natural killer) cell activity 
[15,34,35]. Reduced NK (natural killer) cell cytotoxicity have also been associated with increased 
plasma concentrations of IL-4, IL-10 and IL-12 [27]. 
Cytokines do not act in isolation and are thus most likely highly correlated. Furthermore cytokine 
responses are transient [36]. In order to better understand the role of cytokines in shaping virus load 
profiles, it would be beneficial to consider the temporal profiles of various cytokines simultaneously. 
Most previous studies of cytokine response to PRRSV infection either explored the expression of a 
very limited number of cytokines or only contained cross-sectional or limited numbers of repeated 
measures [12,16]. The recent development of Fluorescent Microsphere Immunoassays (FMIA) allows 
reliable, effective simultaneous quantification of multiple cytokines in porcine sera but is not limited 
to swine data only [25]. FMIA is a new method of cytokine detection for PRRSV and has only been 
used in one previous study for PRRSV infection [12]. In this chapter, FMIA provided 8 longitudinal 
measures from 6 cytokines taken weekly 0-42dpi (days post infection) for 228 pigs from trials 1, 3 
and 5 of the PHGC challenge experiments. The cytokines measured in this chapter were chosen due of 
the availability of the relevant assays. 
The overarching aim of this chapter is to explore the association between the observed PRRS viraemia 
profile characteristics and the corresponding measures of the immune response in the form of 
longitudinal cytokine profiles.  We determine the characteristic features and time trends of each 
cytokine profile, and examine the associations amongst cytokines. We assess the responsiveness of 
pigs to all cytokines and examine the impact of the viral profile class, WUR genotype and genetic 
background on the breadth of cytokine response. We then determine the association between viraemia 
and the ensuing cytokine measures and also the cytokines and the ensuing viraemia measures, and 
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answer the question whether the strength of the serum cytokine response is associated with the rate of 
the serum viraemia decline. Through a multiple regression approach we explore whether cytokines 




4.1 Materials and Methods 
4.1.1 Experimental Data 
The data analysed in this chapter was obtained from a subset of the PRRS PHGC infection trials; a 
detailed description of the experimental protocol is outlined in the introduction and [37,38]. Briefly, 
the pigs were experimentally infected with NVSL 97-7985, a virulent isolate of PRRSV, [39], with an 
infection dose of 10
5
 tissue culture dose50 (TCID50). The cross-bred pigs used in these trials were 
supplied by different commercial breeding companies, so that animals in different trials were 
unrelated and from different genetic backgrounds [40] as outlined in Table 4.1. Hence for the cytokine 
data analysed in this Chapter, trial and genetic background are confounded, as shown in Table 4.1. 
Pigs had been weaned in high health farms that were free of PRRSV, mycoplasma hypopneumoniae 
and swine influenza virus. Upon arrival at the challenge facilities, the commercial cross-bred pigs 
aged between 25 and 35 days were placed randomly in pens of 10-15 pigs and were infected with 
PRRSV after a 7 day acclimation period, i.e. at 0 days post infection (0 dpi). 














3 35 LW x LR 1 
5 77 Duroc x LR/LW 3 
7 117 Pietran x LW/LR 5 
Total 229 - - 
Table 4.1 Animal composition across a subset of the PHGC trials used for studying the cytokine 
profiles. 
1
LW = Large White; LR = Landrace. 
2
Genetic background is defined as pigs from the same 
breeding company and the same breed cross. 
Virus load: Blood samples were collected immediately before infection (0 dpi) and at 4, 7, 11, 14, 
19/21, 28, 35, 40/42 dpi and the level of PRRS viraemia was measured using a semi-quantitative 
TaqMan PCR assay for PRRSV RNA. The viraemia quantity data from RT-PCR was transformed on 
the logarithmic scale to the base 10.  
Cytokines: Cytokine data from serum collected at 0, 4, 7, 10, 14, 21, 28, 35, 42dpi was obtained for 
228 randomly chosen individuals from the three PHGC trials 3, 5, and 7 (with cytokine data from 35, 
77, and 117 pigs in each trial respectively) using Fluorescent Microsphere Immunoassay (FMIA) 
outlined in [25] and [12]. The FMIA Luminex multiplex swine cytokine assay provided simultaneous 
quantitative measures of the concentration of four innate (IL-1¯ , IL-8, IFN®, IL-12), two regulatory 
(IL-10) and Th2 (IL-4) cytokines and a chemokine (CCL2) at each time point of the infection. There 
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was no successful assay for IFN°  as the monoclonal antibody that made the assay is no longer 
available. Trial 7 had missing values at 42dpi and Trial 3 had no observations for IL-1b. The log10 of 
the cytokine observations was used to normalise the data. The cytokine data and the nAb data were 
obtained from separate projects within the PHGC consortium and hence the cytokine data does not 
overlap with the nAb data thus we cannot explore hypotheses between these two measures. The units 
of the cytokine measurements are log 10 pg/mL. 
Genotyping: Ear tissue was collected from all pigs for DNA isolation. Tissues or DNA samples from 
the PHGC trials in this chapter were genotyped with Illumina’s Porcine SNP60 Beadchip v1 (San 
Diego, California) at GeneSeek Inc. (Lincoln, Nebraska). In line with previous studies that identified 
the SNP WUR10000125 (WUR) to be associated with lower cumulative viral load [7,41,42], the 




4.1.2 Smoothing and classification of viraemia and cytokine profiles  
Smoothing Viraemia: As outlined in Chapter 3, the log10 of PRRSV RNA copies per ml of serum 
were fitted to the Wood’s and extended Wood’s functions to provide continuous estimates for log-
transformed viraemia over the 42-day observation period [1]. The Wood’s model was fit to uni-modal 
profiles (~67% pigs) and the extended Wood’s model was fit to bi-modal profiles (~33% pigs). The 
Wood’s curve, an incomplete gamma function often used to model lactation yield in dairy cattle [37-
39], and the extended Wood’s curve was shown to appropriately model viraemia profiles in all the 
PHGC trials in Chapter 3. 
Briefly, the uni-modal Wood’s function is defined as y(t) = a1t
b1e¡c1t, where ( )y t   represents the 
level of viraemia in the blood (log10 RT-PCR) at t   days post infection (dpi). The constant 1a   is a 
scalar quantity and impacts upon the magnitude of all the points on the curve. The parameter  1b   is an 
indicator of the initial rate of increase to the peak viraemia level and the parameter  1c  is an indicator 
of the rate of decline after the peak and dominates the function as  t  .  
The bimodal extended Wood’s model fit to bimodal viraemia profiles is described by the equation:  
 01 1 2 2
( )
1 2 0( ) max(0, ( ) )
t tb c t b cy t a t e a t t e
      
where the model parameters 1 1,a b  and 1c  define the primary phase of the rebound profile as described 
for the Wood’s model above. Time 0t   denotes the onset of the second phase of the profile, which is 
assumed to follow the same (Wood’s) shape as the primary phase and is thus defined by the second 
set of Wood’s model parameters: 2 2 2, ,a b c . For further details on the model fitting and the derived 
model parameters see Chapter 3. 
The full time course of the experiment was considered in this analysis. However the dataset contained 
only a limited number (28) of pigs with bimodal profiles. Therefore extended Wood’s parameter 
estimates associated with the rebound phase only were omitted from the analysis. The viraemia 
measures used in the analyses of this chapter are listed in Table 4.2. Figure 4.1 illustrates the fitted 





Viraemia measures Explanation 
V4, V7, V10, V14, V21, V28, V35, V42 Wood’s model prediction at 4, 7, 10 …42dpi 
A1, B1, C1 Wood’s model parameters associated with the 
primary phase of the infection 
Tmax Time of peak viraemia 
Vmax Peak viraemia value 
deltaT Time of maximal viraemia decline 
deltaV Value of maximal viraemia decline 
cleared, persistent, rebound The viral profile classification 
I4, I21, I28, I35, I42 AUC of the viral profile up to 4, 21, 28, 35, and 
42dpi 
Table 4.2 The viraemia measures generated from the Wood’s model fitting to viraemia profiles 
 
Figure 4.1 A typical viraemia profile with the derived variables from the Woods model annotated. The 
AUC up to 4dpi i.e. I4 is denoted by the orange region and the variables Vmax, Tmax, deltaT and 
deltaV are annotated. (Figure taken from the manuscript in Appendix 3) 
Smoothing cytokines profiles: Visual inspection of individual cytokine profiles indicated that these 
could not be readily represented by known uni- or bimodal functions comprising few parameters. 
Therefore, in order to remove noise from the log-transformed cytokine measures, a cubic spline was 
fit to each individual cytokine profiles, using the data points as knots, in MATLAB[43]. The cytokine 
measures created from the cubic spline fitting are outlined in Table 4.3 and annotated on a CCL2 





Cytokine measures Explanation 
IL8_0, IL8_4, IL8_10, IL8_14, IL8_21, IL8_28, 
IL8_35, IL8_42 
Spline predictions of the log10 of the cytokine 
observation at 0-42dpi (in this example IL8) 
d_IL8_0_4, d_IL8_4_7, 
d_IL8_7_10, d_IL8_10_14, d_IL8_14_21, 
d_IL8_21_28, d_IL8_2835, d_IL8_3542 
Difference between the cytokine spline 
observations associated with different time 
points. d_IL8_0_4 corresponds to the difference 
between the observations at 4 and 0dpi 
A_IL8_4, A_IL8_7, A_IL8_10, A_IL8_14, 
A_IL8_21, A_IL8_28, A_IL8_35, A_IL8_42 
AUC from 0dpi to 4-42dpi as a measure for the 
overall strength of the cytokine response over 
the indicated time period. 
AA_IL8_4, AA_IL8_7, AA_IL8_10, 
AA_IL8_14, AA_IL8_21, AA_IL8_28, 
AA_IL8_35, AA_IL8_42 
AUC above the baseline response (AAUC) 
R_IL8 Binary trait as to whether an individual is a 
responder or non-responder for each cytokine 
respectively. 
Table 4.3 Cytokine measures associated with IL-8 generated from cubic spline fitting. The same 
measures were obtained for the other cytokines considered in this study (IL-4, IL-10, IL-12, IL-1b, 






Figure 4.2 Typical CCL2 cytokine profile obtained from cubic spline fitting with the derived 
variables annotated. The black line delimits the spline model profile; the data is denoted by red 
asterisk; the spline observation at 4dpi i.e. CCL2_4 is denoted by a black dot; the difference between 
spline observations at 0 and 4 dpi i.e. d_CCL2 is shown in pink; the AUC up to 7dpi i.e. A_CCL2 is 
denoted in green; the AUC up to 4dpi with the baseline removed i.e. AA_CCL2_4 is denoted in blue. 
The resulting smoothed cytokine profiles were then used to classify an individual as either responder 
or non-responder to that cytokine. A profile that was a non-responder for a particular cytokine meant 
that all its’ subsequent observations did not significantly differ from the baseline spline observation in 
subsequent measures. To capture potential variation due to experimental measurement accuracy, a 
profile whose subsequent observations did not differ from the baseline within a threshold of 0.5 units 
on the log10 scale was classed as a non-responder in that particular cytokine. A threshold value of 0.5 
units was set based on visual inspection of profiles and taking into account potential variation caused 
by the measurement accuracy of the FMIA. 
We further defined pigs according to their breadth of cytokine response. Individuals in PHGC Trials 
3, 5, and 7 were assigned to one of the following 7 cytokine categories: 0) failed to produce a cytokine 
response in any cytokines 1) only produced a response in one cytokine, 2) produced a cytokine 
response in two cytokines, 3) produced a cytokine response in three cytokines 4) produced a cytokine 
response in four cytokines, 5) produced a cytokine response in five cytokines, 6) produced a cytokine 
response in six cytokines, 7) produced a cytokine response in all the measured cytokines. Analysis 
was conducted on the combined cytokine response class for a broad cytokine response (class 6-7) and 




4.1.3 Statistical Analysis 
The baseline model 
Data and smoothed cytokine and viraemia profiles were analysed using repeated measures, logistic 
regression and multiple regression models, all implemented in a mixed model framework.  The 
following baseline model was adapted to explore different objectives outlined below. Broadly we 
began with a null model containing the fixed and random effects representing the different sources of 
variation within the experimental protocol. Non-significant (P>0.05) fixed and random effects were 
removed from the null model according to significance of the F-test (for fixed effects) and the 
likelihood ratio test (LRT for random effects). The full list of potential fixed effects in the null model 
included: WUR genotype (W), sex (S), age (A), parity (P), trial (T), genetic background (G), viral 
profile class (V), and all corresponding interactions. For testing the association between the viraemia 
and cytokine measures additional covariates (c) were added to the null model and significance was 
determined by the F-test and the LRT compared with the null model (i.e. without Xc). 
Null model for continuous data:  
𝑌 = 𝑋𝑏𝑏 + 𝑍𝑢 + 𝜀 (1) 
Final model for continuous data:  
𝑌 = 𝑋𝑏𝑏 + 𝑋𝑐𝑐 + 𝑍𝑢 + 𝜀 (2) 
Where Y is the vector of the response variables (viraemia or cytokine), b is the vector of fixed effects 
included in the null model, c is the vector of fixed effects for the additional covariates, u is the vector 
of random effects, and ε is the vector of the residual effects. The matrices Xb, Xc, and Z are incidence 
matrices assigning individuals to their corresponding effects. The additional covariates are the 
potential predictors added to the null model (equation 1) and were either cytokine or viraemia 
variables from Table 4.2 or 3.3 for testing the associations between viraemia and cytokine and vice 
versa. 
For analysis of categorical data a generalized linear mixed model (GLMM) was applied with a logit 
link function: 
𝐸[𝑌|𝑢] = 𝑔−1(𝑋𝑏 + 𝑍𝑢)  (3) 
Where Y is the vector of the response variable (i.e. either nAb cross-protection, or breadth of cytokine 
responsiveness), b is the vector of fixed effects, u is the vector of random effects and g
-1
 is the inverse 
logit link function. The matrices X and Z are incidence matrices assigning individuals to their 
corresponding effects.  
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Unless stated otherwise, residual errors were assumed to be independently normally distributed. 
However, models that included repeated measurements serial correlations between consecutive 
measures were implemented in the residual error structure.  
Determining cytokine response over time and examining the associations between cytokines 
The null model defined by equation 1 adapted into a repeated measures model to determine how 
cytokine response changes over time. The null model was extended with the inclusion of the 
observation time Tk (Tk = 0, 4, 7, …. 42dpi) as a class effect in the model together will all possible 
interactions with the other fixed effects, and an autocorrelation structure between the repeated 
measures. A repeated measures model was used for the identification of significant fixed effects on 
the cytokine response over time, implemented with PROC MIXED in SAS 9.3. Autocorrelations 
between repeated measures were examined using the repeat statement of PROC MIXED, and various 
residual covariance matrix structures were explored (e.g. vc -standard variance components; ar(1) -
first order autoregressive; cs- compound symmetry; un -unstructured; toep –toeplitz). The model 
produced least square mean (LSM) estimates for cytokine response at each observation time point. 
The F-test statistics was used to assess whether cytokine profiles differed between pigs from different 
genetic backgrounds, WUR genotypes (0, 1 or 2), or viraemia profile classes (rebound, clearance or 
persistence).  
4.1.4 Associations between cytokine responsiveness with viral profile class, WUR genotype and 
genetic background 
A GLMM, defined by equation 3, was used to obtain odds ratios in order to determine the association 
of nAb cross protection and cytokine responsiveness with viral profile class, WUR and genetic 
background (nAb data was from the same genetic background and hence was not explored). Logistic 
regression was carried out using PROC GLIMMIX in SAS 9.3, assuming an exponential distribution 
of the data, conditional on random effects. The categorical response variable was the cytokine 




4.1.5 The association between viraemia and cytokine responses 
Multiple regression analysis was carried out to determine the associations between viraemia measures 
and their preceding cytokine measures, i.e. using viraemia measures as the response variables and the 
cytokine measures as the potential predictors. Potential predictors were always chosen to be measures 
taken before or at the same time point as the response variable. Additional potential predictors were 
added to the null model by adding them as fixed covariates into the null model, which were the 
measures taken from Table 4.3, i.e. the cytokine spline predictions, cytokine spline prediction 
differences, area under the cytokine spline profiles , and interactions with the binary cytokine 
response class. 
The classification as a responder or non-responder for each cytokine was included as a potential 
predictor. Furthermore the interaction between responder/non-responder binary trait interaction with 
spline observations was also included as a potential predictor (e.g. R_IL8*L_IL8_0) to account for the 
fact that a significant association between cytokine and viraemia response can only be observed in 
individuals eliciting a cytokine response. 
Using the cytokine spline estimates as predictors allows us to determine which are the key cytokines 
and key time points of association with viraemia measures. Inclusion of temporal changes in cytokine 
spline estimates as potential predictors allows us to determine if specific changes in cytokine 
expression is associated with the viraemia characteristics in question. Finally, including the AUC or 
AAUC of the cytokine spline estimates allows us to determine if it is the cumulative strength of 
cytokine response, or the response due to infection that plays a significant role in the viraemia 
profiles. 
Stepwise removal of non-significant additional potential predictors was performed in the full models 
using the F –test at the 95% significance level (P<0.05). A likelihood ratio test was conducted 
between the null model and the final model including the significant potential predictors only to 
assess whether these predictors significantly improve the model fit. To estimate the impact of the 
additional predictors the AIC and Pearson’s correlation coefficients (R
2
) values of the final models 
were compared with the null model. 
Mixed models do not automatically account for co-linearity between predictors, which needs to be 
dealt with due to the risk of over-fitting. Therefore only significant predictors with pairwise R
2
 less 
than 0.5 were included in the final models. In the case that significant predictors were correlated with 
R
2
 values greater than 0.5, the model was refit and the predictor by removing one of the pairs in turn 
and the predictor resulting in the best model according to the AIC was chosen.  
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Furthermore, in order to explore the association between cytokines and the preceding viraemia 
measures the same method applied as outlined above; however the dependent variables were cytokine 
measures (from Table 4.3) and additional potential predictors were the viraemia measures up to and 
including the time point of the response variable (from Table 4.2) i.e. the Wood’s model predictions, 
the areas under the viraemia curves, and the Wood’s model parameters. To explore the association 
between the cytokines both the response variable and the potential predictors added to the null model 





4.2.1 Qualitative assessment of cytokine profiles and classification into cytokine response 
categories  
As shown in Table 4.4, the available cytokine data are not evenly distributed amongst genetic 
backgrounds and viraemia profile classes. Genetic background 5 provided over half of the cytokine 
data, and the majority of cytokine measures came from individuals with cleared and persistent 
viraemia profiles (at approximately equal proportions within and between genetic backgrounds).  
There were only 28 rebound individuals in the cytokine dataset, with 17 of them originating from 
genetic background 3.  The relatively small proportion of rebounders in the cytokine dataset limited 




Cleared (%) Persistent (%) Rebound (%) Total 
1 (3) 17 (49%) 14 (40%) 4 (11%) 35 
3 (5) 28 (37%) 31 (41%) 17 (22%) 76 
5 (7) 64 (55%) 46 (39%) 7 (6%) 117 




WUR 0 (%) WUR 1 (%) WUR 2 (%) Total 
1 (3) 17 (49%) 12 (34%) 6 (17%) 35 
3 (5) 51 (67%) 22 (29%) 3 (4%) 76 
5 (7)  51 (44%) 52 (44%) 14 (12%) 117 
Total 119 (52%) 86 (38%) 23 (10%) 228 
Table 4.4 The number of cleared, persistent and rebound individuals in the cytokine dataset. The 
percentage within genetic background (trial) is shown in brackets. 
The WUR genotypes were approximately evenly distributed between the genetic backgrounds as 
shown in Table 4.5. Genetic background 3 had a lower proportion of WUR 2 and a higher proportion 
of WUR 0 than the other genetic backgrounds; WUR 0, 1 and 2 refers to the number of copies of the 
beneficial B allele found in previous studies [2-4].  
Visual inspection of the log10 cytokine profiles revealed substantial inter-host variation in the 
measured serum cytokine concentrations for all studied cytokines at all the time points, with 
differences of 2-3 log units between the extremes (Figure 4.3). The cubic splines provided a good fit 
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to the log10 of the cytokine data for all cytokines with the maximum difference between the data and 
the spline values of only 0.05 log10 units. As shown in Figure 4.3, the cubic splines successfully 
removed noise from the data whilst retaining the fundamental features of the profiles.   
A       B 
 
C       D 
  





Visual inspection of the smoothed cytokine profiles further indicated that a proportion of cytokine 
profiles only showed minor fluctuations with limited elevation above the baseline levels. In particular, 
Figure 4.3 Individual cytokine cubic spline 
curves for the measured cytokines. Cytokine 
spline profiles (black lines) and the cytokine 
data points (blue asterisks) from 12 randomly 
selected pigs in the cytokine dataset from all 
three viral profile classes. Graph A to G refer 
to IL-4, IL1-b, IL-8, IL-10, IL-12, IFNA and 
CCL2, respectively. The units of the cytokine 
measurements are log 10 pg/mL. 
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for IL4, IL1-b, IL-8, IL-12 the majority of profiles showed only minor fluctuations of less than 1 log 
units between cytokine concentrations associated with different time points. In contrast, many of the 
IFNA and CCL2 profiles tend to exhibit systematic uni- or bi-modals trends (Figure 4.3 F and G). In 
particular, peak levels of INFA were often reached within the first seven days of infection, whereas 
CCL2 levels tended to peak slightly later between 7-14 dpi. A smaller second peak in IFNA was 
typically observed as early as 21dpi although for some pigs it occurred between 21-28dpi and for 
CCL2 at 28-35dpi. 
4.2.2 Associations between cytokines and factors affecting cytokine response over time 
The overall strength of cytokine response due to PRRSV infection was captured by the area under the 
curve (AUC) of the smoothed spline cytokine profiles with the baseline response removed (the 
adjusted AUC, henceforth denoted by AAUC). The AAUC up to 35dpi was used due to missing 
observations at 42dpi for genetic background 5. The immune regulatory cytokines were highly 
correlated with each other, as shown in Table 4.5. The anti-viral cytokine IFNA was moderately 
positively correlated with both the immune regulatory and pro-inflammatory cytokines. The cytokines 
could be grouped into two correlation groups. The first group consisted of: IL-4, IL-10, IL-12 and 
IL1b, and the second group contained: IL-8, IFNA and CCL2 (Table 4.5). The strongest correlation 
among immune regulatory cytokines was found at 35dpi, whilst the strongest correlation between the 
immune regulatory cytokines and the antiviral, or pro-inflammatory, cytokines was at 14dpi. With the 
exception of pro-inflammatory cytokines (IL-1b,  IL-8 and CCL2), the cytokine correlations were the 
lowest at 4dpi. The strength of CCL2 and IFNA expression were highly correlated at 14 and 35dpi, 





















 -      
IL-10
1
 0.41* -     
IL-12
1
 0.45* 0.65* -    
IL-1b
2
 0.45* 0.59* 0.75* -   
IL-8
2
 0.12 0.14* 0.27* 0.12* -  
IFN A
3
 0.25* 0.30* 0.33* 0.38* 0.23* - 
CCL2
2


















 -      
IL-10
1
 0.35* -     
IL-12
1
 0.40* 0.61* -    
IL-1b
2
 0.36* 0.45* 0.67* -   
IL-8
2
 0.22* 0.08 0.31* 0.16* -  
IFN A
3
 0.21* 0.04 0.21* 0.20* 0.38* - 
CCL2
2


















 -      
IL-10
1
 0.17* -     
IL-12
1
 0.27* 0.46* -    
IL-1b
2
 0.28* 0.25* 0.48* -   
IL-8
2
 0.15* 0.02 0.43* 0.21* -  
IFN A
3
 0.06 -0.08 0.16* 0.12 0.12 - 
CCL2
2
 0.13 -0.00026 0.47* 0.20* 0.20* 0.12 
Table 4.5 Pearson correlations of pairwise log10 cytokine concentration area under the curves above 
the baseline response (AAUC). The strongest significant cytokine associations between the AAUCs at 
4, 14 or 35dpi are in bold. 
1
The immune regulatory cytokines, 
2
the pro-inflammatory cytokines and 
3




The association of cytokine characteristics between cytokines 
In the null models, pen within trial was not significant. The significant fixed effects were dependent 
on the response variable; however genetic background and parity were consistently significant across 
the models for the majority of the cytokines. A selection of the mixed models of best fit to the data for 
the viraemia predictions are presented in Table 4.6. As opposed to the correlations the strongest 
associations in the multiple regression models were found in the early stage of infection from 0-10dpi. 
The cytokines were poor predictors of each other at the later stage of infection. IFNA and CCL2 were 
consistently significant predictors for each other in their respective final models, with IFNA being a 
better predictor for CCL2 as opposed to the other way around. IFNA was also significantly associated 
with baseline IL-4 and IL-1b, while CCL2 was also significantly associated with IL-8, IL-10, IL-1b 
and IL-12. The cytokines were poor predictors for IL-8.  IL-4 was significantly associated with 
baseline IL-8, IFNA and IL-1b. IL-10 was significantly associated with baseline IL-4, IL-8 and IL-12. 
IL-12 was significantly associated with IL-1b, IL-10 and IL-4. IL-1b was significantly associated with 
baseline IL-4, IFNA and IL-12. Overall, the inclusion of cytokine measures as predictors for 
cytokines at a specific time point or over a given time period improved the model fit, as confirmed by 





















































































158.8 0.80 0.54 1801* 1959 
Table 4.6 A selection of the final multiple regression models for testing the associations between 





The full repeated measures model with all the fixed and random effects was reduced according to 
significance of the potential effects and interactions at the 95% significance level. None of the three-
way interactions (i.e. the interactions between three fixed effects) were significant. A summary of the 
significant fixed and random effects in the final repeated measures model for each cytokine is 
presented in Table 4.7. According to the likelihood ratio test at the 95% significance level (P<0.05) 
the random effect of pen within trial was significant for all the cytokines. The model residuals were 
normally distributed for each cytokine. 





(95% significance LRT) 
IL-4 G, T Pen 
IL-8 P, G*T Pen 
IL-10 G, P, T, G*T Pen 
IL-12 W, G, P, A, T, G*T Pen 
IL-1b P, T, G*T Pen 
IFNA  G, P, A, T, G*T, V*T Pen 
CCL2 G, P, T, G*T, V*T Pen 
Table 4.7 Summary of the significant effects in the repeated measures models for longitudinal 
cytokine profiles. Where W is the WUR genotype, P is the parity, A is the age, V is the viral profile 
class, G is the genetic background, T is the time, and * represents fixed effect interactions. 
Effects of viraemia classes, genetic background and WUR resistance genotypes on cytokine profiles  
The LSMs for the cytokine at different time points for each genetic background, viraemia class, and 
WUR genotype are presented below for each cytokine in Figures 4.4, 4.5 and 4.6, respectively. Out of 
these fixed effects considered, the genetic background had the biggest influence on LSM cytokine 
response.  
Although time was a significant factor in the repeated measures models for all cytokines, the LSM 
profiles indicate that the profiles of the majority of the cytokines do not deviate substantially from the 
baseline observations at most observation times. However LSM IFNA and CCL2 profiles showed 
systematic time trends, with the general trend for IFNA represented by an  increase to a peak around 
4dpi followed by decline to baseline levels by 14dpi (Figure 4.4F). The dynamics of CCL2 appear 
slower than IFNA, with a gradual increase to peak expression by 10dpi followed by gradual decline, 
as shown in Figure 4.4 G. 
Different genetic backgrounds had different baseline cytokine values or overall magnitudes of 
expression (IFNA, CCL2). Response patterns for the time-trends of the LSM estimates were overall 
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similar (Figure 4.4), although interaction between genetic background and time was significant in the 
repeated measures models of all cytokines. Indeed, genetic background 3 had a tendency to decrease 
from baseline expression in IL-1b, IL-12 and IL-10, whereas IL-1b for genetic background 1 saw a 
general trend of increase from the baseline (Figures 4.4 C, D &E). Furthermore cytokine response 
from genetic backgrounds 1 and 5 remained closer to baseline levels in IL-10 and IL-12 profiles 
compared to genetic background 3. In IFNA the rebound at 28dpi was the strongest for pigs from 
genetic background 5.The CCL2 profiles had similar time trends but genetic background 1 had 
significantly lower levels of expression for the majority of the infection (4-35dpi). 
There were statistically significant differences between the viral profile classes. Rebounders elicited a 
stronger response in most of the cytokines at the later stages of infection (from 28dpi onwards) than 
non-rebounders (Figure 4.5), although the differences were not always statistically significant. There 
were statistically significant differences (P<0.05) between rebound CCL2 at 28dpi and both cleared 
and persistent profiles. Rebound profiles also had statistically significant higher levels of IFNA 
expression at 28-35dpi than cleared profiles and higher IL-8 expression at 35dpi. Differences between 
pigs with cleared and persistent profiles were small and not statistically significant.  Rebound 
viraemia profiles begin with a significantly higher baseline level of IFNA than cleared viraemia 
profiles. The CCL2 profiles for the cleared and persistent viraemia pigs decline to baseline levels after 
peak CCL2 expression, viraemia rebound pigs, however, initially follow the same decline from the 
CCL2 peak but then experience a “rebound” in CCL2 values.  
The time trends and LSM estimates for the profiles of IL-4, IL-8, CCL2 and IFNA were similar for 
the three WUR genotypes as shown in Figure 4.6. The WUR genotype had only a significant effect in 
the final model for IL-12, with significant differences observed in the magnitudes of expression 
between the WUR genotypes in this cytokine. Interestingly the WUR 2 genotype was associated with 
the lowest LSM predictions whilst WUR 1 with the highest. Non-significant differences in the 
expression of cytokines between the WUR genotypes was also observed; WUR 2 had generally higher 
expressions of CCL2 between 4-21dpi, IFNA at 4dpi, IL-10 at 0-7dpi and 20-35dpi, and slower 
dynamics in IL-1b between 0-7dpi than WUR 0 or 1. 
The only statistically significant difference between the WUR genotypes in any of the measured 
cytokines was found at 4dpi between WUR 1 and 2: WUR 2 had a higher estimated level of IFNA 
expression at this observation. Based on the AUC of viraemia WUR 2 represents the more resistant 
individuals which could be related to eliciting a stronger early antiviral response. WUR 2 individuals 
also had slightly higher LSMs for CCL2, IL-8 and IL-10 at the early phase of infection (0-21dpi); 
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Figure 4.4 The effect of genetic background on cytokine profiles. The LSMs with standard errors for 
each genetic background: genetic background 1 is in black, genetic background 3 is in blue, and 
genetic background 5 is in red. There were no IL-1b observations for genetic background 1. The units 
of the cytokine measurements are log 10 pg/mL. 
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Figure 4.5 The effect of viral class on the cytokine profile. The LSMs with standard errors for each 
viral class: cleared is in black, persistent is in blue, and rebound is in red. The units of the cytokine 
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Figure 4.6 The effect of WUR on the cytokine profile. The LSMs for each WUR genotype: WUR 0 is 






4.2.4 Cytokine responsiveness and the association with viral profile class, WUR genotype and 
genetic background 
Individual cytokine profiles could be classed as responders or non-responders to PRRSV infection.  A 
profile was defined as a non-responder if all cytokine spline estimates after 0 dpi differed from the 
baseline level at 0 dpi by less than 0.5 units on the log10 scale. The threshold of 0.5 units was chosen 
to account for variation in observations caused by measurement or smoothing error, and was based on 
visual inspection of the spline profiles. 
A breakdown of the distribution of responder and non-responders within each cytokine is shown in 
Table 4.8. The majority of the pigs responded in the pro-inflammatory and anti-viral cytokines (IL-1b, 
IL-8, CCL2 and IFNA) and also the immune regulatory cytokine IL-10. In particular, the highest 
percentage of responders was found for INFA and CCL2, for which over 95% of pigs elicited a 
noticeable response. The immune regulatory cytokines IL-4 and IL-12 had the highest percentage of 
non-responders (71% and 54%, respectively) compared to the other cytokines.  A breakdown of the 
distribution of responders according to viraemia profile class, genetic background and WUR genotype 





Cytokine Responder (%) Non-responder (%) 
IL-4
1
 66 (29) 162 (71) 
IL-10
1
 209 (92) 19 (8) 
IL-12
1
 96 (46) 114 (54) 
IL-1b
2
 160 (70) 68 (30) 
IL-8
2
 182 (80) 46 (20) 
CCL2
2
 221 (97) 7 (3) 
IFNA
3
 227 (99.6) 1 (0.4) 
Table 4.8 The distribution of responders and non-responders for each cytokine. Superscripts refer to 
1
 
immune regulatory cytokines, 
2






Cytokine Cleared (%) Persistent (%) Rebound (%) 
IL-4 45 (41) 19 (21) 2 (7) 
IL-8 88 (81) 74 (81) 20 (72) 
IL-10 101 (93) 86 (95) 22 (79) 
IL-12 55 (50) 47 (52) 13 (45) 
IL-1b 59 (64)  52 (68) 14 (58) 
IFNA  109 (100) 91 (100) 27 (96) 
CCL2 105 (96) 90 (99) 26 (93) 






IL-4 0 (0) 0 (0) 66 (56) 
IL-8 16 (46) 49 (64) 117 (100) 
IL-10 28 (80) 64 (84) 117 (100) 
IL-12 30 (86) 46 (61) 38 (32) 
IL-1b - 47 (62) 78 (66.7) 
IFNA  35 (100) 76 (100) 116 (99) 
CCL2 33 (94) 73 (96) 115 (98) 
Cytokine WUR 0 (%) WUR 1 (%) WUR 2 (%) 
IL-4 33 (28) 27 (31) 6 (26) 
IL-8 91 (76) 72 (83) 19 (83) 
IL-10 110 (92) 80 (93) 19 (83) 
IL-12 64 (54) 38 (44) 12 (52) 
IL-1b 28 (27) 18 (24) 3 (18) 
IFNA  118 (99) 86 (100) 23 (100) 
CCL2 117 (98) 81 (94) 23 (100) 
Table 4.9 The number and percentage of responders for each cytokine according to viraemia class, 






Figures 4.7-4.9 illustrate the distribution of the responders across viraemia class, genetic background 
and WUR genotype respectively. The distribution between responders and non-responders is roughly 
similar between the viraemia classes for IFNA, CCL2, IL-1b, IL-10 and IL-8 (Figure 4.7). For IL-4 
the cleared profiles have a larger percentage of non-responders than the rebound or persistent classes 
(Figure 4.7A). Genetic background 5 had a bigger proportion of responders in IL-4 than genetic 
backgrounds 1 and 3 (Figure 4.8A). However the distribution of responders and non-responders for 
the other cytokines were similar across the genetic backgrounds for IL-1b, IFNA and CCL2 only 
(Figure 4.8). Genetic background 5 had the highest proportion of responders in IL-8 and IL-10 but the 
highest proportion of non-responders in IL-4 and IL-12 than the other genetic backgrounds. Figure 4.9 
shows that the distribution between responders and non-responders is roughly similar between the 
WUR genotypes, except for IL-4 which had a smaller proportion of responders in WUR 2 than the 
other genotypes.  
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Figure 4.7 The distribution of 
responder and non-responders for 
each cytokine by viraemia class. 
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Figure 4.8 The distribution of responder 
and non-responders for each cytokine by 
genetic background. NB. There were 
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Figure 4.9 The distribution of responder and 
non-responders for each cytokine according 




A measure of the total cytokine responsiveness for each individual was calculated by summation of 
the cytokine responsiveness across all of the observed the cytokines as outlined in Table 4.10. The 
cytokine response classes ranged from 3 to 7. The modal cytokine response class was 6. The cytokine 
response classes were then divided into being a broad or narrow cytokine response, where a broad 
response was defined by elevated expressions in 6-7 cytokines and a narrow cytokine response was 
defined by elevated expression in only 0-5 cytokines. The distribution of broad and narrow responses 
by each viral profile class, genetic background and WUR genotype are shown in Table 4.11. The odds 
ratios of the breadth of cytokine response associated with different viraemia profiles classes, genetic 
backgrounds, and WUR genotypes are presented in Table 4.12. 
The final model used to test the association between the profile-class, genetic background or WUR 
genotype against the cytokine breadth of response contained parity as the only significant fixed effect 
at the 95% significance level (P<0.05), with no other fixed or random effects.  
Cytokine response class  
(#cytokines the pig responds) 
Broad/Narrow class Number of individuals (%) 
0 Narrow 0 
1 Narrow 0 
2 Narrow 0 
3 Narrow 6 (3) 
4 Narrow 43 (19) 
5 Narrow 62 (27) 
6 Broad 94 (41) 
7 Broad 23 (10) 
 Total Broad 117 (51) 
 Total Narrow 111 (49) 
 Total 228 (100) 
Table 4.10 The pooled cytokine response classes. The cytokine response class refers to the number of 
cytokines the individual responds in. The classes were then pooled into a broad or narrow cytokine 
response according to the cytokine response class. (Broad: cytokine response class 6-7, narrow 
cytokine response class 0-5). 
Given that the allele acts in a dominant manner the WUR classes 1 and 2 were pooled (WUR Y) and 
further odds ratios were obtained to compare differences between the WUR 0 and pigs with the 





Viral class Broad (% within 
class) 
Narrow (% within 
class) 
Cleared 60 (55) 49 (45) 
Persistent 50 (55) 41(45) 
Rebound 7 (25) 21 (75) 
Genetic background   
1 24 (69) 11 (31) 
3 31 (41) 45 (59) 
5 62 (53) 55 (47) 
WUR genotype   
0 66 (55) 53 (45) 
1 42 (49) 44 (51) 
2 9 (39) 14 (61) 
Y (Pooled WUR 1 & 
2) 
51 (47) 58 (53) 
Table 4.11 Summary of the distribution of the breadth of cytokine response for viral profile class, 
genetic background and WUR genotype.  
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There was a statistically significant association (p<0.05) between the viraemia profile class and the 
breadth of the cytokine response when the cytokine response was pooled into two groups (i.e. broad 
or narrow). The direction of the odds ratios indicated that rebounders had a significantly narrower 
cytokine response than non-rebounders (p<0.05) (Table 4.12). 
There was a statistically significant association (at the 95% significance level) between the genetic 
background and the breadth of the cytokine response when the cytokine response was pooled into two 
groups (i.e. broad or narrow). The direction of the odds ratios indicated that genetic background 1 had 
a broader response than genetic background 3 (p<0.05) (Table 4.12).  
There were not any statistically significant associations (at the 95% significance level) between the 
WUR genotype and the breadth of the cytokine response when the cytokine response was pooled into 
two groups (i.e. broad or narrow) as shown in Table 4.12.  
Class 1 Class 2 Odds ratio  
(95% Confidence interval) 
P- value 
Clearance Persistence 1.086 (0.607, 1.944) 0.78 
Clearance Rebound 4.414 (1.556, 12.526) <0.05* 
Persistence Rebound 4.063 (1.418, 11.643) <0.05* 
Class 1 Class 2 Odds ratio  
(95% Confidence interval) 
P- value 
Genetic background 1 Genetic background  3 4.332 (1.674, 11.212) <0.05* 
Genetic background 1 Genetic background  5 3.617 (0.974, 13.435) 0.05 
Genetic background  3 Genetic background  5 0.835 (0.293, 2.377) 0.73 
Class 1 Class 2 Odds ratio  
(95% Confidence interval) 
P- value 
WUR 0 WUR 1 1.330 (0.733, 2.413) 0.35 
WUR 0 WUR 2 1.837 (0.711, 4.747) 0.21 
WUR 1 WUR 2 1.382 (0.526, 3.631) 0.51 
WUR 0 WUR Y 1.424 (0.813, 2.494) 0.22 
Table 4.12 Odds ratios for the breadth of cytokine response. Odds ratios indicated the effect of the 
breadth of cytokine response from individuals from Class 1 relative to that from individuals from the 
Class 2. Breadth of cytokine response was classified as narrow response (cytokine class 6-7) or broad 
response (cytokine class 3-5). *statistical significance at the 95% significance level (p<0.05). WUR Y 




4.2.4 Associations between viraemia and cytokine responses 
Correlations between the strength of the cytokine response (AAUC) and infection severity (AUC of 
viraemia curve) were generally weak, indicating that pigs with overall higher viral load did not elicit a 
stronger cytokine response (Table 4.13).  The strongest statistically significant correlations (at the 
95% significance level) were between AUC of viraemia and INFA between 0-21dpi (r = 0.23), and 
between the AUC of viraemia with IFNA and CCL2 between 0-4dpi (r = 0.16 and 0.19), respectively. 
The results indicate that the association between cytokine and viraemia response is stronger at the 
early stage of infection. 
 I4 I21 I35 
IL-4
1
 -0.01 0.03 -0.01 
IL-8
1
 0.04 0.09 0.06 
IL-10
1
 -0.03 0.05 -0.02 
IL-12
1
 0.03 0.04 0.001 
IL-1b
2
 -0.04 0.04 -0.03 
IL-8
2
 0.04 0.09 0.06 
IFNA
3
 0.16* 0.23* 0.09 
CCL2
2
 0.19* 0.05 0.03 
Table 4.13 Pearson correlations of pairwise cytokine AAUC and viraemia AUC at 4, 21 and 35dpi 
(denoted as I4, I21 and I35, respectively). Superscripts refer to 
1
immune regulatory cytokines, 
2
pro-
inflammatory cytokines and 
3
 antiviral cytokine is in red.*indicates statistical significance at the 95% 
significance level (p<0.05). 
Associations between cytokine response and resolution of infection 
Rebounders were removed from the analysis to determine if a stronger cytokine response was 
associated with the faster resolution of infection. The results of fitting a mixed model with the Wood’s 
parameter C1 as the response variable and the AAUCs for different cytokines as potential predictors 
are shown in Table 4.14. In the null model the random effect of pen within genetic background was 
significant and the viral profile class was the only significant fixed effect. The strongest associations 



























C1 AA_IL10_28  
AA_IL12_28  
AA_IL1b_28 






Table 4.14 Goodness of fit statistics for the final mixed model exploring the association between 
cytokine measures and the rate of post viraemia peak decline captured by the Woods parameter C1. 
The strength of the cytokine responses i.e. the AAUCs of IL-10, IL-12 and IL-1b were potential 
predictors in the final model. * indicates significance of the LRT between the final model and the null 
model at the 95% significance level. 
However, the final model for the Wood’s parameter C1 that included cytokine measures as predictors 
was not a statistically significant improvement at the 95% significance level to the null model without 




Cytokine characteristics as predictors of the viraemia curve characteristics 
In the null models pen within trial was only a significant random effect for V4 and Vmax. The fixed 
effects of parity, viral class, WUR, genetic background and age were significant dependent on the 
response variable as outlined in Table 4.15. As expected, IFNA and CCL2 were the two key cytokines 
associated with the viraemia traits. Interactions between the cytokine measures and the responder 
classification in that class were not significant. Genetic background had a significant effect on the 
models. Interactions between WUR and the cytokine predictors were not significant. The genetic 
background interaction was only significant for IFNA at 4dpi in the model for viraemia at 4dpi (V4), 
as shown in Table 4.16. The viraemia class interaction was only significant on the IFNA for viraemia 
at 42dpi. 
The mixed models of best fit to the data for the viraemia predictions are presented in Table 4.15. 
Overall the inclusion of cytokine measures as predictors for viraemia at a specific time point or over a 
given time period improved the model fit, as confirmed by reduction of the AIC value, improved log-
likelihoods and increase in the R2 values. Including cytokine predictors significantly improved the 
models according to the LRT for all the viraemia traits listed in Table 4.15, except for V42 which had 





























V4 IFNA_4   
IFNA_4*Genetic background   







0.13 271.9* 303.0 

























Age   
45.4 0.62 0.08 1398.2* 1443.6 








54.6 0.71 0.07 1710.8* 1765.6 
Tmax L_IL8_0  
L_IFNA_4  





63.9 0.35 0.21 731* 794.9 
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Vmax L_IFNA_0  
L_IFNA_4  




12.9 0.40 0.07 139.6 150.3 
DeltaT L_IFNA_4  
L_IFNA_10 
Parity 
Viral Class   
35 0.39 0.11 952.2* 989.7 
Table 4.15 The final mixed models when the viraemia traits were the response variables and the 
cytokines where the potential predictors. There were no significant cytokine predictors for the 
viraemia trait DeltaV (the value of viraemia at the maximal rate of decline defined in Table 4.15).* 
indicates significance of the LRT between the final model and the null model at the 95% significance 
level.  
IFNA was consistently a key cytokine associated with the viraemia characteristics. CCL2 was also a 
significant predictor, and the baseline expression of IL-8 was associated with the time of the peak 
viraemia. The predictive power of cytokine measures for viraemia levels declined over time, 
suggesting that the variation we observe in viraemia resolution is not captured through the observed 
serum cytokines. The value of the peak viraemia was associated with early IFNA observations. 
Although the effects are significant the improvement to the R
2
 values are relatively small. Interactions 
between the viraemia predictors and the WUR or genetic background were not significant.  
When cytokines were assumed as response variables and viraemia traits the potential predictors in the 
mixed models there was no significant association with the viraemia traits for the majority of 
cytokines, i.e. IL-8, IL-10, IL-1b or CCL2. For IL-4 one significant association with viraemia was 
found, but the relationship was very weak with only 6% of total variance explained by all predictors 
together (Table 4.16). In contrast, for IFNA estimates within the first 2 weeks of infection, several 
significant viral predictors were found, all of which are shown in Table 4.16. Genetic background and 




























0.1 0.06 0.02 330.6 330.7 
IFNA_4 V4 
Genetic 
30.1 0.24 0.12 328.2* 358.7 





28.4 0.37 0.12 311.4* 313.4 




20.3 0.41 0.09 336.7* 338.7 
Table 4.16 The final mixed models when cytokines were the response variables and the viraemia 
traits were the potential predictors. * indicates significance of the LRT between the final model and 
the null model at the 95% significance level. Where Vx and Ix refer to the Woods viraemia 





Typically PRRSV elicits weak innate and adaptive immune responses, is associated with immune 
modulation, but induces a strong immunosuppressive response, resulting in delayed onset of a Th1 
immune response [11,31,34,44]. Out of the seven measured serum cytokines in this study, strongest 
responses following PRRSV infection were observed in the pro-inflammatory cytokine CCL2 and the 
antiviral cytokine IFNA. Inter-host variation was observed in the cytokine responsiveness across the 
measured cytokines in this study and the nAb cross-protectivity. Viraemia profile class differences 
were captured in the breadth of the cytokine responsiveness across the measured cytokines. 
Rebounders had a significantly narrower cytokine response than non-rebounders. Genetic background 
differences had a significant impact upon cytokine responsiveness with genetic background 1 having a 
broader response than genetic background 3. Furthermore it was found that pigs varied in the breadth 
of their nAb cross-protection from exhibiting no neutralising response to exhibiting a nAb response 
against four different PRRSV isolates. Viraemia profile class was also captured in the breadth of the 
nAb cross-protectivity. Viraemia clearance profiles corresponded to a less diverse nAb response than 
persistence and pigs with persistent viraemia had a more diverse nAb response than those with 
rebound profiles.  These results suggest that a slower clearance rate of viraemia in the persistent 
profiles is associated with a more diverse nAb response; this does not hold true for viraemia rebound. 
The WUR genotype did not have any significant association with the nAb cross-protectivity or 
cytokine responsiveness. It is thus likely that host genes other than WUR are likely to capture the host 
genetic contribution to nAb cross-protectivity and cytokine responsiveness. Furthermore it has been 
proposed that many immune competence parameters including in-vitro innate cytokines, adaptive 
cytokines and the host’s IgG response, could be under genetic control and that there may be scope for 
them to be included in future the selection protocols [45-48]. Thus the statistical categorization of the 
nAb cross-protectivity and cytokine responsiveness defined in this chapter could be of potential use in 
future studies in the development of an immune competent pig which is discussed further in the 
General Discussion chapter of this thesis. 
Associations between cytokine response and viraemia characteristics were significant but only 
moderately strong, thus highlighting the complexity of the immune response. IFNA and CCL2 
profiles showed systematic time trends, with the general trend for IFNA represented by an increase to 
a peak around 4dpi followed by decline to baseline levels by 14dpi, whilst the dynamics of CCL2 was 
typically slower i.e. with a gradual increase to peak expression by 10dpi followed by gradual decline 
in expression. Previous studies have already established the antiviral role of IFNA and its association 
with viraemia clearance [49-51], however the role of CCL2 during a PRRSV infection has not yet 
been fully determined. However in this chapter it was found that, CCL2 and IFNA were strongly 
associated with each other in two regards, firstly there were high correlations in the strength of the 
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responses at 14 and 35dpi (AAUC) and secondly their measures were consistently statistically 
significant predictors of each other throughout the entire duration of the experiment. IFNA was a 
marginally better predictor for CCL2 than the reverse relationship. This is a novel finding and 
indicates that CCL2 may play a key role during a PRRSV infection. However the relationships among 
the other cytokines were neither as strong nor as consistent across the full profiles.  It is important to 
note however that the lack of observing elevated expressions the majority of the cytokines in this 
study, may be a result of the time intervals between observations (4-7 days) being too large to capture 
the rapid immune dynamics following infection. 
Of the list of potential fixed effects, the genetic background had the largest impact on cytokine 
expression profiles, with differences being observed at various phases of the infection profile 
depending on the cytokine; typically, the strongest impact was between 4-14dpi. Genetic backgrounds 
differed in the baseline levels of cytokine expression and also the overall magnitudes of expression, in 
particular for IFNA and CCL2. Response patterns for the time-trends of the LSM estimates were 
overall similar across the different genetic backgrounds, although some slight differences in the 
overall trends were observed for some cytokines. For example, pigs from genetic background 3 had a 
tendency to decrease from baseline expression in IL-1b (by ~0.7 log10 units) whilst pigs from genetic 
background 1 saw a general trend of increase from the baseline IL-1b levels (by ~0.7 log10 units). 
Furthermore expression in IL-10 and IL-12 in genetic backgrounds 1 and 5 remained overall closer to 
baseline levels compared to the corresponding decreasing levels observed in genetic background 3 (by 
~0.7 log10 units and ~1 log10 units respectively). 
The WUR “resistance” genotype (WUR 1 and 2) previously found to correspond to lower cumulative 
viraemia (viraemia AUC 0-21dpi) [3,4,7,42] had minimal impact on the cytokine expression profiles 
throughout the infection duration (0-42dpi) for the majority of cytokines in this study. However the 
WUR genotype differences were captured in IL-12 during the primary phase of infection, i.e. from 0-
21dpi, with low expression in WUR 2 and high expression in WUR 1 genotypes, and in the antiviral 
cytokine IFNA resulting in a higher peak expression at 4dpi for WUR 2. Given the impact the 
genotype has on the viraemia it is surprising that these differences between WUR 0 and WUR 1 and 2 
were not reflected in the longitudinal cytokine expression profiles. 
Viral profile class differences were captured in the pro-inflammatory cytokines IL-8, CCL2, and the 
antiviral cytokine IFNA. Rebounder pigs elicited overall a stronger response in most of the cytokines 
at the later stages of infection (from 28dpi onwards) than non-rebounders, although the differences 
were not always statistically significant. “Rebounding” i.e. increased expression of CCL2 at 28dpi, 
IFNA at 28-35dpi and IL-8 at 35dpi was observed for the viraemia rebound pigs (with rebound in 
viraemia typically occurring between 21-42dpi see Chapter 3 for further details). However differences 
in cytokine expression between pigs with cleared and persistent viraemia profiles were small and not 
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statistically significant at all stages of the infection. 
 
Consistent with the longitudinal expression profiles, IFNA and CCL2 were the two key cytokines 
significantly associated with the viraemia traits in the multiple regression models. Inclusion of 
cytokine measures as predictors for viraemia significantly improved the null models capturing 
differences in pig genetic make-up and the experimental setup across the full time course of the 
infection (0-42dpi). The predictive power of cytokine measures for viraemia levels increased over 
time, suggesting that the variation we observe in viraemia resolution could be partly captured through 
the observed serum cytokines. The value of the peak viraemia was associated with early IFNA 
observations accounting for approximately 40% of the variation. The rate of viraemia decline was best 
captured in the strength of the expression of the immune regulatory cytokines IL-10 and IL-12 and the 
pro-inflammatory cytokine IL-1b, however the final model was not a significant improvement on the 
null model. Conversely, the viraemia measures emerged generally as poor predictors for the majority 
of the cytokines in the study across the full time course of the experiment (0-42dpi). One significant 
association between IL-4 and viraemia was found, but the relationship was very weak with only 6% of 
total variance explained by all predictors in the final model. With the exception of a weak relationship 
between IL-4 and viral predictors, viral predictors with significant influence on cytokine expression 
were only found for IFNA estimates within the first 2 weeks of infection. The results reflect that pro-
inflammatory and immune-regulatory cytokines are only indirectly related.   
 
Cytokine response can be very transient [36] , thus a 4-7 day window may not capture sharp 
responses. Cytokines and virus in serum are a ‘spill-over’ from those in the infection target site. This, 
together with the fact that some cytokines are locally produced may weaken the strength of the true 
associations between cytokine and viraemia that would be found directly at the site of infection. In 
addition to viraemia and other known factors of influence, parity surprisingly emerged as a significant 
predictor in the multiple regression models for cytokine response in this chapter, however this was not 
the case for the viraemia profiles in Chapter 2. One potential explanation for this could be due to the 
immune response of sows changing between parities which would influence our results in the 
resulting infected piglets from different parities due to the presence of maternal antibodies in the 
piglets. Cytokine responses to PRRSV have been explored extensively in previous studies both in 
vitro and in vivo for numerous PRRSV strains[10-14,16,52]; however there are often fewer numbers 
of repeated measures from 0-42dpi than in the present study and hence the associations between 
serum cytokine expression and serum viraemia trends such as viraemia rebound have not been 
previously studied.  
 
It is known that the pro-inflammatory innate cytokine IL-8 is released by the macrophages that first 
encounter pathogens and recruits neutrophils, which enter the infected tissue in large numbers in the 
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early stage of the induced response. Their influx usually peaks within the first six hours of an 
inflammatory response [53]. For PRRSV infection, large inter-host variation in the ability to 
synthesise IL-8 has been reported, where strong IL-8  synthesis has been associated with high host 
resistance to PRRSV [20]. In an in vivo PRRSV study involving two different breed crosses (NE 
Index line and a Hampshire-Duroc crossbreed pigs) than those used in the current PHGC trials, pigs 
were categorized into high or low disease burden [54]. High viraemia levels were associated with high 
IL-8 expression in the lung particularly prior to the peak viraemia [54]. In our study breed differences 
were also observed in IL-8 expression, however IL-8 was more strongly associated with the later 
dynamics of the viraemia profile in our study. An elevated response at 35dpi in serum IL-8 was 
observed for the viraemia rebound pigs in our study when compared to the cleared pigs at this time 
(35dpi). Furthermore in an in vivo study investigating the cytokines associated with viral persistence 
of a different North American strain (VR-2332) found that persistent pigs had a lower concentration 
of IL-8 than non-persistent pigs at 14dpi and that IL-8 levels were generally up-regulated early after 
infection with the earliest serum measurement taken at 7dpi [16]. However, a study using the same 
North American strain as in this thesis (NVSL) found that IL-8 levels remained high and largely 
unaffected by the presence of the virus [12]. In the present study we found that the IL-8 cytokine 
profiles of PRRSV infected piglets were generally flat with differences in expression levels of less 
than 1 log unit. However, the lack of capturing elevated expressions in this cytokine, may be a result 
of the time intervals between observations (4-7 days) being too large to capture the rapid immune 
dynamics, with the possible peak within 6 hours of infection [53]. 
 
IFNA was consistently a significant predictor for viraemia characteristics, which is unsurprising due 
to its already established antiviral role and association with viraemia clearance [49-51]. Previous 
studies differ in the nature and magnitude of the IFNA response following a PRRSV infection, with 
the more widely reported lack of significant and low IFNA response compared to other infections 
[9,19,25,51], contrasted with reported increases in serum IFNA levels following PRRSV infection 
[12,27,55], which is in line with our results. In a previous in vitro study it was demonstrated that 
North American PRRS viruses can inhibit the production of type 1 interferon in plasmacytoid 
dendritic cells, which are sources of IFNA [24,56]. This in vitro result could potentially reflect an 
absence of triggering one or more pathways leading to cytokine production and cell maturation in 
vivo. Conversely it has been demonstrated that some PRRSV strains (including north American 
strains: VR-2332, SS144, MN184, JA-1262 and the highly pathogenic field isolate from China 
SY060) induced IFNA secretion by plasmacytoid dendritic cells with little or no down-regulation of 
IFNA production [57]. There is evidence for strain differences in the in-vitro IFNA levels of 
suppression following infection. The highly pathogenic Chinese type 2 isolate SY0608 had a 52% 
inhibitory effect, the type 2 isolate VR-2332 inhibited by 34% and the highly virulent type 2 isolates 
SS144, MN184 and JA-1262, showed lower levels or no inhibitory activity in the in vitro study after 
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20 hours pi [57]. Furthermore a recent in vivo study of the cytokine expression profiles from NVSL 
infected pregnant gilts, with observations taken at 2, 6 and 19dpi only, found a strong expression of 
serum IFNA following infection at 2dpi which could corroborate our finding of increased expression 
of serum IFNA at 4dpi in our study [12]. Given the evidence for strain dependent IFNA suppression 
we could thus hypothesise that NVSL is in line with the other the highly virulent type 2 isolates 
SS144, MN184 and JA-1262 in the low level of IFNA suppression. Furthermore the genetic 
background had a significant effect on IFNA profiles. Indeed IFNA expression was breed dependent 
resulting in either increased or no change in expression from uninfected pigs in the in vivo study by 
Petry et al [54]. The dynamics of serum CCL2 reflected slower dynamics than the IFNA profiles. 
However unlike IFNA, the dynamics or role of the cytokine CCL2 in PRRSV infections has not been 
determined in previous studies. 
 
It is difficult to compare the full time trends observed in the present study to other PRRS studies due 
to the novelty of the several repeated measures taken across the 42day observation period, however 
the changes in serum cytokine expression measured at 6 and 19dpi in a companion study on NVSL 
infected pregnant gilts are similar to the 7dpi and 21dpi measures in our study across all seven serum 
cytokines [12]. However the latter study showed trends of lower levels of expression than baseline 
levels at 2dpi for IL-8, IL-10, IL-1b and IL-12, which was not captured in our study at 4dpi. 
In this chapter, the strength of IL-10, IL-12 and IL-1b expression (i.e. area under the cytokines 
profiles from 0-28dpi with the baseline removed) was positively associated with a faster resolution of 
infection. High serum levels of the pro-inflammatory innate cytokine IL-1b at 14dpi have been 
previously linked to pigs classed as persistently infected following PRRSV infection with a different 
type 2 PRRSV strain [16]. In previous studies IL-12 positive cells have been detected in the lung as 
early as 1 day post infection (dpi) [58].  Furthermore treatment with IL-12 during an infection with 
type 2 PRRSV isolate NADC-8 led to reduced viraemia in vivo [59]. In this Chapter the IL-10 
expression due to infection was relatively weak, without significant up-regulation from the baseline 
levels of expression (i.e. expression at 0dpi). In the PRRSV literature however there are conflicting 
reports in the literature on whether PRRSV infection elicits an up-regulation of IL-10 expression or 
not. Up-regulation of IL-10 has been found in the lung for a type 1 PRRSV infection [10], following 
in vitro infection with various type 2 PRRSV strains [10,44,60,61]. Increased IL-10 expression 
following PRRSV infection can reduce the expression of cytokines involved in viral clearance i.e. 
IFNA, TNFA, IL-12, and IFN-gamma [10]. Conversely no significant IL-10 response was observed 




In many species IL-4 is a cytokine of the adaptive immune response with the principle cellular 
sources from CD4+ T cells and mast cells, targeting B cells (causing isotype switching), T cells 
(causing differentiation and proliferation), and Mast cells (causing proliferation)[64]. However the 
role of IL-4 is species dependent and in swine IL-4 is not a stimulatory factor for porcine B cells, 
instead it blocks antibody and IL-6 secretion and suppresses the antigen-stimulated proliferation of B 
cells [52]. Following a PRRSV infection IL-4 is up-regulated and appears to have some immune-
modulatory consequences [27]. One study reports that swine IL-4 markedly enhanced the protective 
immune response of pigs and improved the efficacy of a modified live vaccine in preventing PRRS 
disease and resulted in a higher antibody titre, higher sera neutralizing efficacy, higher ratio of 
CD3⁺CD4⁺/CD3⁺CD8⁺ T lymphocytes, and lower virus loads in peripheral blood [65]. The 
expression profiles of IL-4 were the least affected by PRRSV infection in our study. Following in vivo 
PRRSV infection serum  IL-4 was up-regulated at 2dpi (increased by ~90%) in a previous study under 
farm conditions [27], which was not captured at 4dpi in our study. In future studies it would be 
informative to include a smaller sampling interval in order to capture the rapid dynamics of IL-4 
expression. 
There are other cytokines known to play a role in PRRSV infection that were not measured in the 
current study. For example, IFN-gamma has been found to be up-regulated following infection with 
NVSL, and other type 2 PRRSV strains and is associated with viral clearance [16,66-68].  Serum IL-6 
expression was also not measured in this study however previous studies have found that pigs with 
high viraemia pigs from 0-14dpi (PRRSV strain 97-7985 infection) had on average higher IL-6 
expression [54]. 
It is difficult to fully disentangle the cause and effect in the associations between the various viraemia 
and immune components, as biologically both types of measures are likely to effect each other with 
possible “predator-prey” type dynamics between the virus and the cytokines or the immune processes 
in which they are involved. For example before the PRRSV challenge one could potentially assume 
that the serum cytokines levels remain at the baseline in the absence of PRRSV infection. Thus we 
could view the early serum cytokine response following infection as being driven by the virus and an 
indication of the host mounting an immune response against the virus. However these elevated 
cytokines may then in turn drive the viraemia i.e. the viraemia clearance dynamics through the 
signalling and triggering of immune processes that reduce the infectivity of target cells or reduce the 
virus replication rate etc., and thus resulting in reduced viral loads. These reduced viraemia levels 
could in turn drive reduced expression of serum cytokines. Fast return of cytokine levels towards 
baseline levels could potentially provide low defence against the remaining or a mutated virus strain, 
thus allowing viral rebound to occur.  The viraemia rebound then drives the cytokine dynamics as 
before thus explaining the elevated IL-8, IFNA and CCL2 observed during the rebound stage of 
infection. However in the multiple regression approach a stronger association was found when 
141 
 
preceding cytokines were predictors for viraemia characteristics at subsequent time points as opposed 
to vice versa which suggests that the cytokines are driving the viraemia dynamics rather than the other 
way round. 
In Chapter 3 the analysis of the nAbs of NVSL infected pigs in collected at 42dpi indicated that there 
was a strong homologous response to the PRRSV challenge, in agreement with observations from 
previous studies [69,70]. We were unable to test the impact of the genetic background on the nAb 
cross-protection since the data on nAb were from pigs of the same genetic background. The WUR 
genotype had no significant impact upon the nAb cross-protection (Appendix 2b), different host genes 
are likely to capture the differences in nAb cross-protectivity. A statistical association between 
viraemia characteristics and nAb cross-protectivity was identified in Chapter 3, which may point to 
the host-pathogen interactions underlying the observed viraemia and antibody patterns. Both virus 
persistence within the host and cross-protection of host antibodies have been previously linked to 
virus mutation and emergence of quasi-species [9, 38]. It should be noted, however, that the observed 
associations between the nAb response and viraemia patterns may equally arise from confounding 
immune quantities affecting both nAb and viraemia, such as immune-regulatory or anti-viral 
cytokines which have been measured in this chapter. Indeed, several alternative hypotheses, not 
necessarily involving virus mutation, emerge as potential causes for viraemia rebound based on our 
findings.  For example viraemia rebound may correspond to the second cycle of an oscillating 
viraemia profile which may arise naturally (and in the absence of virus mutation) from predator-prey 
type interactions between the virus and the immune response [71,72]. The majority of the serum 
cytokine expression profiles in this chapter do not support this hypothesis, however the statistically 
significant elevated expression of IL-8, IFNA and CCL2 coinciding with viraemia rebound, which 
could potentially reflect the hypothesised oscillating behaviour arising from dynamic interactions 
between the virus and immune response. Alternatively, rebound could arise from the heterogeneity of 
the virus distribution in various tissues within the host. Previous studies have observed that although 
viraemia may be below detection in the serum, persistent infection in the tonsils and lymphoid tissues 
can last for longer than 6 months [73]. Thus, the site of replication may be hidden from the serum and 
the infection may remain localised in certain tissues. Rebound may be a manifestation of the virus 
from these localised tissue infections being poured back into the system; thus becoming detectable in 
the serum. The influx of virus into the serum may occur in occasional bursts or as a final out-pouring 
into the serum determined by some environmental stimulus, immune response mechanism, or 
stochastic process. If this were the case we could expect this to be reflected in cytokine profiles 
related to viral clearance or load potentially in the form of bimodal cytokine profiles. The result that 
IFNA and CCL2 were statistically significantly higher for the rebound class at the later phase of 
infection could potentially support this hypothesis. Furthermore the viraemia rebound peak is often 
smaller than the first viraemia peak, due to the initial PRRSV challenge, which may explain why the 
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increased rebound expression of IL-8, CCL2 and IFNA is relatively small. Virus rebound manifesting 
itself in biphasic viraemia profiles is a common phenomenon in equine influenza infections, the 
causative processes of which remain a mystery [74].  Additional information about virus 
heterogeneity and/or nAb characteristics at different stages post infection would be needed to assess 
these hypotheses.  
Similar arguments may be used to interpret the observed high inter-host variation in viraemia decline 
post the initial viraemia peak. Variation in the rate of viraemia reduction may be a function of the 
host’s own immune response, virus mutation mechanisms or the interaction between both processes. 
In Chapter 3 the moderate negative correlation between the NVSL Wood’s parameters 1c  and 2c  (-
0.52) indicates that a slow decline in the first cycle corresponds to faster decline in the second cycle 
and vice versa. This association may be indicative of the temporal evolution of the immune response. 
Furthermore viraemia rebound profiles are associated with high levels of CCL2 during the secondary 
phase of infection, which is interesting from a biological perspective since the role of CCL2 is thought 
to be that of causing an influx of macrophages to the site of infection [53]. A potential hypothesis that 
emerges from the present study is that the increase in CCL2 could result in an influx of new PRRSV 
target cells thus driving the rebound in viraemia that we observe [75,76]. Furthermore, rebound pigs 
had a statistically significantly higher expression of IL-8 at 35dpi than cleared profiles, with an 
increase of 0.16 units on the log10 scale. This statistically significant rebound in IL-8 may support the 
hypothesis that rebound could be caused by a reinfection or could be an indication that higher 
viraemia levels at this stage of the infection result in higher IL-8 expression, ultimately it is difficult 
to disentangle the cause and effect. However the associations between IL-8 and viraemia levels were 
weak during the early phase of infection when the initial viraemia peak is observed; furthermore 
persistent pigs did not have significantly higher IL-8 expression than cleared pigs at 35 or 42dpi. 
If viral rebound was due to immune escape by the virus, which is recognized as re-exposure to the 
virus by the host then we could hypothesize that rebound pigs would have a greater memory B cell 
activity of memory B cells resulting in a higher level of antibody than non-rebound [77]. 
Alternatively, high antibody levels could place selective pressure on the virus which could manifest in 
an increased likelihood of viral rebound occurring [78-82]. Longitudinal antibody response measures 
would thus be needed to test these hypotheses and further determine the relationships between 
viraemia profiles and the antibody response. 
Virulent field PRRSV isolates exhibit longer and more elevated viraemia profiles and can induce a 
faster and more intense humoral response [83]. In the study by Johnson et al [83] highly virulent 
PRRSV field isolates replicated to a substantially higher in vivo titres than attenuated or lower virulent 
isolates. N-protein antibody responses were higher in pigs infected with more virulent isolates, as 
were their viraemia measures. The antibody trends were similar between the isolates but differed in 
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magnitude; thus providing evidence for a strong association between the humoral response and the 
serum viraemia load. The magnitude of the immune response could be related to the virulence and in-
vivo replication rate of the PRRSV strain. Antibody differences could be a reflection of the genetic 
differences between the PRRSV isolates. It would be interesting to compare the nAb responses 
between the NVSL and KS06 isolates in the PHGC dataset. Given the trends observed by Johnson et 
al [83] we could expect to observe a less dominant humoral response in the KS06 infected pigs. 
However it is important to note that even without the development of nAbs viraemia resolution can be 
occur in a PRRSV infection [19,21,84]. However during a PRRSV infection the levels of nAbs 
typically remain low, when compared to other respiratory infections. Hence a strong but inefficient 
antibody response could be responsible for persistent viraemia profiles, i.e. a longer infection 
duration[32], which was confirmed by the result of the odds ratios of nAb cross protection and 
viraemia class. Understanding the host’s ability to mount a non-neutralizing PRRSV-specific antibody 
response could lead to deeper insights related to the non-isolate specific host-response to PRRSV 
infection. Whilst studying the breadth of the nAb cross-protection could lead to the identification of 
pigs with desirable immune response traits, particularly for pigs under field conditions where multiple 
PRRSV strains could be in simultaneous circulation [85]. 
Suppression of the innate system during a PRRSV infection could be responsible for the persistent or 
prolonged viraemia profiles. It has been reported that PRRSV can suppress phagocyting activity and 
the expression of innate cytokines, and alter the expression patterns of the latter [19,22]. However we 
found that there were no marked differences between the cytokine expression profiles between 
persistent and cleared profile; similar cytokine expression led to different trends in viraemia profiles 
and infection duration. 
 
In conclusion, the associations between viraemia and cytokine indicate that cytokines drive the 
viraemia profiles from 4dpi onwards. Associations between IFNA, CCL2 and the viraemia profiles 
were the most consistently significant, with the viraemia rebound trends being captured in these 
cytokines; however, the cause and effect remains hard to disentangle due to the dynamic nature of the 
virus and the immune response interactions. Associations between serum cytokines and viraemia 
rebound could point towards understanding the mechanisms surrounding the variation in viral 
profiles. The “rebound” in CCL2 could be a driving force in the recruitment of new target cells at the 
site of infection, whilst the “rebound “ in IFNA could be a consequence of the elevated viraemia 
levels due to rebound. Future studies are needed to fully determine the underlying factors driving the 
cytokine or nAb response, the role of CCL2 during infection, and the host genetics association with 
the nAb response in order to derive vaccine-ready pigs capable of mounting successful responses 
against a variety of currently circulating PRRSV strains. It would be interesting to assess the 
relationship between the nAbs and the cytokines to determine whether the strength of cytokine 
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response and nAb cross-protectivity were related. However the current data on the nAb and cytokine 
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Chapter 5. Discussion 
5.0 Summary of the novel findings of this thesis and their implications 
The overarching aim of this thesis was to gain novel insights into the within host infection dynamics 
of pigs after an in vivo infection challenge, with one of two PRRS virus isolates, using a statistical 
modelling approach. Empirical models for infection profiles were fitted to virus load and immune 
response measurements over time and statistical analysis was conducted on longitudinal viraemia, 
cytokine measures and nAbs cross-protection data.  We quantified the inter-host variation, explored 
the time trends of the longitudinal viraemia and cytokine measures, and determined the influencing 
factors on them. In total, to date, the PHGC infection trials consist of 15 PRRSV infection trials 
comprising of one of two PRRSV isolates (NVSL or KS06). In Chapter 2 viraemia data from Trials 1-
8, 10-12 and 14-15 were used to explore the influential effects on the PRRS viraemia profiles such as 
the virus strain, the WUR genotype and the genetic background. Thus, in Chapter 2, Trials 9 and 13 
were excluded due to the lack of WUR genotype variation in the pigs, and unusual viraemia profiles 
due to a likely co-infection, respectively. Chapter 3 focused on capturing the inter-host variation in 
viraemia profiles using the Wood’s and Extended Wood’s model. The models were fit individually to 
all pigs, which contained a minimum of 6 repeated measures, in the PHGC dataset in order to generate 
new phenotypes for every individual. These new phenotypes have and will be used in subsequent 
genetic analysis for the selection of pigs with desirable infection traits, such as the study included in 
Appendix 3 and other ongoing studies carried out by the PHGC. The focus of Chapter 4 was on the 
immune response and the relationship between the immune response measures and the viraemia 
profile trends. The longitudinal cytokine response profiles and their time trends, relationships between 
cytokines, and the associations between the cytokines and the viraemia profiles were explored. 
However longitudinal cytokine data was only obtained from a subset of pigs from Trials 3, 5 and 7. 
Categorical data on cytokine responsiveness and the neutralizing antibody (nAb) cross-protection and 
their association with viraemia class, WUR genotype and the genetic background was also examined 
in Chapters 3 and 4. The nAb data was obtained from a subset of pigs from Trials 1-3, which did not 
overlap the cytokine data and hence the associations between the cytokine and nAb responses were 
not examined.  
Novel insights were gained in this thesis on the variation in the host response to an identical infection 
challenge, represented by the wide variation in the longitudinal repeated viraemia and cytokine 
measures for large numbers of pigs in the PHGC trials. Viraemia and cytokine trends, as well as nAb 
cross-protectivity were successfully quantified and pigs were categorised according to their responses 
across trials, genetic backgrounds and PRRSV isolates in this thesis. This is one of few PRRSV 
studies that combines the investigation of viraemia with longitudinal cytokine data and nAb cross-
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protection data. In the following discussion we present the novel findings of our study, their 
implications for the PRRSV infection research, and discuss emerging scientific questions to be 
explored in future studies. 
5.0.1 The Wood’s model 
This thesis, and also the study presented in Appendix 3, has demonstrated the suitability of 
mathematical functions to assess the impact of various factors including host genetics on PRRS 
viraemia kinetics. This is the first study to apply the Wood’s and Extended Wood’s model to PRRS 
viraemia profiles. The Wood’s curve is concisely described by  three parameters, a, b, and c, which 
are related to the magnitude of the values (a), and describe the shape of the curve (b, which is 
dominant pre-peak, and c, which is dominant post-peak) [1]. While other mathematical functions may 
more adequately model PRRS viraemia during infection, the number of data points collected during 
these PHGC trials limited the ability to fit more complex models. Fitting a Wood’s curve is a more 
powerful method for comparing viraemia dynamics than the Loess smoothed fit used in previous 
analyses of a subset of the PHGC data [2-4]. The Loess smoothed fit uses a parameter indicating the 
degree of the polynomial to fit to the data and a smoothing parameter for curve fitting [5], with the 
primary aim of filtering  noise. The limitation with the Loess and other polynomial spline functions, 
however, is that this method does not lend itself to extract fitted parameters that specify particular 
physical properties of a system which have important implications in understanding the dynamics of 
PRRSV infection. Although both methods adequately fit the data, the Wood’s curve parameters 
describe both the magnitude and shape of the curve, which can be used to explore different 
characteristics of the viraemia curves. Exploring Wood’s curve characteristics can provide insight into 
important biological questions, such as which immune responses are associated with the rate of 
decline (parameter c) or timing of the peak viraemia (Tmax), which aspects of host response are under 
strongest genetic control and how selection for one curve characteristic may affect others and, thus, 
the entire response profile (in Appendix 3). It may also be used to explore the relationship between 
curve characteristics and other phenotypes, such as weight gain (WG) under infection in 
accompanying studies (such as Appendix 3 or current studies on disease tolerance  in a PRRSV 
infection).  
Fitting a Wood’s curve provided reliable estimates for the function  parameters while not over-
parameterizing the data to explore: the associations between the immune response measures  at key 
profile characteristics such as the time of the peak (Tmax) and time of maximal viraemia decline 
(Delta T) and the different aspects of the PRRS viraemia curves for subsequent genetic analysis (see 
Appendix 3). Furthermore, comparison of the Extended Wood’s and Wood’s curve functions allowed 
for an objective classification of viraemia profiles using the full time course of the experiment in 
Chapter 3.  
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Limitations of the Wood’s model 
While the advantages of fitting a Wood’s curve to model the dynamics of PRRS viraemia are clear, 
care needs to be taken in the interpretation of the correlations between curve characteristics because 
strong correlations between these curve characteristics are likely to arise partly as an artifact of the 
Wood’s function and partly as they reflect true correlations between curve characteristics that are 
independent of the Wood’s function. One example whereby the genetic correlation between traits is 
likely to be driven by the Wood’s function is the high genetic correlation observed between deltaT 
(time of maximum decline, Tmax, in Appendix 3) and deltaV (value of viraemia at maximum decline, 
Vmax, in Appendix 3) in Appendix 3, because they rely heavily on the b parameter of the Wood’s 
function. 
5.0.2 Review and comparison of the statistical modelling and inferences employed 
Empirical mathematical models have proven useful for describing the temporal evolution of a 
response variable and filtering stochastic noise from dynamic biological systems whilst retaining the 
most fundamental features [6-9]. Linear mixed models are a well-established methodology used to 
model longitudinal data with the inclusion of both fixed and random effects [8,10-13]. The repeated 
measures modelling approach was appropriate for the assessment of influential factors on the time 
trends of viraemia and cytokines in Chapters 2 and 4. The advantage of the repeated measures 
modelling approach was that temporal correlations could be incorporated into the models without 
assuming any prior information about the shape of the profiles. They were thus a logical place from 
which to begin analysing the impact of diverse influencing factors on the longitudinal data [11,13]. 
Through the repeated measures model, LSMs for viraemia and cytokines were obtained at each 
observation time and the effects of the influencing factors on these were examined. However the 
repeated measures modelling approach was limited to the observation times only and could not be 
used to capture the full non-linear time trends of the individual viraemia profiles across the duration 
of the experiment. Although the impact of effects on the LSMs can be tested, this method does not 
result in the generation of biologically interpretable parameter estimates for key profile 
characteristics, which is key for the selection of individuals with desirable infection phenotypes (i.e. 
parameters relating to the rate of viraemia clearance). 
Cubic spline functions were fit to the cytokines data in Chapter 4 in order to remove noise from the 
data prior to subsequent analysis. The splines were successful at smoothing profiles and filtering 
noise. Furthermore spline functions provide estimates for each observation of the experiment, as 
opposed to the repeated measures models which provide LSM estimates at the observation times only. 
However it is difficult to extract fitted parameters from splines that specify particular physical 
properties of a system, which have important implications in understanding the dynamics of PRRSV 
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infection. Similar to the linear mixed models, a mixed modelling approach could be directly applied to 
the spline functions [14-19]. However in this thesis splines were used only as a method to filter out 
noise from the data. 
The Wood’s model and linearized Wood’s model fitting approach was adopted in Chapters 2 and 3 
which allowed the construction of viraemia curves for the entire time course of the experiment, and 
also the examination of the effect of various factors on the model parameter estimates. However the 
residuals from fitting the final linearized Wood’s function in a classical linearized mixed modelling 
framework revealed that the model was a poor fit to the data and, as with the repeated measures 
approach, bimodal profiles reduced the model fit to the data. A better fit was needed in order to 
determine host genetic influence on viraemia profiles (for Appendix 3) and to explore the relationship 
between viraemia profiles and immune response. 
The poor Wood’s model’s fits in Chapter 2 were a likely manifestation of the linearization process as 
opposed to a reflection of the suitability of the Wood’s function as a candidate model for viraemia 
profiles. Mixed models can also be implemented in Bayesian framework [20-25]; however this was 
not explored in this thesis. In Chapter 3 the nonlinear function Wood’s function was fit directly to the 
data using a Bayesian framework. Directly fitting the Wood’s model to the log-transformed viraemia 
data overcame the poor model fits from Chapter 2. However, the Bayesian inference for the Wood’s 
model parameters came at a higher computational cost; taking several months to obtain estimates for 
all the pigs in the PHGC dataset. The Bayesian inference methodology was more flexible than the 
linear mixed modelling approach in Chapter 2 and was able to fit a wider range of functions to the 
data in particular the bimodal Extended Wood’s model. In summary, directly fitting the Wood’s 
model and Extended Wood’s model using a Bayesian approach in Chapter 3 allowed for: a better fit to 
the data, and the opportunity to fit a wider range of functions to the data than the linearized Wood’s 
function in the linear mixed models framework of Chapter 2. 
The Wood’s and Extended Wood's model was used for the modelling of viraemia time trends in this 
thesis however there are other potential mathematical functions that could have been applied to 
capture the time trends in the longitudinal viraemia data such as, but not limited to: Legendre 
polynomials, which have been used to analyse patterns of genetic variation in lactation curves [26],  
the Ali-Schaeffer curve, which is a well-established parametric function [27], Wilmink curve, which 
has an exponential component [28], Lidauer-Mäntysaari function, which also has an exponential 
component [29], and regression splines [30]. For the purposes of our study the Wood’s and Extended 
Wood’s model provided an adequate fit to the data however comparison of the Wood’s approaches 
with other mathematical functions could be pursued in future studies in order to robustly identify the 




5.0.3 Statistical categorization of pigs: viraemia profiles 
The longitudinal viraemia measures from the PHGC PRRSV challenge experiment revealed 
substantial differences in the viraemia profiles between hosts infected with the same PRRSV 
challenge dose, pointing to considerable variation in the host response to PRRSV infections. The 
statistical categorization of pigs from the PHGC trials, combined with model fitting, provides a 
critical basis to generate new phenotypes for the selection of pigs with favourable infection traits. In 
Chapter 3, viraemia profiles were assigned to one of three groups: cleared (uni-modal resolution of 
viraemia by 42dpi, persistent (uni-modal detectable viraemia by 42dpi) and rebound (bimodal 
profiles).  This is the first study to fully quantify the wide variation of host response from a PRRSV in 
vivo challenge.  Bimodal viraemia trends within 42dpi had been observed in previous studies [33-35] 
but were either removed by truncating the data (0-21dpi)[34] or the phenomenon was ignored and left 
both unexplained and unquantified [33,35]. A key and novel insight from this thesis is that viraemia 
rebound was observed across all trials, genetic backgrounds and both PRRS virus isolates. 
Furthermore rebound withstood definition via the robust method using the full duration of the 
experiment with an objective measure of statistical significance that also took measurement error into 
account, as opposed to a threshold of differences between observations determined via subjective 
visual inspection. Thus we can conclude that rebound, or bimodality in viraemia, is a generic 
phenomenon along with clearance and persistence (or prolonged viraemia) of viraemia profiles 
resulting from a PRRSV challenge. The key questions to emerge from this finding are: what are the 
mechanisms, of the host, the virus or both that are behind the observed rebound and what 
implications, if any, does rebound have in driving the epidemiology of the virus within a herd. 
It is interesting that we were able to determine that information derived from the early phase of 
infection could not be used to predict the serum viraemia characteristics at the later stage of infection 
i.e. whether a profile would rebound, clear or persist. Specifically the rebound and clearance profiles 
could not be distinguished based on information from the primary phase of infection (0-21dpi). This 
result has however important implications with regards to the following hypothesis:  considering that 
serum viraemia data were only collected for 42dpi, one may hypothesise that every pig may 
eventually experience rebound, provided that the virus has not been completely cleared, and that 
rebound could only be observed for a subset of pigs in this study due to censoring. However, if this 
hypothesis was correct, there would be a higher probability of observing rebound in individuals with 
faster viraemia decline within 21dpi. But, since no statistical difference was observed between 
rebound and clearance on the truncated dataset, the existing evidence would suggest that only a subset 
of pigs experiences viraemia rebound. Furthermore, we also observed that none of the pigs with non-
detectable viraemia levels for 2 or more weeks experienced viraemia rebound within 42dpi (results 
not shown), thus indicating that rebound is unlikely to occur  if the serum virus has been cleared for a 
period of several weeks. 
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Overall this is the first study to fully capture the full range of viraemia profiles obtained from a large 
scale PRRSV infection experiment. Furthermore the resulting statistical classification of pigs 
according to viraemia response was used in Chapter 4 to examine their association with the immune 
response, and in Appendix 3 as well as ongoing studies, to determine the genetic component 
associated with viraemia profile characteristics and other phenotypes. 
Viraemia Rebound 
Viraemia rebound was observed across trials, genetic backgrounds and virus isolates. Rebound was 
observed more frequently when pigs were infected with the NVSL isolate (17% rebound) than with 
the KS06 isolate (8% rebound). One explanation for this is the presence of quasispecies within a host. 
PRRSV has a very high mutation rate, estimated at 4.7-9.8x10-2 nucleotides/year  [36];  this causes 
within animal PRRSV genome variation  [37], with each variant labelled a quasispecies. Pigs infected 
with NVSL have higher viraemia than pigs infected with KS06 throughout most of the primary 
phased of infection (0-21dpi). Higher viraemia levels correspond to a higher number of virus 
replications i.e. a higher frequency of events in which virus mutation could occur. It can thus be 
hypothesized that there would, as a consequence of a higher virus replication rate, be a greater number 
of quasispecies present within the host of a pig infected with the more virulent NVSL than KS06 
infection. A consequence of the higher viral diversity within the host is an increased potential for the 
emergence of an immune escape-mutant PRRSV strain to emerge, which hypothetically could 
manifest in the observed viraemia rebound in the serum [38]. Furthermore NVSL infected pigs could 
also have a greater number of circulating quasispecies, than during a KS06 infection, if NVSL had a 
higher virus mutation rate; a higher mutation rate would increase the likelihood for the emergence of 
immune escape-mutants of PRRSV during an infection.  
Furthermore from an epidemiological perspective viraemia rebound may be of particular importance 
for herd level persistence; a mutated virus that escapes the immune response mounted against the 
homologous strain could be transferred between pigs thus causing reinfection and viral rebound. 
Cycles of transmission between pigs within the same herd of immune-escape mutants could thus 
perpetuate cycles of future PRRSV infection within a herd [37]. Indeed if viraemia were measured 
over a longer duration, than the 42days in this study, perhaps further cycles of damped viraemia 
oscillations with several waves of rebound would be observed within individual pigs. 
Alternately NVSL may partly avoid the host immune response, possibly escaping the humoral 
immune response by localizing to certain tissues such as the tonsils which have been found to be a 
source of PRRSV viral persistence in previous studies [39,40]. In the tonsils there is an abundance of 
memory B-cells  but a lack in effector plasma-producing, B-cells [41]. Thus a hypothesized stochastic 
“out-pouring” from the persistently PRRSV- infected tonsils into the serum provides an alternative 
explanation for the mechanisms behind the observed viraemia rebound in this thesis. If the ability of 
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the virus to remain in the tonsils and escape the immune response differed between PRRSV isolates 
then differences in tonsil viraemia levels would be apparent; serum viraemia differences would be 
insufficient to test this theory. Hence further studies are underway to address this hypothesis.  
The underlying mechanisms behind the observed viral rebound have yet to be fully determined. 
However the viraemia profile class differences were captured by a higher IFNA and CCL2 expression 
in the secondary phase of infection for rebound pigs (21-42dpi). More data is needed since there were 
a limited number of rebound pigs (28 pigs) in the cytokine dataset in the present study. One 
hypothesis that could be explored in future studies could be that CCL2 up-regulation might be a 
protective mechanism of the host in response to infection. CCL2 is a ligand for CCR2, a receptor 
which is expressed on a subset of monocytes in peripheral blood. In a previous study it has been found 
that the monocyte subset CD14++ CD163low/negative expressed much higher levels of CCR2than 
the CD14 CD163 low/high subset. 
5.0.4 Influential effects on the viraemia profiles 
Virus Isolate: More virulent PRRSV isolates typically elicit higher viraemia measures [42]. NVSL 
and KS06 were isolated from different geographic regions approximately ten years apart, and were 
89% similar at the GP5 nucleotide sequence level. PRRSV glycoprotein 5 (GP5) is a major envelope 
protein, important in virion formation and infectivity and harbors a major neutralizing epitope [43]. 
The corresponding gene is often used to assess genetic differences between PRRSV isolates and is 
suggestive of differences in virulence between isolates [44]. Variation in GP5 impacts the pig’s ability 
to produce nAbs, which may only be protective against specific, but not all, isolates [44,45]. These 
two North American strains are clustered distinctly into two branches according to molecular 
phylogeny [46]. In Chapter 2 we demonstrated that these virus isolates differ in both their virulence 
and in resulting viraemia profile characteristics. Infection with NVSL is characterized by reaching a 
high peak viraemia early, followed by a quick clearance of the virus, whereas the KS06 virus 
accumulates more slowly towards a lower peak viraemia and has a slower rate of viraemia clearance. 
In Chapter 3 the Wood’s and Extended Wood’s model provided a good fit for both virus isolates, with 
fewer rebounding, but higher numbers of persistent profiles for KS06. Given the flexibility of the 
Wood’s function to capture adequately the more rapid, higher peak and more virulent dynamics of the 
NVSL viraemia and the slower, more prolonged infection of the less virulent dynamics of the KS06 
strain we would expect the Wood’s function to perform adequately well for further North American 
strains. 
WUR genotype: The WUR genotype, associated with lower cumulative viraemia (i.e. viraemia AUC 
until 21 dpi)  in previous studies of a subset of the PHGC NVSL challenge data [34,47-49], resulted in 
lower viraemia predictions at all observation times between 0-42 dpi according to the repeated 
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measures model of Chapter 2. However the linearized Wood’s parameters differences between the 
WUR genotypes were not statistically significant despite slight reductions in the viraemia predictions 
for the favourable B allele were observed. The impact of the WUR genotype was found to be isolate 
dependent. In Appendix 3 it was found that pigs with the WUR genotype 1 had a more desirable 
phenotype than WUR 0 pigs for many of the derived Wood’s model traits under NVSL infection, but 
only for cumulative viraemia (viraemia AUC 0-21dpi) and the peak viraemia load (Vmax) for KS06 
with no WUR association for the other traits. Accounting for the WUR genotype had little impact on 
the genetic correlation between isolates, suggesting that there is a substantial polygenic component to 
response to PRRSV infection that is common between these two PRRSV isolates. Our results suggest 
that KS06 is a less virulent PRRSV isolate than NVSL, but, importantly, that genomic selection will 
be effective for selection for improved weight gain (Appendix 3) and reduced viral load under either 
PRRSV infection. This thesis affirms the important influence of the genetic marker WUR on host 
response to PRRSV. The results of the isolate dependent impact of the WUR genotype suggests that 
the influence of this marker may be dependent on the virulence of the PRRSV isolate.    
It is interesting to combine our findings from the viraemia profile isolate differences from Chapters 2 
and 3 with the findings relating to weight gain under infection which was also explored in Appendix 
3. In the latter study it was found that KS06 infection had less of a negative impact on the growth rate. 
Thus we could hypothesize that due to the lower viraemia levels and slower dynamics the piglets 
infected with the KS06 isolate do not need to put as much energy into eliminating the virus, thus 
allowing them to allocate more energy towards growth than those infected with NVSL according to 
resource allocation theory [50]. The genetic correlations between viraemia and weight gain varied 
over time and tended to be more extreme in NVSL infected pigs than KS06 infected pigs, suggesting 
that more energy is required to fight infection with NVSL, and is supported by the lower weight gain 
observed in NVSL infected pigs. The effect of WUR genotype on weight gain was not found in pigs 
infected with KS06. Virus isolate differences were greater than WUR genotype 1 and 2 (refers to the 
number of the favorable B allele) differences on viraemia profiles magnitude, dynamics and derived 
phenotypes from the Wood’s mode (see summary tables of derived phenotypes in Chapter 4). It has 
been found that WUR had the strongest effect on the following Wood’s parameters and derived traits 
obtained from this thesis: Vmax (peak viraemia), Tmax (time of peak viraemia), DeltaT (time of 
maximum viraemia decline) and DeltaV (viraemia at the time of the maximal viraemia decline). 
Genetic background: In this thesis the infected pigs were crossbred commercial pigs from 10 genetic 
backgrounds. Numerous PRRSV in vivo and in vitro studies have pointed to  breed differences in the 
response to infection; which suggest that there is a host genetic component in the host resistance to 
infection [3,34,35,48,49,51-58]. Previously breed differences have also been found in serum viraemia 
[59]. It is thus not surprising that viraemia profile differences were observed between genetic 
backgrounds in our study. The time trends in viraemia were roughly the same between the genetic 
158 
 
backgrounds within each virus isolate, however genetic line differences within isolates were found in 
the time of the peak and the rate of viraemia decline. Exploration of trial differences allowed us to 
partly disentangle the virus and genetic background effect. Pigs of the same genetic background 
infected with different virus isolates had significant differences in response, which is an indication of 
the viraemia isolate differences discussed earlier. However significant viraemia differences between 
pigs of the same background infected with the same virus in the repeated measures approach indicated 
that the trial could have an impact on the viraemia. These differences are more difficult to interpret, 
however it is reassuring that these differences were not captured in the model parameter differences of 
the linearized Wood’s modelling approach. We can thus conclude that the within genetic background 
variation is lower than the between genetic background variation in the PRRS viraemia profiles of this 
study. 
5.0.5 The relationships between the viraemia and the immune response measures  
This is the first study to fully categorize pigs using multiple repeated measures across 7 measured 
serum cytokines following PRRSV infection. In this thesis individual cytokine profiles could be 
classed as responders or non-responders to PRRSV infection. The percentage of responding pigs 
differed between cytokines. However, the majority of the pigs responded in the pro-inflammatory and 
anti-viral cytokines (IL-1b, IL-8, CCL2 and IFNA) and also the immune regulatory cytokine IL-10. In 
particular, the highest percentage of responders was found for INFA and CCL2, for which over 95% 
of pigs elicited a noticeable response. The immune regulatory cytokines IL-4 and IL-12 had the 
highest percentage of non-responders (71% and 54%, respectively) compared to the other cytokines.  
The breadth of the cytokine responsiveness was associated with viral profile class and genetic 
background but not the WUR genotype. Rebounders had a narrower cytokine response than non-
rebounders, and pigs from genetic background 1 had a broader response than genetic background 3. 
The genetic line differences suggest that there a potential host genetic contribution in the breadth of 
the cytokine response. However since the WUR genotype was not found to be significant it is likely 
that the cytokine responsiveness is associated with other host genes which could be explored in future 
studies. 
The rate of viraemia decline, captured by  the Wood’s parameter c was associated with the strength of 
response in IL-10, IL-12 and IL-1b; however the final model, including cytokine measures as 
predictors, was not a significantly better than the null model without cytokine response variables 
included as predictor.   The strength of the early viraemia was correlated with the strength of early 
IFNA and CCL2; however this correlation decreased over time.  
Different genetic backgrounds had different baseline cytokine values and differed in the overall 
magnitudes of expression (IFNA, CCL2), but broadly similar response patterns. However differences 
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in the general trend i.e. whether there was a slight increase or decrease following infection was found 
in IL-1b, IL-12 and IL-10, between genetic backgrounds.  
Viraemia class differences were reflected in the profiles of the cytokines CCL2 and IFNA. 
Rebounders elicited a stronger response in most of the cytokines at the later stages of infection (from 
28dpi onwards) than non-rebounders, although the differences were not always statistically 
significant. Rebound profiles had statistically significant higher levels of IFNA expression at 28-35dpi 
than cleared profiles and higher IL-8 expression at 35dpi. Differences between pigs with cleared and 
persistent profiles were small and not statistically significant.  Somewhat surprisingly, due to the anti-
viral role of the cytokine [60,61], rebound profiles had on average significantly higher baseline levels 
of IFNA than cleared profiles. Rebound profiles have on average a faster post-peak rate of decline 
compared to non-rebound viraemia profiles, hence the higher baseline IFNA could, hypothetically, 
contribute to the fast viraemia decline observed. Furthermore, whilst pigs associated with cleared and 
persistent viraemia profiles experienced a post-peak decline of CCL2 expression to baseline levels, 
pigs with rebound viraemia profiles, however, also experienced a “rebound” in CCL2 values at 
similar times. 
The WUR genotypes had little impact on the cytokine profiles. The cytokine predictors significantly 
improved the models for the majority of the viraemia traits, whereas the viraemia traits were poor 
predictors of the cytokine measures. These results suggest that the cytokines drive the viraemia rather 
than vice versa. IFNA and CCL2 in serum were the key cytokines for serum viral dynamics. IFNA 
was consistently a significant predictor for viraemia characteristics, which is unsurprising due to its 
already established antiviral role and association with viraemia clearance in previous studies [60,61]. 
However the role of CCL2 during an in vivo PRRSV infection is not fully understood. 
Limitations: The distance between the longitudinal measurements of the challenge experiment may 
be relatively large and hence some informative viraemia or cytokine dynamics may be lost. Given that 
the majority of the cytokine measures were of the innate immune response the 4 day gap in the 
observation period could mean that the data failed to capture the early response. The cytokine 
response is very transient [62], so a weekly window may not capture sharp responses. Cytokines and 
virus in serum are a ‘spill-over’ from those in the infection target site. This, together with the fact that 
some cytokines are locally produced may weaken the strength of the true associations that would be 
found directly at the site of infection. 
Implications for future studies: In Chapter 4 we found that the majority of pigs showed responses in 
IFNA and CCL2. IFNA and CCL2 in serum were the key cytokines for serum viral dynamics. IFNA 
was consistently a significant predictor for viraemia characteristics, which is unsurprising due to its 
already established antiviral role [60,61] and association with viraemia clearance in previous studies. 
PRRSV can inhibit the type 1 interferon production in certain dendritic cells with roles in the innate 
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immune response [63]. Conversely some PRRSV strains led to little or no suppression of the IFNA 
expression in the same dendritic cells [64]. Previous studies differ in the nature and magnitude of the 
IFNA response following a PRRSV infection. The more widely reported result is a lack of significant 
and comparatively low IFNA response, compared to other infections [65-68]. However this is 
contrasted by reported increases in serum IFNA levels following PRRSV infection [69-71], which is 
in line with our results from Chapter 4. 
Viraemia class differences were also captured in both IFNA and CCL2 expression profiles. Increased 
cytokine expression during the secondary phase, when viral rebound would occur, suggests that 
cytokine expression of IFNA and CCL2 potentially mimic viraemia trends. Higher levels of viraemia 
were correlated with a higher expression of IFNA.  Unlike IFNA the role of the cytokine CCL2 has 
not been established in previous PRRS studies. The high levels of CCL2 during the secondary phase 
of infection is interesting from a biological perspective since the role of CCL2 is thought to be that of 
causing an influx of macrophages to the site of infection [72]. A potential hypothesis that emerges 
from this study is that the increase in CCL2 could result in an influx of new PRRSV target cells thus 
driving the rebound in viraemia that we observe [73,74]. Few PRRSV studies have examined the role 
of CCL2 in PRRSV infection; studying the CCL2 response could be potentially informative for 
understanding the underlying mechanisms of viral rebound. 
An effective cytokine response following infection may be indicative of the immune-competence of a 
pig which may also have a host genetic component [75]. Identification of pigs with a robust IFNA 
response from 0- 4dpi could be explored in future studies. The genetic selection of pigs with effective 
cytokine responses could be used in the search for breeding for higher levels of immune competence 
during a PRRSV infection, which will be discussed in the following section as an alternative disease 
control strategy. 
5.1 Further Implications 
5.1.1 Genetic selection for host resistance to PRRSV infection 
This PhD was part of a wider project of the PRRS Host Genetic Consortium called “Application of 
Genomics to Improve Swine Health and Welfare” (funded by Genome Canada). The overall goal of 
the PRRS Host Genetics Consortium (PHGC) is to exploit state-of-the art genomic technologies to 
breed healthier pigs with improved resistance to PRRSV infection. Previous studies have provided 
evidence for a host-genetic component in the effectiveness of responding to and clearing a PRRSV 
infection [52-54,76,77]. The data generated from the PHGC PRRSV challenge experiments can be 
used for identifying the genetic loci and pathways that are responsible for the genetic control of 
PRRSV infection responses[51]. Prior to this thesis there was strong evidence for a host genetic 
component to PRRSV infection through the identification of a major QTL on SSC4, i.e. the WUR 
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genotype, that was found to be associated with reduced cumulative viraemia (viraemia AUC up to 
21dpi) [3,4,34,47,49]. The work of this thesis has delivered new phenotypes associated with the 
dynamic aspects of measured infection traits, and led to the statistical categorization of pigs according 
to viraemia, cytokine and nAb responses. We found that the viraemia rebound was not heritable 
(h
2
=0.00000) and the new viraemia phenotypes derived from this thesis have already been 
implemented in other studies (see the manuscript of Appendix 3). The results from Chapter 4 indicate 
that future studies should be conducted with more frequent measures of IFNA and CCL2. Analysis 
into the host genetic components of their respective expression both at the early and late phase of 
infection could be key to furthering our understanding of both viral clearance and also viraemia 
rebound. 
Viraemia traits: The Wood’s model and Extended Wood’s model for viraemia generated new 
phenotypes for host resistance that have been used in subsequent genetic analyses to assess the effect 
of previously identified genetic loci (the WUR SNP) on the viraemia profile characteristics and to 
identify novel genomic regions associated with these for both PRRSV isolates (NVSL and KS06) (see 
for e.g. Appendix 3). In these studies, the WUR SNP was found to be associated with all curve 
characteristics (Vmax, Tmax, deltaT, deltaV, I21, T1, V1 as defined in Chapter 4) in the NVSL trials; 
but only with I21 (AUC of viral load up to 21dpi, VL in Appendix 3) and Vmax (peak viraemia, PV 
in Appendix 3) in KS06 trials, suggesting the effect of the WUR SNP may depend on the virulence of 
the PRRSV isolate. The results thus suggest that genetic selection for reduced susceptibility to 
genetically distinct isolates PRRSV is feasible, but may have different impact on viraemia profiles 
shapes for different PRRSV isolates. Analysis of the relationship between viraemia and weight gain 
via genome-wide association studies over the course of infection in future studies, will allow for a 
more comprehensive understanding of the host genes and genomic regions associated with response to 
PRRSV infection. 
Infection trials involving more isolates of PRRSV are necessary to confirm that genetic factors 
influencing host response to PRRSV infection are consistent under infection with a range of PRRSV 
isolates. Quantitative genetic analyses of the relationship between viraemia and weight gain over the 
course of infection are currently being carried out and will allow for a more comprehensive 
understanding of the host genes and genomic regions associated with both host resistance and 
tolerance to PRRSV infections. Studies currently underway as part of the PHGC includes: field trials, 
infection with a third PRRSV isolate, and the response to vaccination and co-infection with PRRSV 
and PCV2b. For comparison of the impact of traits and viraemia characteristics from the isolates in 
this study it would be useful for the Wood’s functions to be fit to the viraemia data in subsequent 
studies. In this thesis the function has proven to be able to capture viraemia differences in the NVSL 
and KS06 isolates and is thus a potentially good candidate for capturing the viraemia trends of other 
North American PRRSV infections. The resulting derived phenotypes from the model fitting for new 
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isolates could result in a useful dataset to assess the variation in viraemia and sources of variation of 
host responses across a wide range of isolates and infection conditions. 
Another potential strategy in livestock disease management consists of focusing on improving the 
immune-competence of the host. As defined by [78], immuno-competence is the host’s ability to 
mount an immune response of sufficient specificity and magnitude, and therefore represents the 
effective quality of the host’s immune system. It has been proposed that many immune competence 
parameters including in vitro innate cytokines, adaptive cytokines and the host’s IgG response, could 
be under genetic control and that there may be scope for them to be included in future the selection 
protocols [75,78-80]. Indeed in a previous study it was found that gene expression profiling in the 
blood could be used as a phenotype to identify potential biomarkers for the analysis of the host 
immune response; biomarkers were found for various immune measures including IL-12 [78], which 
is one of the cytokines measured in Chapter 4 of this thesis. The analysis and statistical 
characterization of the serum cytokine profiles and nAb responses in Chapters 3 and 4 could 
potentially be used to better characterize the host’s immunity traits in future studies. Thus in the 
following sub-sections we discuss the nAb and cytokine responses in relation to breeding for 
improved immune competence against PRRSV infections. 
The nAb response: Different PRRSV isolates harbor high levels of genetic and antigenic variability 
[81]. Antibody responses can be categorized into a neutralizing antibody response, where the antibody 
directly inhibits the virus function  [82] and non-neutralizing antibody response, where the antibody 
binds to the virus for the identification for viral clearance via other immune mechanisms (e.g. 
phagocytosis)[83]. Following a PRRSV infection, the earliest and strongest antibody response is a 
non-neutralizing (IgG) response against the virus nucleocapsid (N) protein [84]. Virus neutralizing 
antibodies are typically weak and delayed during PRRSV infection however once a nAb is produced 
the response is effective [82]. This effective nAb response is often only restricted to homologous 
isolates of PRRSV. Therefore vaccination with modified live virus (MLV) or previous natural 
infection typically results in only homologous protection against closely related PRRSV isolates [85]. 
However in addition to the strong homologous response a broader nAb cross-protectivity against 
different PRRSV strains was also observed in Chapter 3. 
As observed in previous studies [86,87] the  PRRSV infection elicited a strong homologous  antibody 
response in the majority of pigs in Chapter 3 of this thesis. This is one of only a few studies that 
explore the nAb cross-protectivity of PRRSV infected pigs. It is particularly interesting that a 
diversity in the breadth of the nAb cross-protectivity was observed. This is the first study to find a 
significant association between the viraemia profile class (cleared, persistent or rebound) and the 
cross-protectivity of the nAb response. Clearance corresponded to a less diverse nAb response than 
persistence and pigs with persistent viraemia had a more diverse nAb response than those with 
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rebound profiles. However, there was no statistical significant difference in nAb cross-protectivity 
between pigs that cleared viraemia within 42dpi and rebounders. The WUR genotype was not 
significantly associated with the breadth of the nAb response. The novel insights gained from the nAb 
analysis can be used to develop hypotheses surrounding the observed viraemia variation. 
Understanding the host’s ability to mount a non-neutralizing PRRSV-specific antibody response could 
lead to deeper insights related to the non-isolate specific host-response to PRRSV infection.  In 
contrast, studying the breadth of the nAb cross-protection could lead to the identification of pigs with 
desirable virus neutralizing abilities, particularly for pigs under field conditions where multiple 
PRRSV strains could be in simultaneous circulation [37]. 
One hypothesis is that the breadth and magnitude of the nAb response could have a host genetic 
element. The identification of genomic markers linked to a broad nAb response would be a novel 
finding with significant implications for the selection of pigs that show improved protection following 
vaccination; the so-called “vaccine ready” pig [58]. Thus genetic improvement to enhance the 
response to vaccination could create the opportunity to bring PRRS control closer to achieving an 
effective vaccine. Development of an effective PRRSV vaccine has been widely unsuccessful because 
they lack cross protection against different PRRSV strains [81]. Selection of pigs that are resistant to a 
broad spectrum of currently circulating PRRV field isolates could be a successful disease control 
measure [75,88,89].  
A robust PRRSV-specific non-neutralizing antibody response is observed early and is maintained 
following infection and even after serum clearance of PRRSV [84]. N-protein specific antibody 
response in PRRSV has been found to be favorably genetically correlated with sow reproductive 
performance during a PRRSV outbreak [90]. The development of PRRSV nAb is typically weak and 
delayed [58]. However, at the population level there is evidence to suggest inter-host variation in the 
diversity of the nAb response as shown in Chapter 3. One aspect of the strength of the nAb response 
during infection relates to the genetics of the virus; the removal of glycosylation sites on the virus 
results in increased susceptibility of the virus to nAb and increased production of nAb by the host 
[44]. The categorization of pigs according to their antibody response is crucial for determining the 
host genes associated with the desirable subpopulation of pigs able to produce strong and life-long 
immunity following a PRRSV infection. The characterization of the nAb response in Chapter 3 could 
thus be used to determine the association between different nAb responses and the host genes in 
future studies. The antibody response has the potential to be used as a biomarker for the selection of 
pigs with improved resistance to PRRS [91], however the WUR genotype was not associated with 
differences in nAb cross-protection in Chapter 3. This suggests that other genes may be responsible or 
related to the nAb response. Studies are currently underway exploring the genetic relationships of 
antibody response, viraemia level and weight gain in pigs experimentally infected with PRRSV. It is 
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also important to assess the optimal strength of antibody response that would increase resistance to 
PRRSV, whilst not compromising the host’s ability to combat other disease causing pathogens. 
Antibody responses could provide insight into the causative immune mechanisms resulting in cleared, 
persistent and rebound viraemia profiles. Variation in the rate of viraemia reduction may be a function 
of the host’s own immune response, virus mutation mechanisms or the interaction between both 
processes. In Chapter 3 the moderate negative correlation between the NVSL Wood’s parameters c1 
and c2 (-0.52) indicates that a slow decline in the first cycle corresponds to faster decline in the second 
cycle and vice versa. This association may be indicative of the temporal evolution of the immune 
response. A slow immune response in the primary phase may prolong the conditions required to 
produce neutralising antibodies and thus manifest in a stronger or more diverse nAb at the end of the 
second phase. Conversely, a fast initial immune response may indicate an effective, but narrow nAb 
response during the primary phase so that fewer or less diverse nAb are available for the second 
phase. The identified association between nAb and viraemia categories would support this hypothesis, 
since persistent profiles have the broadest response of all the profile categories.   
If viral rebound was due to immune escape by the virus, which is recognized as re-exposure to the 
virus by the host then we could hypothesize that rebound pigs would have a greater memory B cell 
activity of memory B cells resulting in a higher level of antibody than non-rebound [92]. 
Alternatively, high antibody levels could place selective pressure on the virus which could manifest in 
an increased likelihood of viral rebound occurring [38,93-96]. Longitudinal antibody response 
measures would thus be needed to test these hypotheses and further determine the relationships 
between viraemia profiles and the antibody response.  
Cytokine response: As hypothesised for the antibody response, in the subsection above, the 
effectiveness, strength and breadth of the cytokine response following infection may also have a host- 
genetic component [57]. The cytokine responsiveness may also be an indication of the immune-
competence of a host in dealing with a PRRSV infection. However the WUR genotype was not 
associated with significant differences in longitudinal cytokine expression profiles or the breadth of 
the cytokine responsiveness in Chapter 4. This suggests that other genes may be responsible or related 
to the cytokine responses. Cytokine responses could however provide insight into the causative 
immune mechanisms resulting in cleared, persistent and rebound viraemia profiles; viraemia profile 
differences captured in elevated responses in IFNA, CCL2 and IL-8 during the rebound phase (21-
42dpi) in Chapter 4, which thus supports this hypothesis. 
Previous studies have linked serum cytokines such as IL-8, IFN-gamma and IL-1b to PRRSV 
clearance [42,97]. In particular IFNA, which has already been established as playing an anti-viral role 
during a PRRSV infection [60,61], was found as a consistently a significant predictor for viraemia 
characteristics in Chapter 4. The identification of genomic markers linked to a robust IFNA response, 
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particularly between 0-4dpi, would be a novel finding with significant implications for the selection of 
pigs that could effectively clear the virus. In previous studies numerous immune proteins have been 
identified with roles in viral disease resistance [57]. However future studies could focus on identifying 
the SNPs for specific candidate genes for the serum cytokines associated to viral clearance (i.e. IFNA 
and CCL2), viral rebound (i.e. IFNA, CCL2 and IL-8) and the breadth of the cytokine responsiveness 
across all the measured cytokines. More repeated measures of IFNA and CCL2 need to be collected in 
future studies in order to determine the host genetic component associated with the immune-
competence in relation to resistance to PRRS. It would also be important to ensure improved immune 
competence in relation to PRRS was not at the detriment of other desirable production traits. 
Furthermore it would be important to simultaneously consider immune-competence not only to a 
PRRSV infection but also in relation to other pathogens since it would not be of benefit to breed 
specifically for resistance to PRRS at the expense of significantly improved vulnerability to other 
costly disease causing pathogens. 
5.1.2 Process based mathematical modelling of PRRSV infection 
Process based mathematical modelling is an alternative approach to exploring hypotheses surrounding 
the within host dynamics of viral infections. Systems of ODEs (ordinary differential equations) have 
been used to represent the various components of within host dynamics of virus infections such as 
HIV [98-103], influenza [104-106] and more recently PRRSV [107,108]. Parallels can be drawn 
between HIV and PRRSV, in terms of high mutation rates and immune escape mechanisms, and thus 
gaining insights into modelling approaches that have been used for HIV could aid the development of 
new models for PRRS. Furthermore in equine influenza infection bimodal virus titre curves were also 
observed, for about 50% of the cases, which were modelled through the incorporation of antiviral 
effects of interferon [109].  
The most recent process-based model for PRRSV [107,110] includes a detailed description of the 
host’s immune response. The model describes the evolution over time the PRRSV infection in the 
lung. Briefly, in the model the interactions between the macrophages and the pathogen, the orientation 
of the adaptive response and the cytokine regulations are defined in a system of ODEs with 18 state 
variables. The viral particles, macrophage states during infection (susceptible, latent, viral excreting) 
and the adaptive and innate immune response are represented. Direct comparison between the results 
from this thesis with the predictions of the process based model would need to be adjusted since in 
this study inferences have been made from the serum measurements whilst the process-based model is 
defined for the site of infection.  However the emergence of the distinct types of viraemia responses in 
this thesis could be used to modify, validate and inform the input parameters of the PRRSV process 
based model [107]. A key question to be explored using the current process based model for PRRSV 
infection is what model parameter combinations and key immune components in the model result in 
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the three types of viral profiles observed in this thesis? The answers to which should be tested in 
subsequent experimental studies. Furthermore, the process based model could provide valuable 
information on the expected relationship between immune response components (e.g. cytokine or nAb 
response) and virus load over time, which would be useful for evaluating the direction and strength of 
relationships observed in this study.  
5.1.3 Epidemiological consequences of infection 
Our focus in this PhD has been on the within-host aspect of a PRRSV infection; however, the 
epidemiological consequences of PRRSV infection are also of concern to the industry. The variation 
in viraemia profiles may have important epidemiological consequences. Individuals with persistent 
viraemia profiles are likely to be infectious for longer. From an epidemiological perspective, viraemia 
rebound may constitute a problem as pigs diagnosed as cleared may have high levels of infectious 
virus a few days later. In particular, it would be useful to know whether virus rebound, or persistence, 
was associated with higher levels of infectiousness in future studies. 
From the current study we cannot affirm that there would be infectious and epidemiological 
consequences in the secondary phase of rebound profiles. Inferences made on infectiousness and 
epidemiological consequences using the data obtained via quantitative RT-PCR may be limited due to 
the potential discrepancy between the measured viral genome load and the non-measured true 
infectious viral load. Thus, the observed secondary phase of rebound may be the result of detecting 
circulating junk genomes (i.e. non-functional genomes that do not play a role in the infection 
dynamics) rather than genomes of infectious particles and may thus have no significant 
epidemiological consequence. However, previous studies have explored the relationship between 
diverse viraemia measurements an infectiousness of pigs infected with PRRSV [111-113]. For 
example, Charpin et al. [111] detected viral genome in the blood of inoculated pigs from 7-77dpi 
using RT-PCR, whereas viral genome shedding was detectable from nasal swabs from 2-48dpi. 
Furthermore their study concluded that infectiousness was indeed correlated with the time course of 
viral-genome in the blood measured by RT-PCR and that the decrease in infectiousness was related to 
the increase in antibodies[111]. A North American PRRSV study  observed that even when there were 
low levels of the virus replication the virus was easily transmitted and it was only by 260dpi that pigs 
were no longer able to transmit the virus to sentinel pigs [112]. Thus it has been established that some 
PRRSV-infected pigs can support virus replication and transmit infection for an extended period far 
beyond the duration of the secondary phase of the profiles in our study. By this logic one may argue 
that the observed rebound in viral genome load may indeed have biological consequences in terms of 




5.1.4 Sequencing the virus from rebound, persistent and cleared pigs to understand viraemia 
profile variation 
To explore the hypothesis of virus mutation driving the variation in viraemia profiles it could be 
informative to sequence the virus taken from pigs from the different viraemia classifications to 
determine which specific viral regions, if any, that under-go change are associated to the observed 
viraemia trends in future studies: knowledge that could help us understand the causes behind the 
observed variation in viraemia profiles. There are plans to sequence the virus from the PHGC infected 
pigs in future studies. 
5.2 Limitations 
5.2.1 Viraemia and the immune responses: could different underlying immune responses result in 
similar observed viraemia? 
The role of cytokines such as CCL2 and the orientation of the adaptive immune response needs to be 
determined in future studies since the mechanisms associated with a prolonged infection or persistent 
viraemia profile have not yet been fully determined [114]. It is possible that pigs could differ quite 
considerably in their underlying in vivo immune responses to PRRSV challenge and yet have the same 
infection duration and observed viraemia profiles. A recent process based modelling study [110] and a 
review of the PRRSV literature [42,59,69,115] indicates that some of the key mechanisms assumed to 
determine the infection duration appear to be contradictory. In previous PRRSV infection studies high 
viraemia, infection duration and host susceptibility has been found to be associated to numerous 
factors, which will be discussed below. 
 
The magnitude of the immune response could be related to the virulence and in vivo replication rate of 
the PRRSV strain [116,117]. PRRSV virus isolates differ in their virulence levels as indicated by the 
effect of isolate on the viraemia profiles in Chapter 2. The results from the study by Petry et al.[42] 
indicate that a more virulent PRRSV infection could result in both higher viraemia and higher 
expression of immune function genes. Virulent field isolates exhibit longer and more elevated 
viraemia profiles, and can induce a faster and more intense humoral response [118]. In the study by 
Johnson et al. [118] highly virulent PRRSV field isolates replicated to a substantially higher in vivo 
titre than attenuated or lower virulent isolates. 
 
Antibody differences could be a reflection of the genetic differences between the PRRSV isolates. N-
protein antibody responses have been found to be higher in pigs infected with more virulent isolates, 
as were their viraemia measures [118]. The antibody trends were similar between the isolates but 
differed in magnitude; thus providing evidence for a strong association between the humoral response 
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and the serum viraemia load [118]. Indeed, it would be interesting to compare and contrast the same 
immune measures from Chapter 4 obtained for the NVSL infection for the KS06 isolate. Although 
several more recent studies than [118] have explored antibody responses to PRRSV [119-121] they 
have not combined their analysis of the antibody responses directly with the viraemia profiles. Given 
the trends observed by Johnson et al, (2004) [118] and the more recent study using highly pathogenic 
PRRS strains by Wang et al, (2016) [117] we could expect to observe a less dominant humoral 
response for the less virulently KS06 infected pigs. However it is important to note that even without 
the development of nAbs viraemia resolution can occur in a PRRSV infection [67,114,122]. However 
during a PRRSV infection the levels of nAbs typically remain low, when compared to other 
respiratory infections. Hence a strong but ineffective antibody response could be responsible for 
persistent viraemia profiles, i.e. a longer infection duration[81], indeed persistent profiles had a higher 
nAb cross-protectivity in Chapter 3.  
 
The antiviral cytokine IFNA appears to play a significant role during the PRRSV infection in this 
thesis and was found to be associated with viraemia measures through the course of infection and also 
captured differences between rebound and non-rebound pigs in Chapter 4. Previous PRRSV studies 
typically report a down-regulation of this anti-viral cytokine in vitro [68,123].  However the more 
recent in vivo study using the NVSL strain in pregnant gilts, observed similar trends in IFNA 
response to the IFNA profiles typically observed in Chapter 4 of this thesis [69]. 
 
In the PRRSV literature it has been reported that infection often leads to a low cellular and anti-viral 
cytokine responses, for both the North American and European PRRSV strains [42,57,124-126], 
however there appear to be contradictory reports. A strong cellular response does not always result in 
a short infection duration [127]. Hence we can hypothesise that differing immune responses could 
potentially result in the same infection duration and viraemia trends or profiles.  
 
Suppression of the innate system during a PRRSV infection could be responsible for the persistent or 
prolonged viraemia profiles. It has been reported that PRRSV can suppress phagocytosing activity, 
the expression of innate cytokines and alter their expression patterns [67,124]. However in Chapter 4 
we found that there were no marked differences between the cytokine expression profiles between 
persistent and cleared profile for all the cytokines except IFNA; similar cytokine expression, with the 
exclusion of IFNA, led to different trends in viraemia profiles and infection duration. The underlying 
mechanism behind the variation in observed viraemia profiles is not yet completely understood. 
However since viraemia class differences were reflected in the anti-viral cytokine IFNA (Chapter 4) 
we could hypothesise that higher viraemia drives a stronger expression of IFNA. Higher IFNA 
expression was associated to persistent profiles between 7-21dpi and rebound profiles between 21-
35dpi. High levels of CCL2 from 21dpi suggest that rebound could be driven by the recruitment of 
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new susceptible cells to the site of infection [69]. We have found that the strain, and its virulence, also 
impacts upon the viraemia profiles in Chapter 2. It would be interesting to assess antibody and 
cytokine differences between strains and see where the time trends differed in the timings and 
magnitude of the immune measures in future studies. 
 
5.2.2 Challenge and strain specific conditions 
The PRRSV isolates used in this thesis are all North American strains; the results from the European 
strain are likely to differ quite considerably due to the differences in the severity, virulence and 
immune responses elicited between the virus types [115]. Longitudinal data can allow us to explore 
temporal evolution within a host. There exist three main types of PRRSV infection data explored in 
previous studies: field data, in vitro infection data, and in vivo challenge data. We were ultimately 
concerned with the in vivo PRRSV challenge infection data in this thesis. It may be hard to 
disentangle cause and effect using data from field studies due to the likelihood of co-infections 
making the data incredibly noisy. Furthermore in field conditions it is typical that PRRS exists as 
waves of subclinical infection over several weeks in non-adult pigs [128]. The results and trends 
observed in vitro may not always be representative of what occurs during in vivo infection due to 
complex in vivo dynamics that would not be captured [68]. However in vivo studies with large 
numbers of replicates can be expensive requiring a large number of resources, and be relatively time 
consuming to conduct. The challenge conditions however are useful for limiting the impact of other 
disease causing pathogens, however it may not be fully representative of what we observe in the field; 





5.2.3 Weight gain and tolerance to infection 
There are three broad areas for potential improvement in pigs following a PRRSV challenge: 
resilience, resistance and tolerance [129]. Resilience can be defined as the ability of animals to 
maintain relatively undiminished performance levels whilst subjected to a pathogen challenge, 
resistance can be defined as the ability to reduce pathogen establishment, and tolerance can be defined 
as the ability to maintain performance by counteracting the pathogen causing damage [129].  It has 
been proposed that selection for the improved health of pigs should include disease resistance and 
disease resilience, the latter traits could be based on immune measures, disease incidence or the 
survival rates of pigs [129,130]. Weight gain under infection and tolerance to infection are also 
important traits for livestock production, which play a part in the control of a disease and reflect the 
impact of infection on health and production that have not been explored in this thesis. For growing 
piglets infected with PRRSV an important performance trait would be weight gain under infection 
[131]. The classification of the PHGC infected pigs by the combined virus load and weight gain 
responses under infection indicates that some pigs were “tolerant” to infection; for a subset of pigs 
weight gain was relatively high despite infection[58]. The identification of tolerance genomic markers 
may be challenging due to the complex statistical models required for obtaining tolerance estimates 
[132]. 
The relationship between viraemia and weight gain is likely to depend partly on the viral strain. In 
Appendix 3 it was found that pig growth tended to be less stunted when pigs were infected with the 
KS06 isolate compared to the NVSL isolate. This may be because piglets infected with the KS06 
isolate do not need to put as much energy into eliminating the virus, thus allowing them to place more 
emphasis on growth. These results are consistent with the resource allocation theory, which 
hypothesizes that trade-offs between competing traits (e.g. health and growth) are a consequence of 
limited resources (i.e. energy availability) [50]. The genetic correlations between viraemia and weight 
gain varied over time and tended to be more extreme in NVSL infected pigs than KS06 infected pigs, 
suggesting that more energy is required to fight infection with NVSL, and is supported by the lower 
weight gain observed during an NVSL infection.  
5.3 Conclusions 
In conclusion following an in vivo PRRSV challenge we observe a wide variation in the viraemia 
profiles with: cleared (uni-modal resolution of viraemia by 42dpi), persistent (uni-modal detectable 
viraemia by 42dpi) and rebound (bimodal profiles) being observed.  Identification of the viraemia 
classes can be used in the selection of candidate pigs from which the virus is sequenced, in future 
studies, in order to determine which specific viral regions, if any, under-go change are associated to 
viraemia trends, and if indeed the quasispecies hypothesis for rebound is correct. The Wood’s and 
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Extended Wood’s model analysis allowed for the characterisation of the viraemia curve 
characteristics and has generated valuable new phenotypes for subsequent genetic analysis for the 
selection of pigs with desirable infection traits. However our findings need to be validated in field 
conditions, across further PRRSV isolates and the epidemiological consequences of rebound need to 
be determined. The viraemia trends were captured in immune measures of the longitudinal serum 
cytokine profiles for IFNA, CCL2 and the breadth of the nAb cross-protection; associations which 
generate new hypothesis of the causative immune mechanisms for the observed viraemia variation to 
be tested in future experimental studies. Future studies measuring the serum cytokine levels should 
use smaller intervals between observations to allow for the innate dynamics to be captured. Inter-host 
differences in cytokine responsiveness, and breed differences in certain cytokine time-trends, indicate 
that the role of the measured immune response in serum is highly variable, complex and yet can lead 
to similar viraemia trends. Ultimately the statistical characterisation of pigs according to viraemia 
response, cytokine response and nAb cross-protection could be used in the identification of desirable 
traits for commercial pigs in future quantitative genetic studies. Furthermore the identification of 
broad nAb cross-protective pigs, could be used to breed for a “vaccine-ready” pig if future 
quantitative genetic studies found strong genomic associations to the breadth of nAb response. It is 
interesting that there was variation in the responsiveness in certain cytokines; with pigs being defined 
as responders or non-responders according to each cytokine profile. The statistical categorization of 
pigs according to immune responses in this thesis could be used in future studies exploring immune-
competence of the host during PRRSV infection. However it remains a biological enigma as to why 
the cytokine responsiveness was not a strong predictor and was poorly reflected in the viraemia 
profile trends; in future studies it would be interesting to determine what measures during infection 
the cytokine responsiveness is related to. The answer could lie in the fact that in this thesis we are 
analysing measurements taken from the serum, hence it would be useful to contrast the associations 
found in this thesis with the associations found for comparable measures but taken at the site of 
infection. The methods of parameterising the host response to a PRRSV infection used in this thesis 
including analysis via the Woods model for viraemia and the assessment of the change in cytokine 
baseline levels using cubic splines have the potential to be used on data from other PRRSV challenge 
trials and for other infectious disease data. Indeed subsequent studies have already utilised the models 
developed in this thesis thus pointing to the impact of the work in this thesis for the development of 
enhancing our understanding of a PRRSV infection [49,133].Ultimately we have identified new key 
questions that could be explored in future studies such as: what immune processes cause the variation 
in observed viraemia, and what is the role of CCL2 in a PRRSV infection?  
A summary of the answers to the scientific questions raised in the introduction of this thesis: 
From Chapter 2 we apply the linear mixed model framework to analyse viraemia time trends and the 
corresponding influencing factors:  
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 The PHGC viraemia follows the time trend of rise to a peak by 7dpi followed by a 
decline to viraemia clearance. 
 Inter-host variation increases over time and there are a subset of viraemia profiles that 
exhibit bimodal behaviour in the viraemia after the initial peak. 
o The time trends of the viraemia are influenced by the virus isolate, genetic 
background, PHGC trial and WUR genotype.  
o NVSL viraemia profiles have a higher peak, faster rate of decline than KS06 
infected pigs. 
 The bimodal viraemia profiles could not be adequately captured in the linear mixed 
models framework. 
 The presence of bimodal viraemia profiles reduce the model fit to the data but do not 
impact upon the significance of the significant fixed effects. 
The limitations in the ability to fit bimodal functions and the poor fit of the linearized approach in 
Chapter 2 led to a Bayesian model fitting approach being adopted in Chapter 3: 
 Viraemia rebound (or bimodal viraemia profile) phenomenon occurred across all 
trials and viraemia isolates (NVSL and KS06). 
 Information derived from the early stage of infection could not be used to predict 
viraemia rebound. 
 The Woods model and the extended Woods model successfully quantified the inter-
host variation from all types of viraemia profiles. 
 An objective method of classifying viraemia profiles using the model fits was 
derived. 
 The Woods model adequately represented the full range of viraemia profiles obtained 
from this large scale PRRSV infection experiment, and was used these to determine 
quantitative characteristics of infection dynamics. 
o Derived parameters of the model represented the peak viraemia, time to the 
peak etc. 
 There was a strong homologous nAb response 
o Clearance profiles had a less diverse nAb response than persistent profiles 
o Persistent profiles had a more diverse response than rebound profiles 
o There was no significant difference between clearance and rebound nAb 
response 




In Chapter 4 we combined the viraemia profiles with measures of the immune response in the form of 
longitudinal cytokine profiles: 
 Distinct time trends following infection were observed in IFNA and CCL2 
 There was variation in the responsiveness in the measured cytokines 
o The time trends for IFNA, CCL2 and IL-8 captured the viraemia profile class 
rebound 
o Persistence and cleared profiles were not distinguishable from the cytokine 
expression profiles 
o The genetic background differences were captured in different baseline levels 
of expression (0dpi) but the general time trends remained the same across the 
genetic backgrounds.  
o The WUR genotype had little impact on the expression of the majority of the 
measured cytokines 
 Higher IFNA was observed for the WUR 2 genotype at 4dpi 
indicates the more resistant WUR 2 pigs could be due to a stronger 
early anti-viral response. 
 CCL2 was a significant predictor of early IFNA expression and vice versa 
 The majority of pigs were responders in IFNA and CCL2 
 Rebound pigs had a narrower cytokine response 
 Genetic background 1 had a broader response than genetic background 3 
 The WUR genotype was not associated with the responsiveness in the cytokines 
 The cytokines CCL2 and IFNA driving viraemia is a stronger relationship then vice 
versa 
 CCL2 has slower dynamics than IFNA 
 Rebound in CCL2 could be related to an influx of macrophages at the site of infection 
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The effect of the removal of bimodal profiles on the linearized 
Woods model curves from Chapter 3 
1. Virus differences: removing the bimodal profiles 
The removal of the bimodal profiles (i.e. model fitting to dataset 2) results in the same significant 
fixed and random effects in the final linearized Wood’s model and parameter differences. 
 
Figure S1 Wood’s model for dataset 2: Virus 1(NVSL) in black and Virus 2(KS06) in red. The dashed 
lines delimit the respective confidence intervals constructed by the model predictions from the 
upper and lower parameter estimates determined by: LSM(model parameter) §1.96 SE(model 
parameter). Repeated measures model with bimodal removed: Virus 1 (NVSL) in green and Virus 2 
(KS06) in blue.  
2. WUR genotype differences: removing the bimodal profiles 
The removal of the bimodal profiles (fitting the model to dataset 2) results in the same significant 
fixed and random effects in the final linearized Wood’s model and significant parameter differences.  
 
Figure S2 Wood’s model predictions for WUR genotype 0(black), 1(blue), 2(red). The WUR genotype 
0 has the highest level of peak viraemia compared to WUR 1 and 2. The dashed lines delimit the 
respective confidence intervals constructed by the model predictions from the upper and lower 
parameter estimates determined by: LSM(model parameter)§ 1.96 SE(model parameter). 
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3. Genetic background differences: removing the bimodal profiles 
The removal of the bimodal profiles results in the same significant fixed and random effects in the 
final linearized Wood’s model for the genetic groups. 
 
Figure S3 Wood’s model predictions for each genetic background (lines) and the repeated measure 
model LSMs for each genetic group (asterisks) from dataset 2. 
4.The PHGC trial 
The Woods models and repeated measures approach yield similar results for dataset 2, when 
bimodal profiles are removed as shown in Figure S4.  
 
Figure S4 Wood’s model for each trial (lines) and the repeated measures LSMs (asterisks). Figure 







KS06 Wood’s and Extended Wood’s model residuals 
The model residuals for the KS06 infected pigs followed similar trends to NVSL infected pigs. In this 





Figure S5 The Wood’s model residuals (A) and the Extended Wood’s model residuals (B) for the KS06 
isolate. The red lines show the residual mean and the blue lines delimit two standard deviations 
from the mean. 
Appendix 2b 
The breadth of nAb cross-protectivity was distributed similarly across the WUR genotypes as shown 
in Table 4.9. Given that the allele acts in a dominant manner the WUR classes 1 and 2 were pooled 
(WUR Y) and further odds ratios were obtained to compare differences between the WUR 0 and pigs 
with the favourable B allele. There were not any statistically significant associations (at the 95% 
significance level) between the WUR genotype and the nAb cross-protectivity as shown in Table 
4.10. 
WUR genotype No cross protection 
(% within WUR 
class) 
Cross protection 
(% within WUR class) 
0 188 (59) 131 (41) 
1 67 (61) 42 (39) 
2 8 (73) 3 (27) 
Y (Pooled WUR 1 & 
2) 
75 (62.5) 45 (37.5) 
Table 4.9 The distribution of the nAb cross-protectivity by WUR genotype. 
  
 
Class 1 Class 2 Odds ratio  
(95% Confidence interval) 
P- value 
Clearance Persistence 0.61 (0.38, 0.98) 0.04 
Clearance Rebound 0.86 (0.53, 1.38) 0.53 
Persistence Rebound 1.40 (0.80, 2.45) 0.24 
Class 1 Class 2 Odds ratio  
(95% Confidence interval) 
P- value 
WUR 0 WUR 1 1.06 (0.68, 1.68) 0.79 
WUR 0 WUR 2 1.72 (0.43, 6.81) 0.44 
WUR 1 WUR 2 1.62 (0.39, 6.64) 0.51 
Class 1 Class 2 Odds ratio 
(95% Confidence interval) 
P- value 
WUR 0 WUR Y 1.107 (0.71, 1.72 ) 0.65 
Table 4.10 Odds ratios for the nAb cross protection. Odds ratios of the cross protectivity of 
neutralising antibodies (nAbs) from individuals from Class 1 relative to that of Class 2. The nAb class 
was pooled into the binary trait: cross-protective (nAb class 1-2) or not cross-protective (nAb class 3-
5). The 95% significance level was used (p<0.05).  
The breadth of nAb cross-protectivity was distributed similarly across the WUR genotypes as shown 
in Table 4.9. Given that the allele acts in a dominant manner the WUR classes 1 and 2 were pooled 
(WUR Y) and further odds ratios were obtained to compare differences between the WUR 0 and pigs 
with the favourable B allele. There were not any statistically significant associations (at the 95% 
significance level) between the WUR genotype and the nAb cross-protectivity as shown in Table 
4.10. 
WUR genotype No cross protection 
(% within WUR 
class) 
Cross protection 
(% within WUR class) 
0 188 (59) 131 (41) 
1 67 (61) 42 (39) 
2 8 (73) 3 (27) 
Y (Pooled WUR 1 & 
2) 
75 (62.5) 45 (37.5) 
Table 4.9 The distribution of the nAb cross-protectivity by WUR genotype. 
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was pooled into the binary trait: cross-protective (nAb class 1-2) or not cross-protective (nAb class 3-
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COMPARISON OF HOST GENETIC FACTORS INFLUENCING PIGLET RESPONSE 
TO INFECTION WITH TWO DIFFERENT ISOLATES OF PORCINE 
REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS SUGGESTS 
SELECTION FOR REDUCED SUSCEPTIBILITY TO PRRSV INFECTION IS 
FEASIBLE ACROSS ISOLATES 
Hess, A.S., Islam, Z., Hess, M.K., Rowland, R.R.R, Lunney, J.K., Doeschl-Wilson, A., Bishop, 
S., Plastow, G.S, Dekkers, J.C.M 
ABSTRACT  
Porcine Reproductive and Respiratory Syndrome (PRRS) is one of the most important swine   
diseases in the world and genetic selection of pigs that are less susceptible to PRRS is an 
attractive method to improve swine herd health status. Pigs were infected with one of two 
genetically distinct PRRSV isolates: NVSL-97-7895 (NVSL; ~1500 pigs) and KS-2006-72109 
(KS06; ~700 pigs). The Wood’s curve was fitted to repeated viraemia measurements during the 
first 42 days post infection (dpi) and five curve characteristics were derived. The goal of this 
study was to compare genetic and phenotypic response to infection with either NVSL or KS06 
PRRSV isolates and evaluate whether a genetic marker (WUR10000125), associated with viral 
load and weight gain under infection with NVSL, has an effect on response to infection across 
PRRSV isolates. Infection with NVSL was characterized by reaching a 14±2% higher peak 
viraemia (PV) 2.5±0.6 days earlier than KS06 (TP), followed by 36±14% faster virus clearance 
(Vmax) which occurred 3.9±0.7 days sooner (Tmax). Weight gain from 0-42 dpi (WG) tended to 
be higher under infection with KS06 than NVSL (3.7±1.5 kg). Viral Load from 0-21dpi (VL) 
(NVSL: 0.31±0.06; KS06: 0.51±0.09) and WG (NVSL: 0.33±0.06; KS06: 0.31±0.09) were 
shown to have moderate heritabilities for both PRRSV isolates. Strong negative genetic 
correlations were observed between VL and WG for both NVSL (-0.74±0.10) and KS06 (-
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0.52±0.17) infected pigs. Pigs with the AB WUR genotype had a more desirable phenotype than 
AA pigs for all traits under NVSL infection (VLAA-VLAB=4.5±0.4%; WGAA-WGAB=-2.0±0.2 kg; 
PVAA-PVAB=2.8±0.4%; TPAA-TPAB=0.20±0.09 days; TmaxAA-TmaxAB=0.68±0.16; VmaxAA-
VmaxAB=-3.8±1.5%), but only for VL and PV for KS06 (VLAA-VLAB=4.2±0.9%; PVAA-
PVAB=3.4±0.7%), with no WUR association for the other traits. Genetic correlations of host 
response between isolates were high for VL (0.86±0.19), WG (0.86±0.27), and PV (0.94±0.28). 
Accounting for WUR genotype had little impact on the genetic correlation between isolates, 
suggesting that there is a substantial polygenic component to response to PRRSV infection that is 
common between these two PRRSV isolates. These results suggest that KS06 is a less virulent 
PRRSV isolate than NVSL however, importantly genetic selection for reduced susceptibility to 
either of these genetically distinct isolates will reduce susceptibility to the other. 
INTRODUCTION 
Porcine Reproductive and Respiratory Syndrome (PRRS) costs the U.S. swine industry $664 
million per year [1]. Past efforts to contain PRRS have had limited success, in large part due to 
the rapid mutation rates and antigenic variability of PRRS virus (PRRSV), which have 
encumbered efforts to produce vaccines that are cross-protective to different PRRSV isolates [2].  
Genetic selection of pigs that are less susceptible to PRRS is an attractive method to improve the 
swine herd health status [3]. The goal of the PRRS Host Genetics Consortium (PHGC) is to 
identify host genes or genomic regions associated with reduced susceptibility of pigs to PRRSV 
infection [4]. Previous studies using multiple contemporary North American crossbred weaner 
pigs experimentally infected with the NVSL-97-7895 (NVSL) isolate of PRRSV identified 
heritable genetic components to viral load and weight gain, and found an association between the 
single nucleotide polymorphism (SNP) WUR10000125 (WUR) on chromosome 4 and these two 
186 
 
host response traits [5-7]. A putative gene in high LD with WUR, GBP5, was identified by 
Koltes et al. [8] that plays a crucial role in the NLRP3-mediated formation of the inflammasome, 
which is involved with inflammatory response [9]. It is currently unknown whether the host 
genetics influencing response to PRRSV infection is consistent across PRRSV isolates.  
The objectives of this study were to 1) compare responses to infection with NVSL and the 
genetically distinct PRRSV isolate KS-2006-72109 (KS06); 2) estimate the genetic parameters 
of response to infection when pigs are infected with either NVSL or KS06; and 3) estimate the 
associations of the WUR SNP with response following infection with NVSL or KS06. It was 
hypothesized that the host genetics influencing response to infection would be highly correlated 
between the two virus isolates and that associations of the WUR SNP with response would be 
similar. The Wood’s function has previously been shown to appropriately model PRRS serum 
viraemia following experimental infection [10]. Thus, curve characteristics of the fitted viraemia 
profiles derived from the Wood’s curve parameters were used to quantify different aspects of the 
dynamics of host response to PRRSV infection with these two isolates. 
MATERIALS AND METHODS 
Study Design 
A detailed description of the design, data collection and molecular techniques used in PHGC 
trials is in [4]. The Kansas State University Institutional Animal Care and Use Committee 
approved all experimental protocols for these trials. Pigs used for this study were from 14 PHGC 
trials of ~200 weaner pigs (Table 1). Pigs were provided from commercial breeding programs in 
the United States and Canada. Four breeding companies supplied pigs of the same breed cross 
for more than one trial, with pigs from one trial infected with KS06 and one or more trials with 
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NVSL (Table 1). Pigs from the same breeding company and the same breed cross were from the 
same genetic background. Within each challenge trial, pigs were from a single high health farm 
and genetic background, except for trials 5, 8 and 12, which each included pigs from one genetic 
background but two farms. All source farms were free of PRRS, Mycoplasma hyopneumoniae, 
and swine influenza. Animals were transported at weaning (average age of 21 days) to Kansas 
State University and randomly placed into pens of 10 to 15 pigs. After a 7-day acclimation 
period, pigs were experimentally infected, both intramuscularly and intranasally, with 10
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(TCID50) of either NVSL-97-7985, a highly virulent PRRSV isolate [11] for trials 1-8 and 15; or 
with KS-2006-72109, a more contemporary PRRSV isolate, for trials 10-14. NVSL and KS06 
are 89% similar at the GP5 nucleotide sequence level [12]. Blood samples were collected at −6, 
0, 4, 7, 11, 14, 21, 28, 35, and 42 days post-infection (dpi). Body weight was measured at 0, 7, 
14, 21, 28, 35, and 42 dpi. Pigs were euthanized at 42 dpi. Trials 7 and 8 were stopped at 35 dpi 
due to facility unavailability.  
Serum viraemia was measured using a semi-quantitative TaqMan PCR assay for PRRSV RNA, 
as described in Boddicker et al. [5-7] and Ladinig et al. (2015). Assay results were reported as 
the log10 of PRRSV RNA copies per mL of serum. A time course of viraemia levels for each 
animal within a trial was plotted in order to provide an initial assessment of the response to 
infection and to confirm all animals were initially infected (Supplemental Figure 1). Trial 13 was 
excluded from further analysis due to unusual viraemia profiles not observed in any other PHGC 
infection trial: some trial 13 animals showed delayed presence of serum viraemia, and all 
individuals had low, noisy viraemia levels compared to individuals in other trials, suggesting the 
virus was attenuated or the pigs were not naïve. If the pigs were not naïve it could be due to the 
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presence of maternal antibodies as a result of previous infection or vaccination in the herd from 
which they were sourced [13]. 
Ear tissue was collected from all pigs for DNA isolation. Tissues or DNA samples for trials 1-10 
were genotyped with Illumina’s Porcine SNP60 Beadchip v1 (San Diego, California) at 
GeneSeek Inc. (Lincoln, Nebraska) and samples from trials 11-15 were genotyped with 
Illumina’s Porcine SNP60 Beadchip v2 (San Diego, California) at Delta Genomics (Edmonton, 
Alberta). Only SNPs that were included on both versions of the Illumina’s Porcine SNP60 
Beadchip were used in this study. SNPs were removed if they were fixed within a breed, or if 
they were unmapped or mapped to a sex chromosome in build 10.2 of the swine genome 
(http://www.ncbi.nlm.nih.gov/genome/guide/pig/, accessed August 13, 2015); this left 48,164 
SNPs. Missing genotypes were assigned the average genotype (on 0,1,2 scale) for animals in that 
trial for that SNP. This set of SNPs will be referred to as 60k SNPs. 
Across all nine trials infected with NVSL, 12% of pigs died or were euthanized for humane 
reasons before 42 dpi. Mortality rate was similar in the KS06 trials, with 9% pigs dying or 
euthanized before 42 dpi across the five trials. Dead pigs were necropsied and subsequent gross 
and microscopic pathology by a board-certified pathologist identified PRRS associated disease 
as the major source of mortality, except for trial 6. Death loss was high in trial 6 (46% by day 
42), due to secondary bacterial infections, as identified by pathology, including Escherichia coli, 
Streptococcus suis, Staphylococcus aureus, and Mycoplasma hyopneumoniae. 
Modelling viraemia profiles with the Wood’s function  
The Wood’s curve, an incomplete gamma function often used to model lactation yield in dairy 
cattle [14-16], was shown to appropriately model viraemia profiles in PHGC trials 1-8 [10].  
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V(t) =  a1t
b1e−c1t 
where V(t) is serum viraemia on the log10 scale at time t dpi, a1 impacts the magnitude of all 
points on the curve, b1 is an indicator of the initial rate of increase to peak viraemia, 𝑐1 is an 
indicator of the rate of decline after the peak and dominates the viraemia profile at the later 
stages of infection. The three function parameters were estimated for each individual that had at 
least five time points measured using Bayesian inference with a likelihood framework, 
implemented using a Markov chain Monte Carlo method [10].  
The raw viraemia profiles of some pigs appeared bi-modal, so an extended Wood’s curve was 
also fitted for each piglet using the same methodology above: 
V(t) =  a1t
b1e−c1t + max(0, a2(t − t0)
b2e−c2(t−t0)) 
whereby t0 denotes the onset of the second phase of the profile, which is assumed to follow the 
same Wood’s shape as the primary phase and is thus defined by a second set of Wood’s model 
parameters. A piglet was classified as experiencing viraemia rebound based on the Akaike’s 
Information Criterion (AIC) if AICWOOD’S-AICEXTENDEDWOOD’S was greater than 1.488, 
corresponding to the 95% significance level of the likelihood ratio test between these models 
[10]. A total of 16% of NVSL pigs and 6% of KS06 pigs were classified as rebound pigs.  
Using the piglet specific curve parameters estimates, a1̂, b1̂, and c1̂, a fitted viraemia value can be 
estimated for each piglet for each time point (V(t)̂ ). 
Viraemia curve characteristics 
In previous studies, Boddicker et al. [5-7] used area under the viraemia curve (AUC) or viral 
load (VL) from 0-21 dpi as a measurement of response to PRRSV infection. Area under the 
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curve is a summary phenotype of the viral burden but it does not explicitly capture the dynamics 
of an individual animal’s curve that can influence this viral burden; two animals that have 
different viraemia curves can have the same VL. Analysis of different aspects of the viraemia 
curve may aid in the understanding of differences in virulence in the two virus isolates, as well as 
insight into the role host genetics plays in response to infection [10]. The genetic mechanisms for 
one curve characteristic may be highly conserved across isolates, while highly variable across 
isolates for another curve characteristic.  
Five curve characteristics were derived to describe individual viraemia profiles using the 
estimates of the curve parameters (a1̂, b1̂, c1̂) of the single or the extended Wood’s curve. The 
primary phase was chosen for this study because this phase has previously been shown to have a 
heritable genetic component, while heritability for rebound was previously estimated to be 0.03, 
suggesting that this phase is largely governed either by viral escape or other environmental 
factors [10]. 
The first characteristic evaluated, area under the Wood’s curve, hereafter referred to as viral load 
(VL), was given by the definite integral: 





VL is a measure of both the level of viraemia and the extent to which viraemia is maintained. 
The range 0-21 dpi were chosen to capture the uni-modal phase of infection common to all pigs. 
Previous analyses on trials 1-8 fitted a Loess curve through viraemia and integrated to get area 
under the curve from 0-21 dpi [5-7], which will be denoted by VLB. It was unknown how similar 
VLB and VL were to each other, which may impact the interpretation of the results and 
comparisons that are drawn between this study and previous studies. Therefore, the pedigree 
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relationship matrix was constructed in ASReml 3.0 [17] for all animals used in the analysis. 
Pedigree information was available for all pigs in all trials. Trials 1-3 had the most extensive 
pedigree information, with records up to two generations back, while the rest of the trials only 
had sire and dam recorded. As such, there were no relationships between animals in different 
trials, except for trials 1-3 which consisted of animals from the same breeding company in 
consecutive parities. Pedigree was corrected using parental genotypes for trials 1 through 8, as 
described by Boddicker et al. [7]. The 1250 highest quality 60k SNPs, based on GC score and 
call rate, were used in Cervus 3.0 [18] to verify pedigree information for trials 11 and 15, and 
assign sire for trials 12 and 13, because pooled semen was used in these two trials. Parental 
genotypes were unavailable for trials 10 and 14. A bivariate model using pedigree information 
for VL and VLB was fitted separately for the KS06 and NVSL trials, using ASReml 3.0. It was 
concluded that VL based on the Wood’s curve describes the same biological trait as VLB due to 
similar heritabilities and high genetic and phenotypic correlations (Table 2); therefore VL 
derived based on the Wood’s curve was used for all remaining analyses. 
The second curve characteristic evaluated was time to peak viraemia (TP), derived by setting the 





The third curve characteristic was peak viraemia (PV), which was calculated by setting t = TP in 
the Wood’s equation: 








TP and PV are related to the host’s ability to respond during the replication-dominant phase of 
early PRRSV infection [19]. PV is reached when the rate of virus clearance from serum is equal 
to the number of virus particles released into the blood stream. TP is the time it takes to reach 
PV, with animals that can mount a response early in infection expected to have a shorter TP. 
Curve characteristics that relate to the host’s response to the post-peak, clearance-dominant 
phase of PRRSV infection were also evaluated. The maximal decay rate (Vmax) is reached when 
the rate of viral clearance from serum is highest compared to the rate of viral replication. Time to 
maximal decay (Tmax) was derived by setting the second derivative of the Wood’s equation to 





Plugging this value in for t in the first derivative and taking the absolute value gave Vmax: 







Vmax was defined as the absolute value of the first derivative for ease of interpretation, whereby 
an animal with a larger Vmax cleared viraemia from the serum more quickly. 
Fitting Daily Weights 
Raw weights were collected weekly and used to interpolate daily weights. In ASReml, a random 
regression model was fitted to each individual’s weight data using second order Legendre 
polynomials in the following model: 
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W(t) = ∑ Ln(t)
2
n=0
+ P + A + S + ∑ Ln(t)
2
n=0
∗ R + ∑ Ln(t)
2
n=0
∗ An + Tr +  Pen(Tr) + ε 
where Ln(t) denotes the nth order Legendre polynomial at t dpi. Ln(t), P, A, S and Ln(t)*R were 
fitted as fixed effects. Ln(t) was fitted as a covariate, whereby t ranged from 0-42 dpi, P was the 
parity of dam, classified as first, second, or later parities, A was the age of the individual at 
inoculation, S was the sex of the individual and Ln(t)*R was the interaction between the nth 
order Legendre polynomial at t dpi and rebound status. This model was fitted separately for 
animals infected with NVSL and KS06. Ln(t)*An, Tr, and Pen(Tr) were included as random 
effects and denoted the interaction between the nth order Legendre polynomial at t dpi and 
Animal, trial and the interaction between trial and pen, respectively. Ln(t)*An modeled an 
individual’s weight at each time point, and captured both genetic and permanent environmental 
effects, and used an unstructured variance-covariance structure. Residual variances were 
modeled separately for each t dpi, in order to allow for an increase in variance over time. Trial 
and Trial*Pen were included to capture environmental effects. This model was then used to 
obtain fitted values of each pig’s weight for each dpi (0-42) (W(t)̂), using all coefficients 
estimated from the above model. 
Genomic Relationship Matrices 
Due to the limited pedigree information and availability of genotypes on almost all animals, a 
genomic relationship matrix (G-matrix) among all animals was constructed from the 60k SNP 
genotype data, using the VanRaden method [20]. The G-matrix (G) included relationships 
between animals in different trials. In some cases, fitting relationships between breeds can 
absorb between-breed differences that could be due to selection, this can overestimate the genetic 
variance because the “base population” is the population from which the breeds subsequently 
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diverged [21]. A block diagonal G-matrix was also constructed (GB-matrix) that only took 
relationships between animals from the same genetic background into account, with zero 
relationships between animals from different companies. Results from analyses with the GB-
matrix are expected to be similar to what would be found from a pedigree-based analysis of these 
data if the pedigree was more extensive. A third G-matrix was constructed that was the block 
diagonal matrix GB but only consisted of animals from trials that were paired across isolates (GP-
matrix), to assess whether the estimated correlations between NVSL and KS06 could be biased 
due to different breed crosses being evaluated for each isolate. In order to further assess the 
impact of the WUR region on each trait, the G, GB and GP-matrices were also constructed 
excluding the 118 SNPs in the 5Mb region surrounding the WUR SNP previously identified to 
be associated with VL and WG in pigs infected with the NVSL PRRSV isolate [5-7]; these new 
matrices are designated G-W, GB-W and GP-W, respectively and were used to estimate the genetic 
correlation between NVSL and KS06 of response traits for the rest of the genome. 
Statistical Models  
All analyses were conducted using an animal model in ASReml 3.0 [17]. The model was:  
Y = μ + P + A + W + S + R + An + Li + Tr +  Pen(Tr) + error? 
Y is the dependent variable of daily fitted viraemia values, weekly weights, VL, TP, PV, Tmax, 
Vmax, weight gain from 0-42 dpi (WG). Parity of the dam (P), classified as first, second, or later 
parity, and sex of the piglet (S) were fitted as a fixed class effects. To account for potential 
model differences in curve fittings between rebound and non-rebound pigs, a fixed class effect of 
rebound (R) was included in the model. Age (A) and weight (W) of the piglet at infection were 
fitted as linear covariates. Random effects included animal genetic effects (An; using the full G-
matrix), litter (Li), trial (Tr), and Pen nested within trial (Pen(Tr)). 
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Comparison of NVSL and KS06 Viraemia Profiles and Pig Weight Gain during Infection  
Data from paired trials (Table 1) and the full G-matrix were used to estimate daily fitted viraemia 
values, weekly weights, VL, TP, PV, Tmax, Vmax or WG for each isolate by including isolate as 
a fixed class effect into the above model. Phenotypic differences between virus isolates were 
assessed using the t-statistic reported by ASReml 3.0, with a significance cutoff of α=0.05. 
Within Isolate Genetic Parameters 
Within-isolate heritabilities, and phenotypic and genetic correlations were estimated for VL, 
WG, TP, PV, Tmax or Vmax using the full G-matrix in order to quantify the relationships 
between the response traits. Heritabilities and litter effects were estimated using a univariate 
model. A multivariate model using all traits was attempted for genetic and phenotypic 
correlations between traits but this model did not achieve convergence, so bivariate models were 
used to get phenotypic and genetic correlations between traits. Estimates of correlations were 
considered statistically significant based on a t-test with 1496 degrees of freedom for NVSL and 
670 degrees of freedom for KS06. 
The genetic correlation between viraemia and weight gain was expected to change throughout 
the experiment due to different host genetic control of these traits during different phases of 
infection. To assess how the relationship between viraemia and weight gain change over time, 
the genetic correlation between the fitted viraemia values (V(t)̂ ) and three-day weight gains from 
the fitted weight values (W(t)̂) were estimated. Correlations between (V(t)̂ ) at every other dpi 
(i.e. 1, 3, 5, …, 41) and three-day weight gain at 42 dpi were estimated by replacing W in the 
above model with the weight 3 dpi prior (with the exception of weight at 1 dpi, which was 
adjusted for weight at infection). Viraemia at each time point was adjusted for weight at 0 dpi. 
Correlations between these weight gains (WG) and viraemia were also assessed every other day 
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(i.e. WG0-1,WG0-3, WG2-5…WG38-41). These correlations were calculated for NVSL and 
KS06 separately. This resulted in two 21x21 matrices of genetic correlations between viraemia 
and three-day weight gain, which was visualized in a heat map (Figure 4). 
Associations of WUR Genotypes with response to NVSL and KS06 Infection 
The association of the WUR genotype with VL, WG, TP, PV, Tmax and Vmax were estimated 
for infection with NVSL and KS06 by including the interaction of isolate with WUR genotype 
into the above model, with the full G-matrix representing the relationship between animals. This 
model was also fitted to daily fitted viraemia values and weekly weights to generate viraemia 
and weight curves for each isolate by WUR genotype combination. Statistical differences 
between each isolate by WUR combination were assessed using the t-statistic reported in 
ASReml and the residual degrees of freedom from the model, with a significance cutoff of 
α=0.05. 
Genetic Parameters of Response between Isolates 
The G-matrices described above were used to estimate genetic correlations between virus 
isolates for VL, WG, TP, PV, Tmax or Vmax using a bivariate model. Genetic correlations were 
considered statistically significant using a t-test with 2168 degrees of freedom when using G, G-
W, GB and GB-W, and 1378 degrees of freedom when using only paired trials (GP and GP-W). 
RESULTS 
Comparison of NVSL and KS06 Viraemia Profiles and Pig Weight Gain during Infection  
Raw viraemia profiles suggested differences in pig response to infection with the NVSL versus 
the KS06 PRRSV isolate (Figure S1). To statistically quantify these differences, a selection of 
curve characteristics were derived from the Wood’s function parameters and compared between 
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isolates using data from trials that were paired by genetic background to remove confounding 
between isolate and genetic background (Table 1). Pigs infected with NVSL had 16±2% higher 
VL than pigs infected with KS06 (Table 3, Figure 1). Both TP and PV are related to the host’s 
ability to respond during the replication-dominant phase of PRRSV infection. Pigs infected with 
NVSL had 14±2% higher PV and reached PV 2.5±0.6 days earlier than pigs infected with KS06 
(Table 3, Figure 1). Tmax and Vmax are related to the host’s ability to clear PRRSV. Compared 
to pigs infected with KS06, NVSL infected animals reached maximal PRRSV clearance 3.9±0.7 
days earlier and cleared at a 36±14% faster maximal rate than their KS06 counterparts (Table 3, 
Figure 1). When comparing the impact that infection had on weight gain, pigs infected with the 
NVSL isolate had a tendency to grow more slowly than their KS06 counterparts (Table 3, Figure 
1). Taken together, these results indicate that NVSL is more virulent than KS06 because it 
reached a higher PV more rapidly and resulted in higher overall VL and lower growth rate. KS06 
appears to be more persistent than NVSL as shown by a longer time to maximal decay rate, 
lower maximal decay, and a larger percentage of pigs classified as persistently infected, defined 
as a non-rebound pig with a fitted log10 serum viraemia value greater than 1 at 42 dpi (56% in 
KS06 vs 40% in NVSL). 
Heritability Estimates 
Heritability estimates were similar between NVSL and KS06 for WG, TP, and Tmax. These 
traits also had similar estimates of the litter components between NVSL and KS06. VL, PV, and 
Vmax all had lower heritabilities and larger litter components in NVSL compared to KS06. 
Summing the heritability and litter components for each of VL and PV gave similar results in 
each isolate even though the heritabilities were quite different between isolates (Table 3). The 
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larger number of animals infected with the NVSL isolate compared to KS06 may mean the 
heritability and litter component are more accurately separated by the model. 
All traits were estimated to be moderately to highly heritable except for Vmax under infection 
with NVSL. The traits with the highest estimated heritability under infection with NVSL were 
VL and WG and these traits also had high heritability estimates under infection with KS06. 
Vmax had the lowest estimated heritability under infection with NVSL, but a moderate 
heritability under infection with KS06 (Table 3). The estimated genetic variance of Vmax is 
similar under infection with NVSL or KS06 (0.00053 vs. 0.00072) so the difference in 
heritability is driven by a larger estimated environmental variance under infection with NVSL 
compared to KS06 (0.0057 vs. 0.0027). 
Estimates of heritability of VL and WG during NVSL infection were similar to previously 
reported estimates (VL: 0.31±0.06 vs 0.44±0.13; WG: 0.33±0.06 vs 0.29±0.11) (Table 3; [7]. 
The differences between the estimates can be attributed to the use of the G-matrix rather than the 
A-matrix, the inclusion of trial 15, and the inclusion of age and weight at infection in the model 
used in this study but not in the Boddicker et al. (2014b). Age and weight at infection are 
important to include in the analysis because pigs that are older or heavier at infection tend to be 
able to mount a stronger immune response, independent of the host’s genetic ability to combat 
the virus [22,23]. The use of the G-matrix halved the standard errors of estimates compared to 
using the A-matrix because the G matrix more accurately captures the true relationship between 
animals, especially because there was limited pedigree information available on the pigs used in 
these trials. 
Viral Load and Weight Gain 
199 
 
The genetic and phenotypic correlations between VL and WG were negative and of similar 
magnitude across isolates (Tables 4 & 5). The genetic correlation estimate was more negative for 
the NVSL infected pigs than previously reported (rg: -0.74±0.10 vs -0.46±0.20; rp: -0.33±0.03 vs 
-0.29±0.03) [5-7] which can be attributed to the combination of using the G-matrix rather than 
the A-matrix, the addition of trial 15, and the inclusion of age and weight at infection. Strong 
genetic correlations between VL and WG suggest that there may be common genes or pathways 
that affect these two traits. WUR is a SNP that has been shown to be associated with both VL 
and WG in pigs infected with NVSL [5-7]. The genetic correlations between isolate for VL and 
WG are strong and not significantly different from one (Table 6), indicating that the host genetic 
control of VL and WG is very similar under infection with either the NVSL or KS06 isolate. 
Viral Load and Viraemia Curve Characteristics 
VL, defined as area under the Wood’s curve from 0-21 dpi, was largely driven by PV as shown 
by the high genetic and phenotypic correlations between these two traits within isolate (Tables 4 
& 5). PV had the highest genetic correlation between PRRSV isolates, suggesting that the 
correlation for VL is primarily due to their genetic correlation for PV, as no other curve 
characteristic had a between virus isolate genetic correlation estimate that was significantly 
different from zero while the genetic correlation between virus isolates for PV was not 
significantly different from one (Table 6). 
Tmax and Vmax had strong negative correlations with each other for both isolates; however, 
they were only highly correlated with VL for NVSL (Tables 4 & 5). Time to maximal decay rate 
(Tmax) was approximately 19.3 dpi for KS06 but at 15.4 dpi for NVSL (Table 3), therefore 
Vmax is expected to play a bigger role in VL for NVSL than for KS06, because VL was 
calculated from 0-21 dpi in this study. No conclusions can be drawn about the genetic 
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correlations between isolate for either Tmax or Vmax because the estimates are not significantly 
different from zero or one due to large standard errors (Table 6). 
The two time-related traits (TP and Tmax) had strong, positive genetic and phenotypic 
correlations in both isolates (Tables 4 & 5) because TP (
b
c




). The genetic correlation between isolates for TP was significantly different to one 
(Table 6), indicating that host genetic control of the time until maximal virus decay rate may 
differ between virus isolates. 
Weight Gain and Viraemia Curve Characteristics 
PV had a moderate negative genetic correlation with WG for NVSL (Table 4) infected pigs but 
this genetic correlation was not significantly different from zero for KS06 infected pigs (Table 
5), due to a larger standard error and a less negative estimate. Vmax also had a significant 
genetic correlation with WG. These results suggest that the reduction in growth is caused by an 
overall high viraemia level over a prolonged period of time, which is further supported by the 
highest observed genetic and phenotypic correlations being between WG and VL (Tables 4 & 5). 
Genetic Correlations between VL and WG across Time 
A more thorough exploration of the relationship between PRRS viraemia and weight gain was 
accomplished through the estimation of genetic correlations between fitted viraemia and three-
day weight gain values (Figure 4). In animals infected with NVSL, animals that had high 
viraemia from 0-7dpi tended to have high WG later on in the trial but low WG early on. During 
the early stages of infection, pigs with high viraemia may need to allocate more energy to 
fighting the infection than growing, resulting in a negative genetic correlation between early 
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viraemia and early weight gain. It appears that under infection with NVSL, pigs that have higher 
viraemia and lower weight gain early in infection may reap the benefits later in infection with 
higher weight gain. Therefore, animals with higher early viraemia divert more resources to 
fighting infection early on, which pays off in the long run with higher weight gain at the end of 
the trial. This notion is supported by the weaker genetic correlations between early viraemia and 
weight gain under infection with the less virulent isolate, KS06 (Figure 4B), which has lower 
pre-peak viraemia (Figure 1). It is also likely that pigs with high early viraemia also suffer a loss 
in appetite [24], which may further reduce weight gain in these animals. The positive correlation 
between early viraemia and late weight gain could reflect a return to homeostasis after infection 
in these pigs [25]. 
While the relationship between weight gain and early viraemia may differ between isolates, the 
ability of the animal to effectively clear the virus from serum is crucial for maintaining growth. 
This is made evident by a block of highly negative correlations between viraemia 15-28 dpi and 
from 22 dpi onward in pigs infected with NVSL. The time period 15-28 dpi corresponds to the 
time in which pigs are clearing PRRSV from serum the most rapidly. There also appears to be a 
relationship between viraemia after 28 dpi and later weight gain, in particular viraemia at 33 dpi. 
This negative correlation is likely observed due to rebound pigs, as this time point corresponds 
with the average time that rebound pigs reach a secondary peak viraemia.  
Similar to NVSL, KS06 infected pigs showed strong negative correlations between viraemia and 
weight gain that corresponded to viral clearance. In KS06 infected pigs, this critical period 
seemed to be viraemia after 17-28 dpi and weight gain after 17 dpi. This time period corresponds 
to the time in which antibodies, specifically IgG, are being produced at the highest rates, 
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suggesting that the ability to clear the virus effectively may be dependent on the pig’s ability to 
mount a successful adaptive immune response [26].  
These genetic correlations provide insight into how host genetic control of Viraemia and WG 
changes throughout the trial. In order to further elucidate the host genetic mechanisms that are in 
common between viraemia and weight gain, it would be beneficial to conduct a genome wide 
association study of these traits at different time points to reveal which regions of the genome 
have an effect at each stage. This has the potential to identify further loci that would improve 
host response to PRRSV infection across isolates if selected upon. 
Associations of WUR Genotypes under NVSL and KS06 Infection 
The least square means of the WUR genotype were estimated by fitting the interaction between 
isolate and WUR genotype for all trials simultaneously. There were very few pigs with the BB 
genotype at the WUR locus, and therefore estimates of the least square means for the BB 
genotype had high standard errors. Furthermore, BB animals were not significantly different 
from AB animals while significantly differing from AA animals, when AA and AB animals were 
significantly different, suggesting complete dominance, as previously reported by Boddicker et 
al. (2012, 2014a, 2014b). Results for BB animals will not be discussed further for these two 
reasons. 
Pigs with the AA WUR genotype had 4.5±0.4% higher VL (P<0.001) and grew 2.0±0.2 kg less 
than pigs with the AB genotype after infection with NVSL (P<0.001). These estimates are 
consistent with previous estimates of the association of WUR under infection with NVSL 
(Boddicker et al. 2014b). WUR genotype was also found to be associated with VL under 
infection with KS06, whereby VL was 4.2±0.9% higher in AA animals than AB animals 
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(P<0.001). In contrast to infection with NVSL, no association was found between WUR 
genotype and WG (P=0.32).  
The WUR genotype was associated with all curve characteristics in pigs infected with NVSL 
(Figure 2). Compared to AA animals, AB animals had 2.8±0.4% lower PV (P<0.001), which was 
reached 0.20±0.09 days earlier (P<0.02); AB animals also had a 3.8±1.5% faster maximal decay 
rate (P<0.02) which was reached 0.68±0.16 days sooner (P<0.001). In KS06 trials, WUR was 
associated with 3.4±0.7% higher PV in AA animals compared to AB animals (P<0.001) but no 
association was found for Vmax (P=0.36) (Figure 2). Compared to AA animals, AB animals 
tended to reach peak viraemia 0.30±0.16 (P=0.052) days sooner and maximal decay rate 
0.47±0.29 (P=0.078) days later.  
Plotting viraemia and weight curves for AA and AB WUR genotype pigs, by isolate (Figure 3), 
provided results that were consistent with regards to the estimated effects of WUR on WG, VL, 
and the curve characteristics. For KS06, the effect of WUR on VL was mainly driven by 
differences in PV but the difference in viraemia level between AA and AB was not maintained 
due to a slightly lower rate of clearance in AB compared to AA animals, resulting in similar 
viraemia levels at the end of the trial (42 dpi). Conversely, for NVSL, the difference in viraemia 
levels between AA and AB animals first appeared around peak viraemia and became larger 
during the primary stages of infection due to a faster clearance rate for AB animals.   
The effect of WUR genotype was significantly different between the NVSL and KS06 isolates 
for both WG (P=0.001) and Vmax (P=0.041) (Figure 2). These effects were observed due to 
large effects of WUR genotype on WG and Vmax in the NVSL trials that were not detected in 
the KS06 trials. The effect of WUR genotype on Vmax after infection with KS06, though not 
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significantly different from zero, was in the opposite direction to the WUR genotype effect after 
infection with NVSL (Figure 2).  
The WUR genotype had an effect on all shape characteristics of the Wood’s viraemia curve for 
NVSL, which contributed to the large effect observed for VL in the NVSL trials (Figure 2). In 
general, the WUR genotype had a lower association with response to infection in pigs infected 
with KS06 than pigs infected with NVSL; suggesting that the magnitude of the effect of the QTL 
in high LD with WUR may be dependent on the virulence of the PRRSV isolate. 
Impact of the WUR Region on Heritabilities and Genetic Correlations 
Heritabilities of response traits were estimated including all SNPs in the full G-matrix (Table 6) 
and also including all SNPs except the 5Mb region surrounding the WUR locus (G-W; Table 7). 
In the NVSL trials, estimated heritabilities were lower for all traits when the G-W-matrix was 
used, except Vmax, which remained the same. Estimated heritabilities for WG and Tmax were 
the same whether the G-matrix or G-W-matrix was used, while the estimated heritabilities for all 
other traits dropped when the G-W-matrix was used, with the largest drops in PV and VL. 
Genetic correlations between isolates were also estimated for the response traits using both the 
full G-matrix (Table 6) and the G-W-matrix (Table 7). The estimated genetic correlations between 
isolates for WG and Vmax were slightly higher when using the G-W-matrix compared to the full 
G-matrix, while the estimated genetic correlations between isolates for all other response traits 
decreases, with the largest decreases in PV and VL. 
Genetic correlation estimates for VL, WG and PV were significantly different from zero and not 
significantly different from one when using both the full G-matrix and the G-W-matrix. This 
indicates that host genetic control of response to infection is highly conserved across isolate for 
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these three traits. The high genetic correlation estimates for these traits when using the G-W-
matrix indicate the conserved host genetic response between isolate for VL and PV is not solely 
dependent on WUR genotype, but likely has a large polygenic component. The increase in 
genetic correlation between isolates for WG when using the G-W-matrix compared to the full G-
matrix is consistent with the observed effect of WUR in pigs infected with NVSL but lack of 
effect in pigs infected with KS06. Estimated genetic correlations between isolates for Tmax and 
Vmax have large standard errors when using both the full G-matrix and G-W-matrix, therefore no 
conclusions can be drawn because these estimates are not significantly different from zero or 
one. Estimated genetic correlations for TP were significantly different from one but not 
significantly different from zero for both the full G-matrix and G-W-matrix, indicating that host 
genetic control of TP is not highly conserved across isolate. 
Genetic Parameter Estimates Using Different G Matrices 
Three different types of G matrices were constructed for both the full G-matrix and the G-W-
matrix that were based on different types of information. The GB matrix only contained the 
relationships between animals from the same genetic background, with zeros for the 
relationships between animals of different backgrounds. The full G-matrix contains information 
about both the within-genetic background and between-genetic background genetic variance 
when calculating the heritabilities and genetic correlations for the response traits, while the GB-
matrix only contains information about the within-genetic background genetic variance. The GB-
matrix is more similar to the A-matrix than the G-matrix is, because there is usually no pedigree 
information between animals from different genetic backgrounds so the relationship between 
animals from different genetic backgrounds is zero. The GP-matrix is a block diagonal matrix 
using only pigs from the same genetic background that were paired across isolates and was used 
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to avoid biases in estimates that were due to including different breeds in the analyses for each 
isolate. In general, the estimates using the GP-matrix were consistent with estimates using the 
GB-matrix. 
Estimates of genetic correlation between isolates for PV are very similar for the full G-matrix 
and GB-matrix (Table 6), indicating that host genetic control of PV is conserved across genetic 
backgrounds. The genetic correlation between isolates for WG was slightly higher using the GB-
matrix compared to the full G-matrix (Table 6), suggesting that pigs from the same genetic 
background have similar host genetic control of WG during infection with NVSL and KS06 and 
there are some differences in host genetic control of WG between genetic backgrounds. 
The genetic correlation estimate for VL dropped substantially when the GB-matrix is used, 
compared to the full G-matrix (Table 6); this suggests that while the genetic correlation between 
isolates for VL may be moderate within genetic backgrounds, some genetic backgrounds have 
high VL under infection with both NVSL and KS06 while some genetic backgrounds have low 
VL under infection with both NVSL and KS06, so when the relationships between genetic 
backgrounds are considered (using the full G-matrix), the genetic correlation between isolates for 
VL is high. This suggests that as a whole, selecting for improved VL during infection with one 
PRRSV isolate is likely to improve VL during infection with another PRRSV isolate, but the 
extent to which selection is successful across-isolate is likely to vary based on genetic 
background. 
The estimate of genetic correlation between isolates for TP increased when the GB-matrix was 
used rather than the full G-matrix (Table 6), such that the estimate from the GB-matrix was no 
longer significantly different from one, but still not significantly different from zero, as with the 
estimate using the full G-matrix. Genetic correlation estimates between isolate for Tmax and 
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Vmax remain not significantly different from zero or one when using the GB-matrix compared to 
the full G-matrix (Table 6).  
The GB and GP-matrices were also constructed without the 5Mb WUR region (GB-W and GP-W, 
respectively) and these results were as expected based on the differences between the full G-
matrix and G-W-matrix, and also the GB and GP matrices compared to the full G-matrix (Tables 6 
& 7). 
DISCUSSION 
Our results suggest that KS06 is a less virulent PRRSV isolate than NVSL, but, importantly, that 
genomic selection will be effective for selection for improved weight gain and reduced viral load 
under either PRRSV infection. This study affirms the important influence of alleles at the genetic 
marker WUR10000125 on host response to PRRSV. The effect of genotype at this locus was 
consistent between isolates for traits associated with serum viraemia, but a significant impact 
was only observed in NVSL for weight gain, suggesting that the influence of this marker on 
weight gain may be dependent on the virulence of the PRRSV isolate.    
Modelling Viraemia using the Wood’s Curve 
Advantages 
This study has demonstrated the utility of mathematical functions to assess the impact of host 
genetics and virus isolate on PRRS viraemia kinetics. The Wood’s curve uses three parameters, 
a, b, and c, which are related to the magnitude of the values (a), and describe the shape of the 
curve (b, which is dominant pre-peak, and c, which is dominant post-peak) [14]. While other 
mathematical functions may more adequately model PRRS viraemia during infection, the 
number of data points collected during these trials limited the ability to fit more complex models. 
Fitting a Wood’s curve is a more powerful method for comparing viraemia kinetics than the 
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Loess smoothed fit used in previous analyses of these data [5-7]. The Loess smoothed fit uses a 
parameter indicating the degree of polynomial to fit to the data and a smoothing parameter for 
curve fitting [27], with the primary intent of filtering out the noise from the data. The limitation, 
however, is that this method doesn’t lend itself to extract fitted parameters that specify particular 
physical properties of a system, which have important implications in understanding the 
dynamics of PRRSV infection. Although both methods adequately fitted the data, Wood’s curve 
parameters describe both the magnitude and shape of the curve, which can be used to explore 
different characteristics of the viraemia curves. Exploring Wood’s curve characteristics can 
provide insight into important biological questions, such as which aspects of host response are 
under strongest genetic control, and how selection for one curve characteristic may affect others 
and thus the entire profile. It may also be used to explore the relationship between curve 
characteristics and other interesting phenotypes, such as WG under infection. Fitting a Wood’s 
curve provided the necessary parameters to explore different aspects of the PRRS viraemia 
curves while not over-parameterizing the data. Furthermore, comparison of the extended Wood’s 
and Wood’s curve functions allowed for an objective method for separating primary infection 
from rebound infection viraemia curves (Islam et al. 2013). 
Limitations 
While the advantages of fitting a Wood’s curve to model the dynamics of PRRS viraemia are 
clear, care needs to be taken in the interpretation of the correlations between curve characteristics 
because strong correlations between these curve characteristics are likely to arise partly as an 
artifact of the Wood’s function and partly as they reflect true correlations between curve 
characteristics that are independent of the Wood’s function. One example whereby the genetic 
correlation between traits is likely to be driven by the Wood’s function is the high genetic 
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correlation observed between Tmax and Vmax, because they rely heavily on the b parameter of 
the Wood’s function. 
The Impact of PRRSV Genetic Diversity on Host Response to PRRSV 
Infection 
Differences in Viraemia and Weight Gain during infection with NVSL and KS06 
PRRSV glycoprotein 5 (GP5) is a major envelope protein, that plays a vital role in the virion’s 
formation and infectivity, and harbors a major neutralizing epitope [28]. This gene is often used 
to assess genetic differences between PRRSV isolates and is suggestive of differences in 
virulence between isolates [29]. Variation in GP5 impacts the pig’s ability to produce 
neutralizing antibodies, which may not be protective against different isolates [29,30]. NVSL 
and KS06 were isolated from different geographic regions nearly ten years apart, and are 89% 
similar at the GP5 nucleotide sequence level. Molecular phylogeny clustered these viruses into 
two distinct branches [12]. Forsberg et al. [31] found that, on average, PRRSV isolates have a 
substitution rate of 0.073 per nucleotide across isolates at ORF5, while the maximum 
substitution rate between two isolates was 0.153 substitutions per nucleotide; NVSL and KS06 
have a substitution rate of 0.11 per nucleotide at the GP5 level [12]. 
This study has demonstrated that these virus isolates differ in both their virulence and in 
resulting viraemia profile characteristics. Infection with NVSL is characterized by reaching a 
high peak viraemia early, followed by a quick clearance of the virus, whereas the KS06 virus 
accumulates more slowly towards a lower peak viraemia and takes longer to clear from serum. 
Pig growth tended to be less stunted when pigs are infected with the KS06 isolate compared to 
the NVSL isolate (Table 3). This may be because piglets infected with the KS06 isolate do not 
need to put as much energy into eliminating the virus, thus allowing them to place more 
emphasis on growth. These results are consistent with the resource allocation theory, which 
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hypothesizes that trade-offs between competing traits (e.g. health and growth) are a consequence 
of limited resources (i.e. energy availability) [32]. The genetic correlations between viraemia and 
weight gain varied over time and tended to be more extreme in NVSL infected pigs than KS06 
infected pigs, suggesting that more energy is required to fight infection with NVSL (Figure 4), 
and is supported by the lower weight gain observed in NVSL infected pigs (Figure 1). 
Viral Rebound 
Rebound (i.e. a bi-modal viraemia profile) was observed more frequently when pigs were 
infected with the NVSL isolate than with the KS06 isolate. One explanation for this is the 
presence of quasispecies within a host. PRRSV has a very high mutation rate, estimated at 4.7-
9.8x10-2 nucleotides/year which was the highest reported for an RNA virus in 2010 [33]. This 
high mutation rate causes within-animal variation in the PRRSV genome [34], with each variant 
termed a quasispecies. Pigs infected with NVSL have higher viraemia than pigs infected with 
KS06 throughout most of the pre-rebound phase (Figure 1). This increased level of viraemia 
means that more replications, and therefore mutations, have occurred, so there is likely a greater 
number of quasispecies present in animals infected with NVSL than KS06. The greater the 
number of quasispecies, the greater the chance that a variant is able to escape host immune 
response and cause viral rebound [35]. NVSL could also have a greater number of quasispecies if 
the mutation rate is higher in NVSL than KS06. Animals in the same pen could also transfer 
quasispecies between each other, whereby a quasispecies from one pig could be transferred to 
another pig and cause reinfection and viral rebound [34]. 
Alternately, NVSL may avoid the host immune response, possibly escaping humoral immune 
response by localizing to certain tissues. Previous research has identified that the tonsils are a 
primary source of viral persistence [36,37]. This may be due to an abundance of memory B-cells 
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in the tonsil, but the lack of effector, plasma-producing, B-cells [38]. An abundance of PRRSV 
in tonsils may result in a cyclical reappearance of circulating virus. If the ability of the virus to 
localize to tissue to escape immune response differs between isolates, this will be reflected in the 
tonsil viraemia levels. Studies are underway to address this possibility.  
Impact of WUR10000125 on PRRS Disease Resistance 
Consistent with previous reports, WUR was significantly associated with VL during PRRSV 
infection, whereby animals carrying a B allele had lower VL [5-7]. The effect of WUR on VL 
appears to be primarily driven by the pig’s ability to control the level of virus replication, as 
made evident by the large effect the marker had on PV. This was the only curve characteristic 
that was significant for both NVSL and KS06 infected pigs (Figure 2), which is likely due to the 
role the putative gene plays in the host’s immune response. The putative gene responsible for the 
observed WUR effect has been identified to be GBP5. GBP5 showed allele specific expression 
based on WUR genotype, and animals that have the AA genotype do not produce functional 
GBP5 [8]. GBP5 plays a role in the innate immune response during infection. Specifically, 
NLRP3 interacts with tetrameric GBP5 to promote inflammasome assembly with apoptosis-
associated speck-like protein containing a caspase activation and recruitment domain protein [9]. 
While WUR genotype does appear to play a significant role in host response to PRRSV 
infection, there are a substantial polygenic effects on VL and PV. WUR genotype explained 13% 
of the total genetic variance for VL [5-7]. Consistent with this finding, accounting for WUR 
genotype did not account for all of the heritability, and the genetic correlation between isolates 
dropped, but still remained high and not significantly different from one (Table 7). 
Interestingly, an effect of WUR genotype on WG was not found in pigs infected with KS06. The 
difference in VL between isolates was greater than the difference in VL between AA and AB 
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genotypes, therefore individuals infected with KS06 with the AA genotype had lower VL than 
individuals infected with NVSL with the AB genotype. This may mean a lower amount of 
energy is needed to fight the virus during infection with the KS06 isolate of PRRSV, and weight 
gain is not as affected, as evidenced by the higher weight gain during infection observed when 
pigs were infected with KS06. Thus, the effect of WUR on WG may only be present during 
infections with more virulent isolates of PRRSV due to the increased severity of infection. 
Isolate-specific QTL have been identified in a number of infection (fungal, bacterial, and viral) 
studies in plants [39-41] and in a study on Dengue Virus in mosquitoes [42].  
It is likely that WUR affects the severity of infection, and its effect on WG is through the 
increased resources that have to be allocated to fighting the infection when viraemia is higher. 
The relationship between VL and reduction in WG is likely to be non-linear, which may explain 
why the direction of the WUR effect on WG is the same for both PRRSV isolates, but the 
magnitude of the effect differs. A high genetic correlation for WG between isolates was 
observed, despite the lack of a significant WUR effect for KS06 (Table 7). Given the number of 
genetic factors that can influence WG, it is likely that what is in common for WG between these 
two isolates are the polygenic effects, which would explain the high genetic correlation between 
isolates despite the lack of a QTL in the WUR region in the KS06 trails. The WUR region 
explained 9% of the total genetic variance for weight gain for the NVSL trials, while few other 
genomic regions explained greater than 1% of the total genetic variance [6]. 
Potential Avenues of Selection for Increased Resistance to PRRS 
Potential for Selection on WUR Genotype 
This study has shown that the WUR genotype has an effect on VL and PV (Figure 2A,D) across 
two distinct PRRSV isolates, indicating that selection for the B resistance allele may help with 
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reducing PRRS VL across isolates. Reducing viral burden has the potential to decrease the costs 
associated with PRRS through reducing PRRS incidence because a lower viral burden is 
associated with reduced virus shedding [43], which reduces the chance that PRRS will infect 
other pigs. Even though WUR did not have a significant effect on WG under infection with 
KS06, the direction of the effect was the same, therefore selection for the WUR B allele is likely 
to improve WG under infection with more virulent isolates of the virus, and is unlikely to have a 
negative effect on WG under less virulent isolates (Figure 2B). 
Selecting for WUR has the potential to reduce VL and PV across breeds and isolates, however 
the extent to which it can do this is limited by it being a single locus. As the B allele approaches 
fixation, selection for the WUR B allele will not have much of an effect on decreasing the VL 
under PRRSV infection in that population. VL and PV have large polygenic effects that are 
conserved across isolates and breeds and independent of WUR (Table 6 & 7), therefore genomic 
selection for VL or PV in combination with marker assisted selection on WUR may hold the 
highest potential for improved resistance to PRRS. 
Potential for Genomic Selection 
Genomic selection uses markers spaced throughout the whole genome to predict the genetic 
merit of an individual. All traits had a moderate-to-high heritable genetic component (Table 3), 
suggesting that genomic selection for different aspects of host response to PRRSV infection is 
feasible. There are high genetic correlations between VL, WG and PV in both isolates, except for 
PV and WG in KS06 (Tables 4 & 5), suggesting that genomic selection for one trait is likely to 
improve response in the other two. There are also high genetic correlations between isolates for 
VL, WG and PV (Table 6), suggesting that genomic selection for response under one isolate is 
likely to result in improvement across isolates. 
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A limitation of genomic selection is the size of the data that will need to be generated on a 
continual basis in order to ensure the accurate prediction of breeding values. Genomic 
predictions tend to be more accurate the more animals are in the training set. It has been shown 
that the greater the number of generations between the training and prediction sets, the lower the 
prediction accuracy [44], so periodic re-training on new phenotypes and genotypes will be 
necessary.  
Potential for Selection on Response to Vaccination 
While genomic selection for response to PRRSV sounds appealing, one issue is that in order to 
get accurate predictions, you need quality infection data on many animals. Information on 
naturally infected commercial pigs can feed back into the nucleus in order to make selection 
decisions based on the commercial pigs’ response. However there are several factors that cannot 
be controlled in a natural infection setting such as virus dosage, time since infection, and the age 
and weight of the pig at infection, with all of these having an effect on how the pig responds to 
infection.  
A major current PRRS vaccine is a modified live virus which has reduced virulence compared to 
commonly occurring wild type isolates [45], so vaccinated pigs will have circulating viraemia 
which can be measured as with infection with any natural PRRSV isolate. Measuring response to 
vaccination overcomes the limitations of natural infections because it is a controlled infection. 
Before this can be implemented in industry, it is necessary to evaluate the genetic correlation 
between response to vaccination and response to natural infection with a variety of isolates. 
Response to vaccination could be evaluated using PV, which has the benefit of needing only a 
single serum sample, rather than multiple samples throughout the course of infection as is needed 
for VL. Host genetic response to PV is expected to be highly conserved between isolates, both 
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within-breed and across the North American pig population (Table 6), and is highly correlated 
with VL under infection with both NVSL and KS06 (Tables 4 & 5). To be most effective, the 
timing of PV and correlation between PV and VL after vaccination will need to be evaluated. 
Conclusions 
Despite pronounced differences in viraemia profiles between NVSL and KS06, the underlying 
genetic factors influencing host response to infection are largely the same for VL, PV, and WG 
across these two PRRSV isolates. NVSL and KS06 are diverse isolates, therefore these results 
suggest that genomic selection for VL, PV, or WG during infection with one isolate would 
improve these traits when infected with another virus isolate. The WUR SNP, previously 
identified to be associated with VL and WG under infection with NVSL, was also found to be 
associated with all curve characteristics in NVSL trials; but only with VL and PV in KS06 trials, 
suggesting the effect of WUR may depend on the virulence of the PRRSV isolate. Infection trials 
involving more isolates of PRRSV are necessary to confirm that genetic factors influencing host 
response to PRRSV infection are consistent under infection with a range of PRRSV isolates. 
Analysis of the relationship between viraemia and weight gain via genome-wide association 
studies over the course of infection will allow for a more comprehensive understanding of the 
host genes and genomic regions associated with response to PRRSV infection. Studies currently 
underway as part of the PHGC include field trials, infection with a third PRRSV isolate, 





TABLES AND FIGURES 














1-3 507 LW x LR A 
4 191 Duroc x LW/LR B 
5 182 Duroc x LR/LW C 
6 109 LR x LR D 
7 186 Pietran x LW/LR E 
8 158 Duroc x LW/LR F 
15 166 Pietran x LW G 
KS-2006-72109 
10 184 Pietran x LW G 
11 177 LW x LR A 
12 146 LR x LW H 
13
3
 173 Duroc x LW/LR F 
14 165 Duroc x LR/LW C 
 
1. LW = Large White; LR = Landrace 
2. Genetic background is defined as pigs from the same breeding company and the same 
breed cross. 
3. Trial 13 was excluded from analyses due to unusual viraemia profiles as seen in Figure 
S1. 
 
Table 2. Comparison of Boddicker Viral Load and Wood’s Curve 0-21 dpi Viral Load 




























Figure 1. Comparison of Response to Selection when Pigs are infected with NVSL (red) or 
KS06 (blue) PRRSV isolates. For comparison between viruses, trials were matched based on genetic 
background. Least Square Means of daily viraemia, predicted using the monophasic Wood’s curve parameters, and 
weights were estimated using ASReml with the full G-matrix. Viraemia, Weight, Time to Peak, Peak Viraemia, 






































Days Post Infection 
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Time to Maximal 
 Decay Rate 
Maximal 






Table 3. Least Square Means, Heritabilities, Litter Effects, and Phenotypic Standard 































































































































1.) Full G-matrix used 
2.) Estimates were obtained by fitting isolate into the model, and only included trials paired with 
NVSL and KS06 
3.) Estimates were obtained by using the full G-matrix. NVSL and KS06 estimates were 













































































Phenotypic correlations (above diagonal), Genetic correlations (below diagonal) were estimated 
using an Animal model in ASReml. 









































































Phenotypic correlations (above diagonal), Genetic correlations (below diagonal) and 






Figure 2. Least Square Means of WUR genotype effects in pigs infected with either the 
NVSL or KS06 PRRSV isolate. Least Square Means of the WUR genotype for VL (A), WG42 
(B), TP (C), PV (D), Tmax (E), and Vmax (F) when fitting the Isolate*WUR interaction into the 
Animal model in ASReml using the full G-matrix. All trials, except trial 13, were used for the 
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Figure 3. Least Square Means of WUR genotype effects of predicted viraemia and weight 
in pigs infected with either the NVSL or KS06 PRRSV isolate. Least Square Means of the 
WUR genotype for predicted viraemia and weight for NVSL (A) and KS06 (B) when fitting the 
Isolate*WUR interaction into the Animal model in ASReml using the full G-matrix. All trials, 











































Days Post Infection 
Viremia NVSL AA Viremia NVSL AB




































Days Post Infection 
Viremia KS06 AA Viremia KS06 AB





Table 6. Genetic Correlations of Response to infection between PRRSV Isolates 
Trait 
Full (G) Block Diagonal (GB) 











NVSL KS06 NVSL KS06 NVSL KS06 
VL 













































































































Table 7. Genetic Correlations of Response to infection between PRRSV Isolates when 
Excluding the 5 Mb WUR Region from the G Matrix  
Trait 
Full (G-W) Block Diagonal (GB-W) 











NVSL KS06 NVSL KS06 NVSL KS06 
VL 
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Figure 4. Time course genetic correlation between viraemia and weight gain in pigs 
infected with either the (A) NVSL or (B) KS06 PRRSV isolate. Genetic correlations from 
fitting a bivariate animal model in ASReml using the full G-matrix. NVSL and KS06 were 
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